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We are developing a unique approach to the synthesis of macromolecules with programmable 
shape. These scaffolds are assembled from stereochemically pure orthogonally protected bis-
amino acids that are interconnected by two amide bonds. This ladder-like arrangement restricts 
the conformational flexibility of bis-amino acids to a large extent which in turn drastically 
reduces the number of allowed conformations for an oligomer. As a result, significantly lesser 
computing power is needed for the final three-dimensional structure prediction. Several 
stereochemically pure bis-amino acid monomers have been synthesized by our research group 
and incorporated into a number of homo- and hetero-oligomers. 
In this dissertation we present the synthesis of a new pipecolic acid based bis-amino acid 
building block pip5(2S5S). Assembly of this monomer into a short spiroladder oligomer utilizing 
solid-phase synthesis followed by in situ activation by dicyclohexylcarbodiimide and N-
hydroxysuccinimide has been demonstrated. The structure of the oligomer was determined in 
aqueous solution using two-dimensional NMR.  
We report improved conditions for rapidly and simultaneously closing multiple 
diketopiperazines on solid support. These new conditions involve either heating of a suspension 
of solid supported amino-tetrafluoropropyl esters in acetic acid/triethylamine catalyst solution in 
a microwave oven or continuous flow of catalyst solution through the resin, heated in a special 
flow cell apparatus. 
Finally, the synthesis of the first functionalized bis-amino acid monomer proAc(2S3S4R) 
that carries an acetyl side chain is presented. This monomer was incorporated into a short 
oligomer and the solution phase structure was determined using two-dimensional nuclear 
magnetic resonance. The solution structure confirmed the intended connectivity and 
stereochemistry of the oligomer. This first functionalized bis-amino acid represents a milestone 
towards functionalized bis-peptide nanostructures for catalytic, molecular recognition and 
nanotechnology applications. 
Expanding the complexity and functional diversity of bis-amino acid building blocks 
Sharad Gupta, PhD 
University of Pittsburgh, 2009
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1 
1.0  INTRODUCTION 
Most of the biological functions such as transportation, molecular recognition, catalysis, storage 
and self replication are carried out by large macromolecules. These macromolecules are 
essentially oligomers, made of only a few monomers. For example DNAs and RNAs are 
polymers of nucleotides, while monosaccharides serve as monomer units for carbohydrates. 
However, the most complex of these oligomers are proteins that are made of 22 natural amino 
acids. Proteins consist of long peptide chains that fold into well defined secondary structures 
such as α-helices. These secondary structural elements organize themselves into tertiary and 
quaternary structures that are held together in a functional form by weak non-covalent 
interactions. 
The versatility and the variety of tasks that these “Nanomachines of Nature” perform is 
astonishing. Scientists have longed to develop tools that allow an access to artificial 
macromolecules that could rival natural proteins in their function.1-3 However, it is extremely 
difficult to emulate nature and design proteins that could perform a desired task. The biggest 
hurdle being ‘The Folding Problem’:4-6 For a protein to attain its native state, the linear peptide 
chain must fold into a specific 3-D shape. In a natural environment, proteins fold on microsecond 
timescales but it takes years of CPU time to simulate those few ‘microseconds’. 
2 
In recent years, researchers have developed an understanding of molecular basis for 
folding and function. There is a growing consensus that protein folding and its assembly into a 
functional form is largely regulated by noncovalent interaction and this hypothesis has been 
tested by the successful design of proteins from scratch by computational methods. 7-9 
Chemists have adopted another powerful approach toward protein mimicry that focuses 
on oligomers and polymers that adopt defined conformations. These molecules have come to be 
known collectively as “foldamers”10-12 that adopt a secondary structure stabilized by non-
covalent interactions (which are essentially similar to those found in natural peptides). These 
foldamers mimic the ability of proteins, nucleic acids or polysaccharides to form well-defined 
secondary structures, such as helices and ß-sheets.10-12 
Foldamers are chemically assembled from a myriad of non-natural monomers. These 
monomers come in a variety of sizes, shapes and arrangements and can lead to the efficient 
designs of molecular scaffolds. A number of functional foldamers have been synthesized that 
display a number of interesting biological properties. They mediate cell penetration13, 14 and bind 
to proteins,15-20 RNAs,21, 22 and membranes.23-25 Recently, there has been a renewed interest in 
peptidomimetic oligomer that has been fuelled by an increase in efforts toward new peptide 
based drugs development.26-30 In this chapter we present a few highlights from this emerging 
field of foldamers. Later part of this chapter discusses our contribution to this growing field of 
research. 
3 
1.1 FOLDAMERS RESEARCH 
Advent of foldamer research can be dated back to 1975 when Karle, Handa and Hassall first 
studied the conformation of a 14-membered cyclic peptide that contained β-amino acids.31 This 
field came to limelight only in 1993 when Zuckerman32 examined peptoids in detail. Since then 
foldamers research has come of age and great progress has been made by scientists. 
Foldamers can be broadly divided into two categories based on the types of monomers 
used. The first category contains foldamers made of aliphatic monomers such as β peptides33-35 
and γ peptides,36 azapeptides,37, 38 oligoureas,39-41 peptoids42, 43 and α-aminoxy peptides.44 The 
second category includes aryl based foldamers. Some examples are phenylene ethynylenes,45-48 
anthranilamides49, 50 and substituted pyridines.51, 52 Structures of a few represenative monomers 
are shown in Figure 1. 
H
N
R1
N
H
R2 H
N
H
N
R1
H
N
O
O O R2
H
N
O
N
N
N
R1 O
R2 O
R3
H
N
R1
N
H
N
H
H
N
O R2 H
N
O
H
N
R1
N
H
N
H
N
O R2
O R3
O
O
OR1
O
OR2
α-peptide β-peptide peptoids
oligoureas azapeptides
oligo(m-phenylene ethynylene)s
NH
N
H
OO
O
oligoanthranilamides oligopyridines
N
N
N
 
Figure 1: Structures of some foldamer backbones 
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β-Peptides were first prepared and investigated by Seebach and coworkers in 1996.53, 54 
Their approach was based on the conformationally rigidified residues that limit the degrees of 
freedom about the C -C β bond.55-58 These β-peptides and α/β hybrid peptides have been shown 
to bind to a variety of protein targets. Some of the targets include major histocompatibility 
complex (MHC) proteins,59 the oncoprotein RDM260 and G-protein coupled somatostatin hsst 
receptors.61-63 
Gellman and coworkers in 1999 reported the synthesis of a hexameric β-peptide and 
showed that it exists as short stable helices in aqueous solution.64 Apart from forming helices 
these oligomers also form β-sheet and hairpin turns.65-67 They have recently developed one such 
helical foldamer made of α/β-amino acids that binds to anti-apoptotic protein BCL-XL with 
nanomolar affinity.18, 68-70 
α-Aminoxy acids were first studied by Yang and coworkers in 1996 when they reported a 
novel turn structure in the peptides that contain these analogs of β-amino acids.71 Homochiral 
oligomers form an extended helical structure (1.88 helix).72, 73 A bent reverse turn structure is 
formed if the chirality is reversed.73, 74 These α-aminoxy acids have good affinities toward 
anions and this property has been exploited to create cyclic and acyclic anion receptors for Cl- 75, 
76 and chiral carboxylate77 anions. 
Recently, Barron and coworkers have reported the development of poly-N-substituted 
glycine (peptoid) analogs of surfactant protein C (SP-C33).78 By utilizing peptoid scaffold they 
were able to mimic helical structure and hydrophobic patterning of SP-C33 and slowed down the 
enzymatic degradation that was a big concern with natural α-amino acid based mimics.79-82 
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In 1999, Moore and coworkers45, 83 observed that oligo(phenylene ethynylene)s fold into 
a helix in solution and later on continued to demonstrate that these foldamers can be used for 
molecular recognition.84-86 The helical conformation formed by these foldamers has an internal 
cavity lined with non-polar surfaces and forms complexes with hydrophobic molecules of 
appropriate size.87-90 These oligomers have led to the discovery of new polymeric materials such 
as self healing polymers and elastomers that change color as they are stretched.91-93 
Hamilton and coworkers in 1996 reported an arylamide oligomer made from anthranillic 
monomers that fold into a helical strand.49 The helical conformation of these oligomers is 
stabilized by hydrophobic interactions.49, 50 A variety of scaffolds has been prepared that bind 
and recognize surfaces of proteins,94, 95 disrupt protein-protein interaction,96-98 influence cellular 
processes in vivo by binding selectively to biological targets.99-102 
Other examples of these aryl-based foldamers include cationic arylamides that bind to 
heparin,79-82 fluorescent oligoindole foldamers that bind anions,103 and meta/para linked benzene 
backbone based foldamers that form hollow crescents, helices and macrocycles.104-106 
1.2 OUR BIS-PEPTIDE APPROACH 
Foldamers are being used to study various types of biomolecular interactions such as protein-
protein, protein-oligosaccharides and peptide-membrane interaction. They are good candidates 
for these applications as the synthesis of foldamers is highly modular that enables rapid assembly 
of desired oligomers. A fewer number of monomeric units are required to attain a desired well 
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defined secondary structure. Usually, the reactions required for coupling two monomers are very 
efficient. They are generally more stable to enzymatic degradation than natural peptides.107 
Despite these advantages they suffer from a serious drawback: Foldamers need to fold 
into well defined secondary structures to attain their functional form. This is similar to the 
natural proteins. The substitution of proteins with foldamers reduces the problem from predicting 
the folding in a large protein to a small macromolecule but an enormous computational effort is 
still required. In the light of this problem, bis-peptide oligomers assembled from the 
stereochemically pure bis-amino acid monomers synthesized in our lab could be an effective 
alternative. 
A generic bis-amino acid monomer (e.g. pro4(2S4S) as shown in Figure 2) carries two α-
amino acid moieties installed on a cyclic framework. These functionalities are orthogonally 
protected to enable solid phase peptide assembly. One of these two amino acid functionalities is 
consumed in assembling a head to tail peptide like oligomer while the second functionality is 
utilized to rigidify this flexible oligomer. A judicious choice of orthogonal protecting groups is 
required for a successful synthesis of a desired oligomer. 
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Figure 2: Structural features of pro4(2S4S) bis-amino acid monomer 
 
The overall synthesis of a rigidified oligomer is conveniently carried out in two phases. 
The first phase, termed as “elongation”, involves assembly of the desired oligomeric sequence 
from its constituent bis-amino acid monomers. We employ standard Fmoc based solid phase 
peptide synthesis techniques for this elongation process. A schematic representation is shown in 
Figure 3. 
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Figure 3: A schematic representation of the elongation phase in oligomer synthesis 
 
In second “rigidification” phase these flexible oligomer sequences are subjected to 
appropriate reaction conditions that are conducive for the aminolysis of an ester by a secondary 
amine. A second amide bond between two adjacent monomers is formed and the net result is a 
rigidified oligomer. This rigidification results in the formation of the 1,4-diketopiperazine 
framework and eliminates any possibility of free rotation of the amide bonds. This simultaneous 
formation of multiple 1,4-diketopiperazines is depicted in Figure 4. The resulting bis-peptides 
are mostly water soluble (unless decorated with hydrophobic groups) and, in purified form, are 
stable under neutral or acidic aqueous conditions for weeks. 
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Figure 4: A schematic representation of the rigidification phase 
 
These rigidified oligomers are conformationally restricted and have access to only a 
limited number of conformations. The oligomers need not go through a complex folding process 
that is required in the case of natural peptides and the functional forms are held together by 
covalent bonds. The overall structure of a rigidified oligomer depends on the stereochemistry and 
the conformational preferences of the monomers involved. This ability to rigidify a peptide like 
backbone that greatly simplifies the prediction of structure of large functional macromolecules 
could be a milestone towards reducing the folding problem. 
We aim to study the conformational preferences for different monomers by determining 
the structure of small oligomers by NMR and X-ray crystallography and comparing them with 
those predicted by computational methods. By applying the knowledge gained from these initial 
experiments, we expect to perfect our computational models so that we can predict structures of 
large sequences in silico and design macromolecules with the desired shapes and functions for 
various applications related to peptidomimetics and nanotechnology. 
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Towards this goal, our lab has previously synthesized bis-amino acid monomers 
pro4(2S4S),108 pro4 (2S4R),109, 110 pro4(2R4R),109, 110 pro4(2R4S),109, 110 and hin(2S4R7R9R).111 
These monomers are easily coupled to each other to form rods and turns. To access a larger 
universe of structures we needed more building blocks. 
 
 
Figure 5: Bis-amino acid building blocks previously developed by Schafmeister group 
 
This inspired us to undertake the synthesis of pipecolinic acid based monomers that are 
described in Chapter 2.112 We report a new approach for the formation of DKP between two 
adjacent pip5(2S5S) monomers that was successfully used to synthesize a three-mer. We also 
present the solution phase NMR structure of this oligomer. 
Chapter 3113 primarily details our efforts toward the development and optimization of 
various catalysts and reaction conditions for DKP formation. We report synthesis of 2,2,3,3-
tetrafluoropropyl ester versions of bis-amino acid monomers that in combination with 
AcOH/Et3N solution in a non-polar solvent such as xylene and heat could form multiple DKPs in 
less than an hour. 
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In Chapter 4,114 we describe the synthesis of a functionalized bis-amino acid monomer 
proAc(2S3S4R) that carries an acetyl side chain. The synthesis presented for this monomer is 
highly reproducible and easily applicable for the introduction of other functionalities as well. We 
also report the synthesis of a short oligomer that contains this monomer. The solution phase 
structure of this monomer was determined by NMR and compared with the molecular mechanics 
predicted structure. 
Chapter 5 details progress made towards the synthesis of other stereochemical isomers of 
proAc(2S3S4R) monomer and preliminary results for the synthesis of a functionalized monomer 
that carries a methylimidazole side chain. 
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2.0  PIPECOLIC ACID BASED MONOMERS AND OLIGOMER ASSEMBLY 
Our long-term goal is to design, synthesize, and study macromolecules that have well defined 
three-dimensional structures displaying various functional groups in desired orientations. This 
shall enable us to develop functional molecules for various applications such as binding protein 
surfaces, stereoselective catalysts and molecular sensors. Earlier, the synthetic access to bis-
amino acid monomers (pro4108, 109 and hin111 class of monomers) had been developed in the 
Schafmeister research group. A combination of pro4 (4 monomers) and hin (2 monomers) 
building blocks in sequence M monomers long gives access to a total of 6M possible structures. 
However, more building blocks with diverse structural features were needed to access an even 
larger universe of structures; thus enhancing the probability of synthesizing a predesigned 
molecule for a specific application that has all the required functional groups in optimum 
orientation. This inspired us to undertake the synthesis of pipecolic acid based monomers, later 
named as pip5112 and pip4. In this chapter the synthesis of pip5 monomers and their successful 
assembly into a short rigidified oligomer will be discussed. 
L-Pipecolic acid (Figure 6), a natural α-amino acid and a homologue of L-proline is a 
constituent of immunosuppressants115 such as rapamycin116 and several antibiotics.117-119 Similar 
to proline, introduction of a pipecolic acid in a peptide induces a β-turn and this property has 
been exploited in various β-turn mimics.120, 121 Pipecolic acid has been successfully utilized as 
proline substitute in a number of peptidomimetic drug candidates to enhance their biological 
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activity and/or specificity.122-124 When incorporated into a peptide, pipecolic acid residue adopts 
a chair conformation as revealed by X-ray crystallography.125, 126 Empirical calculation show that 
chair conformations are preferred over boat conformations by 3-5 kcal/mol.125 Recently this has 
been substantiated by quantum mechanical calculations.127 The synthesis of pipecolic acid based 
monomers was further inspired by the fact that the chair conformation of six-membered rings are 
easier to assign by NMR than envelop and twisted conformations of their five-membered ring 
counterpart. 
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Figure 6: Proline and pipecolic acid. 
2.1 SYNTHESIS OF PIP5(2S5S) MONOMER 
In principle, the pip5 series of monomers e.g. pip5(2S5S) 3 can be obtained from the ketone 4 
via a methodology similar to the one developed for pro4 monomers (Figure 7). The ketone 4 is a 
homologue of ketone 5 and several one carbon insertion methods based on diazomethane 
derivatives have been reported in literature to affect this type of transformation.128-133 The ketone 
5 was easily available from trans-4-hydroxy-L-proline 6 via a three step process108 which had 
previously been optimized for large scale synthesis in our lab. Since the proposed protecting 
group scheme was the same as for the pro4 monomers108, we expected the solid phase assembly 
and the subsequent rigidification to be straightforward. 
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Figure 7: Retrosynthetic analysis of pip5(2S5S) monomer. 
 
2.1.1 Synthesis of hydantoins 
The ketone 5 was synthesized from inexpensive trans-4-hydroxy-L-proline 6 in three steps in 
good yield. The synthetic sequence started with Cbz protection of 6 with benzylchloroformate.134 
This was followed by Jones oxidation135 and subsequent t-butyl esterification with isobutylene 
and catalytic sulfuric acid as reported in a previous study.136 The crude ketone 5 was then 
subjected to a ketone homologation reaction that yielded a mixture of the regioisomeric ketones 
4 and 8 as reported in literature.137 This homologation was a two step reaction, the first step 
being ring expansion by reaction with ethyl diazoacetate in the presence of BF3.Et2O at 0 °C in 
anhydrous ether (Scheme 1, Figure 8).138-140  
This was followed by a Krepcho decarboethoxylation141 which removed the residual 
carboethoxy group from the previous step. We observed that the insertion of a purification step 
prior to decarboethoxylation (mixture of 7a and 7b) enhanced the yield and simplified the 
chromatographic separation of the mixture of regioisomeric ketones (4 and 8) following the 
decarboethoxylation reaction. 
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Scheme 1: Synthesis of homologous ketone 4 
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Figure 8: Mechanism of ring expansion reaction 
 
We found that the optimum conditions for the decarboethoxylation reaction were to heat 
at 140-150 °C for 4-5 hours. A further increase in temperature reduced the reaction time, but 
raised the amount of byproducts formed due to thermal decomposition and this complicated the 
separation step. Ketones 4 and 8 were separated by flash chromatography on SiO2 gel using a 
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5%-25% EtOAc in hexanes gradient. A typical chromatographic run yielded about 40-50% 
recovery of purified ketones from the mixture and a total of three sequential chromatographic 
runs were required to affect > 90% recovery of purified ketones. (Scheme 1) 
After purification, ketone 4 was subjected to a Bucherer-Bergs reaction,142, 143 thereby 
installing a quarternary stereocenter with a diasterselectivity of 5:2 as determined by NMR of the 
crude mixture of hydantoins 9a and 9b. The best yields were obtained by using 1.1 equivalents 
of KCN and DMF/H2O (1:1) as the solvent. We observed that heating at 60 °C for 4 hours in a 
sealed pressure vessel was sufficient to complete the desired transformation. (Scheme 2) 
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Scheme 2: Synthesis and separation of bis-Boc protected hydantoins 
 
This mixture of diastereomeric hydantoins (9a and 9b) thus obtained was found to be 
inseparable by silica gel chromatography. However, after protection with Boc groups the 
hydantoins became easily separable. These bis-Boc protected hydantoins 10a and 10b were 
separated by flash chromatography on SiO2 gel using a 10%-30% EtOAc in hexanes gradient 
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(Scheme 2). We avoided prolonged contact with silica gel during the chromatographic separation 
and high temperature, while concentrating, as the Boc groups were found to be moderately labile 
under these conditions. We also observed that in the event of a partial removal of Boc groups, 
residual mono protected hydantoins can be easily re-protected with Boc anhydride and purified 
to recover additional quantities of bis-Boc protected hydantoins 10a and 10b. This extra effort 
ensured a near quantitative recovery of the purified products 10a and 10b. 
2.1.2 Determination of stereochemistry 
Previously, for pro4 series of monomers, the stereochemistry of the diastereometric hydantoins 
had been determined by taking advantage of the difference in the proximities of the amide –NH 
of the hydantoin to α, β and δ protons of the pyrrolidine ring which is detectable by ROESY or 
NOESY spectra.108 We decided to use a similar approach to determine the relative 
stereochemistry for pip5 series of monomers. Because of the unavailibilty of pure hydantoins 9a 
and 9b, bis-Boc protected hydantoins 10a and 10b, available in pure form were deprotected to 
unmask the amide –NH. This was achieved by stirring 10a or 10b in a 3:7 mixture of TFA/DCM 
for 3 hours. This removed the two Boc groups and the t-Bu group to yield deprotected 
hydantoin-acids 11a and 11b (Figure 9a). 2D NOESY spectra were recorded for 11a and 11b in 
DMSO-d6 at ambient temperature on a 600MHZ NMR instrument. Spectral analysis showed a 
correlation of amide hydrogen 7NH with 4Hα and 6Hα for hydantoin 11a. However, for 11b the 
amide hydrogen 7NH shows a correlation only with 3Hβ. These correlations are justified only if 
11a and 11b are assigned S and R stereochemistry respectively at quarternary centre 5C. To 
further support this assignment, a stochastic conformational search144 of the hydantoins 11a and 
11b was carried out in vacuo using the AMBER94145 force field within molecular mechanics 
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package MOE.146 The modeled structures at the global energy minimum confirmed the 
experimentally observed correlations and suggested that both 11a and 11b existed in chair form 
(Figure 9b). 
 
 
Figure 9: Stereochemistry of hydantoins: (a) Synthesis of hydantoin-acids and (b) NOESY correlation 
projected upon corresponding lowest energy conformations as determined by MOE. 
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2.1.3 Methyl ester version of pip5(2S5S) monomer 
The major diasteromer 10a was hydrolyzed using 1:1 2M-KOH/THF to give the corresponding 
amino acid 12.147 This amino acid was suspended in dichloromethane with DIPEA and TMS-Cl 
and refluxed to yield N,O-bis-TMS intermediate (not isolated).134 After cooling, Fmoc-Cl was 
added to the reaction mixture and stirred until the reaction is complete. After an acidic workup, 
Fmoc protected amino acid 13 was obtained. We observed that the amino acid must be well dried 
for this reaction. Such a level of dryness can be obtained by storing the amino acid in a vacuum 
oven at 60-80 °C for a couple of days. This intermediate 13 was than esterified by treatment with 
trimethylsilyldiazomethane to give the fully protected ester 14. Subsequent removal of the t-Bu 
group by treatment with 3:7 TFA/DCM exposed the carboxyl functionality to give the 
orthogonally protected building block 3, that was suitable for sequential solid phase coupling. 
(Scheme 3) 
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Scheme 3: Synthesis of methyl ester version of pip5(2S5S) monomer. 
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2.2 TRIAL ASSEMBLY OF A HOMO-OLIGOMER 
In order to test the ability of monomer 3 to form spiro ladder oligomers, a dimer was synthesized 
on 6.3 μmole scale on rink amide resin148 using Fmoc solid phase peptide synthesis methods 
(Scheme 4). Two methyl ester monomer units 3 were sequentially attached to the resin followed 
by an Fmoc-L-tyrosine residue. The role of tyrosine was to provide a UV active group. Each 
residue was activated as the HOAt ester149 and near quantitative coupling to the previous 
monomer was achieved through double coupling of 2 equivalents of activated monomer with 
respect to the resin loading. We observed that longer coupling times were needed (90-120 
minutes) as compared to the pro4 monomers (20-30 minutes) to affect quantitative couplings. 
After removal of the terminal Fmoc group the oligomer 15 was cleaved from the resin by 
treatment with 95:2.5:2.5 TFA/water/triisopropylsilane150 for 2 hours. Hydrogenolysis gave the 
completely deprotected oligomer 16, which was used for subsequent studies on DKP closure. 
(Scheme 4) 
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Scheme 4: An attempt to form DKP between two pip5(2S5S)(OMe) monomers 
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Oligomer 16 was incubated in a solution of 20% piperidine in DMF, first at room 
temperature and then at higher temperature (Scheme 4). These conditions for aminolysis were 
used effectively for the oligomers containing pro4 (at ambient temperature) and hin (at elevated 
temperature) monomers. To our surprise oligomer 16 did not undergo aminolysis even under 
forcing conditions (4 days and temperatures up to 100 °C). No trace of expected product 17 was 
detected and after a few days oligomer 16 decomposed. 
These observations led us to conclude that secondary amines on the pip5 (2S4S) 
monomer were not as reactive as those in the pro4 and hin monomers. This relatively poor 
nucleophilicity of secondary amines in piperidine derivatives than those in pryrolidine 
derivatives has been widely observed. The coupling of a DCC activated acid to methyl prolinate 
has been found to be much faster than to a methyl pipecolinate.151 Piperidine reacts much slower 
than pyrrolidine towards aromatic nucleophilic substitution and the difference in rates varies with 
reaction conditions.152 The reaction of an amine with a ketone to give enamine is slower for 
piperidine than pyrrolidine.153 This lower nucleophilicity of piperidine has been attributed to 
stereoelctronic effects in the transition states leading to the products.154 Similiarly, piperazic 
acids that contain a six-membered piperidazine ring and their derivatives are very resistant to 
acylation at the α-nitrogen.155 
In light of these precedents, we concluded that the rate enhancement provided by 
prolonged heating at high temperatures in 20% piperidine/DMF was unable to compensate for 
the deceleration caused by the 6-membered piperidine ring of the pip5(2S5S) monomer and a 
different approach for DKP closure was needed. 
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2.3 ALTERNATIVE STRATEGY: BENZYL ESTER VERSION OF PIP5(2S5S) 
MONOMER 
The most widespread method to form an amide bond in peptide chemistry is through in-situ 
activation of carboxylic acids by reaction with activating reagents.156-158 A wide range of peptide 
coupling reagents such as uronium reagents (e.g. HBTU,159 TBTU158), carbodiimide reagents 
(e.g. DCC,160 DIC161 ), or acid halogenating reagents (e.g. cyanuric fluoride162) are commercially 
available and each can be screened to find appropriate reaction conditions. However, some 
modification of the monomer 3 was required before applying this approach. A benzyl ester was 
chosen to replace the methyl ester, as the hydrogenolysis conditions employed for Cbz 
deprotection also remove benzyl groups to unmask the carboxylic acids in a single step. A 
retrosynthetic approach is shown in Figure 10. 
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Figure 10: A retrosynthetic approach for in situ DKP formation 
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Pip5(2S5S)(OBn) 18, a benzyl ester version of the monomer was synthesized from the 
intermediate 13 as shown in Scheme 5. A simple esterification with benzyl alcohol via DMAP 
catalyzed DCC activation yielded fully protected ester intermediate 19. The t-Bu group was 
quantitatively removed by treating with 30% TFA in DCM to yield the monomer 18 with a free 
carboxylic acid for peptide synthesis. 
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Scheme 5: Synthesis of benzyl ester version of pip5(2S5S) monomer 
2.4 ASSEMBLY AND STRUCTURAL ANALYSIS OF PIP5(2S5S) OLIGOMER 
2.4.1 Solid phase assembly of a trimer 
A homo-oligomer consisting of three pip5(2S5S) monomer units 18 was synthesized on a 16.5 
μmol scale on Rink acid resin148 using Fmoc solid-phase peptide synthesis techniques (Scheme 
6). The mild deprotection conditions (10% TFA/DCM) used for Rink acid resin ensured a clean 
product with near quantitative yield. The sequence consisted of gly-pip5(2S5S)-pip5(2S5S)-
pip5(2S5S)-(L)-tyrosine. A glycine residue was first attached to the resin followed by two benzyl 
ester monomers 18 and a methyl ester monomer 3. Each residue was activated as an HOAt ester 
and near quantitative coupling to the previous monomer was achieved through double-coupling 
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of 2 equivalents of activated monomer with respect to the resin loading. Finally, an Fmoc-L-
tyrosine residue was added, and the amine of the tyrosine was capped with a trimethyl acetyl 
group to stop the terminal DKP formation, thus reducing the hydrophilic character of the the 
oligomer. The oligomer was then cleaved from the Rink acid resin using 10% TFA/DCM. The 
carboxybenzoyl (Cbz) and benzyl groups were removed simultaneously by hydrogenolysis under 
hydrogen atmosphere using 10% Pd/C to yield oligomer 21 that has a free amine and a free 
carboxylic acid between each adjacent pair of monomers. 
2.4.2 Rigidification of homo-oligomer 
The carboxylic acids on oligomer 21 were then activated in situ using 1,3-
dicyclohexylcarbodiimide (DCC) and N-hydroxysuccinimide163-165 (HOSu) in the presence of 
base (DIPEA), in NMP. These conditions were found to be the most efficient with cleanest 
product after screening a few commercially available coupling reagents in a separate set of 
experiments with a dimer. We qualitatively observed that the anhydride based reagents were 
more effective than the activated-ester based reagents. Also, DCC by itself in the absence of 
NHS was mildly active and gave poor yield. 
Intramolecular amide formation took place between each adjacent pair of monomers to 
yield the rigidified scaffold 22 (Scheme 6). This in situ coupling reaction simultaneously forms 
three diketopiperazine rings and produces a single pure product as determined by C18 RP-HPLC 
and NMR. This indicates that the diketopiperazine rings form faster than any other macrocycles 
that would result from one of the three amines N8, N18, or N27 attacking one of the other 
activated carbonyl groups at C9, C19, or C28. 
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Scheme 6: Assembly of a pip5(2S5S) oligomer and DKP closure 
2.4.3 Solution phase NMR structure and conformational analysis 
The molecular mechanics package MOE was used to carry out a stochastic conformational 
search of the three-mer sequence gly-pip5(2S5S)-pip5(2S5S)-pip5(2S5S) in order to locate the 
lowest energy minima in vacuo using the AMBER94 force field. The modeled structure at the 
global energy minimum suggests that the sequence forms a helical rod and each pipecolic acid 
ring adopts a chair like conformation, placing the amide nitrogens N11, N20, and N29 in the 
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axial positions. A superposition of next several lowest energy predicted conformations revealed 
that a change in any of the chair conformations to the boat conformation raised the energy by at 
least 6.3 Kcal/mol. This suggested that the preference of pip5(2S5S) monomers to adopt this 
chair like conformation, when incorporated into a bis-peptide oligomer is very strong and that 
should translate into a high degree of rigidity and thus high predictability for the overall 
oligomer structure. 
We determined the conformational preferences of the component rings of the oligomer 22 
using two-dimensional NMR in H2O:D2O 90:10 at 25°C. The 1H and 13C resonances were 
assigned through the interpretation of a collection of 2D spectra including a DQF-COSY, a 
TOCSY, an HMQC, an HMBC and a ROESY. The assignment was carried out using the 
software package SPARKY.166 Diastereotopic hydrogens are labeled “α” if they go into the page 
and “β” if they come out of the page. For protons that were correlated to several other protons in 
the ROESY spectrum, the relative intensity of the cross-peaks were assigned as strong, medium 
or weak based on integrated intensity. 
The overall conformation of 22 is that of a left handed helix. The chair conformation of 
each pipecolic acid ring was indicated by the correlation of three axial protons syn to each other 
on each ring. On the B ring of 22, correlations are seen between H3, H5α and H7α and the axial 
orientation of the amine substituent N11 is indicated by the correlation between H11 and H4β. 
On the the D ring of 22, protons H13, H15α, H17α are correlated and the axial orientation of 
N20 is seen in the correlation between H20 and H14β. In the F ring of 22 correlations are seen 
between H22, H24α and H26α. The amine substituent N29 is not the part of a diketopiperazine 
ring and can rotate freely. However, we observe a correlation between H29 and H23β, 
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suggesting that N29 is axial to ring F. These observations are consistent with rings B, D and F 
each being in a chair conformation. 
The conformation of the diketopiperazine ring C is not clear because the only correlation 
seen across this ring is a very weak correlation between H11 and H13. A correlation is seen 
between H17β and H23β suggesting that the diketopiperazine ring E is in a boat conformation 
that places C23 and C17 in a pseudoaxial orientation. Combining these conformational 
preferences allowed us to validate a three-dimensional model of the spiro-fused ring structure of 
22 at the global energy minimum shown in (Figure 11). 
 
Figure 11: The global minimum energy structure of compound 22 with the ROESY correlations 
superimposed. The piperazine rings are shaded purple. The ROESY correlations were most consistent with the 
minimum energy structure using the Amber94 force field. The colors of the ROESY correlation lines are related to 
the intensity of the ROESY correlation peak (red=strong, yellow=medium, green=weak). 
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2.5 EXTENSION TO LONGER SEQUENCES 
After successfully demonstrating that three DKP rings in a pip5(2S5S) homooligomer can be 
closed simultaneously we focused on developing pip5(2S5R) monomer and extend this 
methodology to longer sequences comprising different combinations of monomers. Bis Boc 
protected minor hydantoin 10b was hydrolyzed and the resulting amino acid 23 was protected 
with an Fmoc group to yield 24. This intermediate 24 was than esterified with benzyl alcohol 
using DCC in the presence of catalytic DMAP to yield fully protected ester 25. Subsequent t-Bu 
deprotection gave 26, the orthogonally protected benzyl ester version of the pip5(2S5R) 
monomer. 
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Scheme 7: Synthesis of pip5(2S5R)(OBn) monomer 
 
We assembled a heterooligomer sequence tyr-pip5(2S5R)-pip5(2S5R)-pip5(2S5S)-
pip5(2S5S) on trityl chloride resin using the Fmoc solid phase methodology as described earlier. 
Each residue was activated as HOAt ester and terminal amino group was protected by acyl 
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group. After the cleavage from the resin and hydrogenolysis, a fully deprotected oligomer 27 was 
recovered in moderate yields only. The hydrogenolysis reaction was very sluggish and low 
yielding. The oligomer 27 had 5 pairs of free carboxylic acids and free amines on adjacent 
monomers and was sparingly soluble in NMP, DMF and other polar aprotic solvents. A 
suspension of 27 in NMP was activated with DCC and NHS in the presence of DIPEA. Even 
though the suspension was sonicated repeatedly and the stirring was continued for days, we 
could obtain only a trace amount of fully rigidified oligomer 28. 
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Scheme 8: Extension of the in situ DKP closure methodology to longer sequences 
 
These observations, supported by the other experiments on similar sequences led us to 
hypothesize that as the sequence grows, the number of pairs of free amines and free carboxylic 
acids on adjacent monomers also increases. Consequently, the oligomers increasingly adopt 
30 
polar zwitterionic structure and their solubility in organic solvents decreases. This in turn slows 
down rigidification process resulting in low yield. 
The oligomer 27 was readily soluble in water. This prompted us to test water soluble 
coupling reagents such as EDC167 and DMT-MM168 in buffered as well as in biphasic medium 
but no product was observed. 
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2.6 SUMMARY 
In this chapter we demonstrated a successful synthesis of pipecolic acid based bis-amino acid 
monomers, namely pip5(2S5S) and pip5(2S5R). By incorporating these monomers in short 
oligomers, we confirmed that these monomers are amenable to solid phase synthesis. A new 
approach for DKP closure in oligomers containing pip5(2S5S) monomers was developed that 
utilized in situ activation of carboxylic acid by DCC and NHS. We determined the 
conformational preferences of the monomers within the oligomer, and together they suggested 
that the oligomer forms a left-handed helix. 
Our attempts to extend this approach for DKP formation to longer sequences for DKP 
closure were unsuccessful and we concluded that in situ activation approach for DKP ring 
closure, though very powerful and high yielding was limited to small sequences only and a 
universal methodology that works for all types of monomers and sequences of all lengths 
required further development. 
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2.7 EXPERIMENTAL METHODS 
2.7.1 General methods 
THF was distilled from Na/benzophenone under N2. CH2Cl2 was distilled from CaH2. All other 
reagents were used as received unless otherwise noted. All reactions were carried out in flame-
dried or oven-dried glassware under N2 atmosphere unless otherwise noted. Column 
chromatography was performed either manually using ICN Silitech 32-63 D (60 Å) grade silica 
gel or using Redisep normal phase flash chromatography silica columns on CombiFlash 
companion purification system from ISCO Inc. TLC analysis was performed on EM Science 
Silica Gel  60 F254 plates (250 μm thickness). NMR experiments were performed on Bruker 
Avance 300 MHz, Bruker Avance DRX 500 MHz or Bruker Avance DRX 600 MHz 
spectrometers. Chemical shifts (δ) are reported relative to CDCl3 or DMSO-d6 residual solvent 
peaks, unless otherwise noted. If possible, rotational isomers were resolved by obtaining spectra 
at 77 °C in DMSO-d6. IR spectra were obtained on a Nicolet Avatar E.S.P. 360 FT-IR. Optical 
rotations were obtained on a Perkin-Elmer 241 polarimeter at the indicated temperatures. High 
resolution ESI-MS was performed on a Waters LC/Q-TOF instrument. HPLC analysis was 
performed on a Hewlett-Packard Series1050 instrument with diode array detector, using a Varian 
Chrompack Microsorb 100 C18 column (5 μm packing, 2.6 mm x 250 mm). HPLC-MS analysis 
was performed  on a Hewlett-Packard Series 1100 instrument with diode array detector, HP 1100 
MS detector (ESI), using a Waters Xterra MS C18 column (3.5 μm packing, 4.6 mm x 100 mm). 
Purification by preparative HPLC was performed on a Varian ProStar 500 HPLC system with a 
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Varian Chrompack Micrsorb 100-C18 column (8 μm packing; 21.5mm x 50mm; designated “prep 
Varian C18). 
2.7.2 Monomer synthesis 
(5S,8S)-2,4-Dioxo-1,3,7-triazaspiro[4.5]decane-7,8-dicarboxylic acid 7-benzyl ester 8-tert-
butyl ester (9a) and (5R,8S)-2,4-Dioxo-1,3,7-triazaspiro[4.5]decane-7,8-dicarboxylic acid 7-
benzyl ester 8-tert-butyl ester (9b) 
A solution of ammonium carbonate (6.0 g, 62 mmol), and potassium cyanide (0.9 g, 14 mmol) in 
deionized water (63 mL) was transferred to a 350 mL pressure vessel. To this vessel a solution of 
(2S)-5-Oxopiperidine-1,2-dicarboxylic acid 1-benzyl ester 2-tert-butyl ester (4) (4.1 g, 12.5 
mmol) in DMF (63 mL) was added. The pressure vessel was sealed and the reaction mixture was 
heated at 60 °C for 4 hours with vigorous stirring. After cooling to 0 °C, the pressure vessel was 
opened cautiously and the reaction mixture was poured into a 500 mL beaker. Reaction mixture 
was neutralized by addition of 1N HCl and pH was reduced to ~2. The resulting solution 
including any oily residue (soluble in EtOAc) was transferred to a separatory funnel and 
extracted with EtOAc (500mL). The aqueous layer was extracted back with EtOAc (3 x 200mL). 
All the organic Layers were combined and washed with brine (200 mL) and dried over 
anhydrous Na2SO4. The solvent was removed in vacuo by rotary evaporation to yield a crude 
mixture of products 9a and 9b in a ratio of ~ 5:2 (as determined by 1H NMR of crude). This 
mixture was found to be inseparable by flash chromatography and taken to the next step without 
further purification. 
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(5S,8S)-2,4-Dioxo-1,3,7-triazaspiro[4.5]decane-1,3,7,8-tetracarboxylic acid 7-benzyl ester 
1,3,8-tri-tert-butyl ester (10a) and (5R,8S)-2,4-Dioxo-1,3,7-triazaspiro[4.5] decane-1,3,7,8-
tetracarboxylic acid 7-benzyl ester 1,3,8-tri-tert-butyl ester (10b) 
The crude mixture of hydantoins (9a and 9b) from previous reaction was dissolved in dry THF 
(190 mL) in a 500 mL round bottom flask. Di-tert-butyl dicarbonate (8.2g, 37.5mmol) and 
catalytic amount of DMAP (230mg, 1.9mmol) was added to the flask under N2 flow. The 
reaction mixture was stirred for 3 hours to ensure complete conversion to the desired products 
and was monitored by TLC. The reaction volume was reduced to ~50 mL by rotary evaporation 
and then adsorbed on celite. Any residual solvent was removed by drying under reduced 
pressure. This was immediately followed by purification and separation of the desired products 
10a and 10b by automated flash chromatography (40 gm silica columns; Solvent A: Hexanes, 
Solvent B: EtOAc; Gradient elution: 0-5 CVs, solvent B 10% followed by 5-45 CVs, solvent B 
10% to 30%). The fractions containing pure products 10a or 10b were combined separately and 
concentrated by rotary evaporation under reduced pressure. In vacuo drying of the resulting 
viscous oils yielded 10a (2.6g, 34.4% yield based on 7 over two steps) and 10b (1.1g, 14.5% 
yield based on 7 over two steps) as white foams, along with a mixture of 10a and 10b (0.9g). 
 
Less polar 10a: 
(5S,8S)-2,4-Dioxo-1,3,7-triazaspiro[4.5]decane-1,3,7,8-tetracarboxylic acid 7-benzyl ester 
1,3,8-tri-tert-butyl ester (10a) [α]23D = 4.8 (c 1.8, CHCl3); IR (film) νmax 2981, 1825, 1783, 
1731, 1423, 1370, 1309, 1253, 1149, 976, 843, 757, 698 cm-1; 1H NMR (300 MHz, 20 °C, 
CDCl3) ( mixture of rotamers) δ 7.26-7.28 (m, 5H), 4.99-5.21 (m, 2H), 4.69-4.91 (m, 1H), 3.92-
4.17 (m, 2H), 2.39-2.62 (m, 2H), 2.22-2.25 (m, 1H), 1.80-1.86 (m, 1H), 1.37-1.53 (m, 27H); 13C 
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NMR (75.4 MHz, 20 °C, CDCl3) (mixture of rotamers) δ  169.7, 169.5, 167.7, 167.6, 155.5, 
155.3, 148.3, 148.2, 146.9, 146.8, 144.9, 136.2, 136.0, 128.3, 128.2, 127.9, 127.8, 127.7, 127.5, 
86.5, 85.2, 82.0, 67.7, 67.4, 60.4, 60.3, 53.7, 53.3, 42.8, 42.4, 27.8, 27.5, 25.6, 22.1, 21.9; 
HRMS-ES (m/z): 626.2720 (C30H41N3O10 + Na+ requires 626.2690). 
 
More polar 10b: 
(5R,8S)-2,4-Dioxo-1,3,7-triazaspiro[4.5] decane-1,3,7,8-tetracarboxylic acid 7-benzyl ester 
1,3,8-tri-tert-butyl ester (10b) [α]23D = -16.6 (c 2.9, CHCl3); IR (film) νmax 2980, 1826, 1785, 
1740, 1422, 1369, 1317, 1254, 1143, 843, 752, 698 cm-1; 1H NMR (300 MHz, 20 °C, CDCl3) 
(mixture of rotamers) δ 7.26-7.31 (m, 5H), 4.93-5.19 (m, 2H), 4.26-4.44 (m, 2H), 3.66-3.82 (m, 
1H), 1.95-2.37 (m, 4H), 1.32-1.52 (m, 27H); 13C NMR (75.4 MHz, 20 °C, CDCl3) (mixture of 
rotamers) δ 170.4, 170.0,169.2, 168.9, 154.9, 154.8, 148.0, 146.4, 144.5, 135.9, 135.7,128.0, 
127.9, 127.6, 127.4, 127.2, 86.3, 84.6, 81.0, 67.0, 66.8, 63.3, 63.1, 54.7, 54.5, 46.5, 46.2, 27.4, 
27.2, 21.7, 21.0; HRMS-ES (m/z): 626.2709 (C30H41N3O10 + Na+ requires 626.2690). 
 
General procedure for the hydrolysis of t-Boc protected hydantoins (10a and 10b) 
The bis-Boc protected hydantoin was dissolved in a mixture of 3:7 TFA/DCM (40 mL per mmol 
of ester) and stirred at room temperature for 3 hours. The reaction progress was monitored by 
TLC. After the complete deprotection, the reaction mixture was diluted with some toluene and 
the solvents were removed by rotary evaporation. The residual viscous oil was dissolved in DCM 
and evaporated in vacuo to yield the desired product as white foam in near quantitative yield. 
The products were analyzed without any further purification. 
 
36 
(5S,8S)-2,4-Dioxo-1,3,7-triazaspiro[4.5]decane-7,8-dicarboxylic acid 7-benzyl ester (11a): 
[α]23D = 32.5 (c 1.3, MeOH); IR (film) νmax 3242, 1721, 1429, 1230, 1147 cm-1; 1H NMR (600 
MHz, 20 °C, DMSO-d6) ( mixture of rotamers) δ 13.14 (br s, 1H), 10.64-10.68 (m, 1H), 7.91-
7.93 (m, 1H), 7.32-7.35 (m, 5H), 5.06-5.11 (m, 2H), 4.80 (br s, 1H), 3.99-4.02 (m, 1H), 2.98-
3.13 (m, 1H), 2.31 (br s, 1H), 2.04 (br s, 1H), 1.92-1.94 (m, 1H), 1.55-1.57 (m, 1H); 13C NMR 
(75.4 MHz, 20 °C, DMSO-d6) δ 176.4, 172.1, 156.0, 155.0, 136.7, 128.4 (2C), 127.8 (2C), 127.3, 
66.7, 57.1, 52.9 and 52.5 (rotamer), 46.3, 29.0, 21.6; HRMS-ES (m/z): 370.1023 (C16H17N3O6 + 
Na+ requires 370.1015). 
 
(5R,8S)-2,4-Dioxo-1,3,7-triazaspiro[4.5]decane-7,8-dicarboxylic acid 7-benzyl ester (11b): 
[α]23D = 8.0 (c 1.1, MeOH); IR (film) νmax 3240, 1717, 1422, 1254, 1146 cm-1; 1H NMR (600 
MHz, 20 °C, DMSO-d6) ( mixture of rotamers) δ 13.20 (br s, 1H), 10.82-10.83 (m, 1H), 8.70-
8.71 (m, 1H), 7.30-7.35 (m, 5H), 5.06-5.16 (m, 2H), 4.77 (br s, 1H), 3.86-3.90 (m, 1H), 3.09-
3.27 (m, 1H), 1.99-2.12 (m, 2H), 1.63 (br s, 2H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6) δ 
175.9, 172.1, 156.3, 155.4 and 155.3 (rotamers), 136.7, 128.5 and 128.5 (rotamers, 2C), 127.9, 
127.5 and 127.4 (rotamers, 2C), 66.7, 60.5, 53.2 and 52.8 (rotamers), 47.8 and 47.6 (rotamers), 
28.4, 21.2; HRMS-ES (m/z): 370.1017 (C16H17N3O6 + Na+ requires 370.1015). 
 
(2S,5S)-5-Aminopiperidine-1,2,5-tricarboxylic acid 1-benzyl ester 2-tert-butyl ester (12) 
Pure bis-Boc hydantoin 10a (2.1g, 3.5mmol) was dissolved in THF (14 mL) in a 100 mL round 
bottom flask. To this solution 2M aqueous KOH solution (14 ml) was added and the resulting 
mixture was stirred vigorously for 30 minutes at ambient temperature. The reaction mixture was 
extracted with EtOAc (10 mL). The aqueous layer was saved and the organic layer was further 
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extracted with water (2x5 mL). All the aqueous layers were combined in a beaker and cooled to 
0 °C. This cooled solution was acidified by a dropwise addition of 40% aqueous HCl under 
mechanical stirring. A thick white precipitate appeared as the pH approached 4-5. The addition 
of HCl solution was continued until no further precipitation was observed. The solution was 
filtered through a sintered glass funnel (medium pore size) and the precipitate was washed with 
ice cold deionized water (~ 50 mL). This precipitate was first air dried overnight and then in 
vacuo over anhydrous calcium sulphate. This yielded the desired amino acid 12 (1.2 gm, 91%) as 
a white powder that was used as such for the next step: [α]23D = -26.0 (c 0.5, MeOH); IR (film) 
νmax 3314, 2977, 1730, 1526, 1449, 1368, 1328, 1251, 1152, 758, 698 cm-1; 1H NMR (300 MHz, 
77 °C, DMSO-d6) δ 7.33 (br s, 5H), 5.06 (br s, 2H), 4.48 (br s, 1H), 4.32 (br s, 2H), 4.22 (d, J = 
12.4 Hz, 1H), 2.72 (d, J = 12.4 Hz, 1H), 1.85-2.01 (m, 3H), 1.39 (br s, 9H), 1.13-1.17 (m, 1H); 
13C NMR (75.4 MHz, 20 °C, DMSO-d6) δ 173.9, 170.4, 155.8 and 155.1 (rotamers), 136.9, 
128.3 (2C), 127.6, 127.2 (2C), 80.9, 66.1, 55.5, 53.7, 48.8, 30.1, 27.6 (3C), 23.1; HRMS-ES 
(m/z): 401.1715 (C19H26N2O6 + Na+ requires 401.1689). 
 
(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester (13) 
Amino acid 12 (800 mg, 2.11 mmol) was suspended in dry DCM (21 mL) under N2 atmosphere 
in a 100 mL 3-neck round bottom flask fitted with a condenser. To this suspension DIPEA (1.07 
mL, 8.46 mmol) was added in one portion that resulted in a clear solution. A dropwise addition 
of TMS-Cl (1.47 mL, 8.46 mmol) released sufficient heat to start the reflux that was continued 
for an additional 90 minutes. The reaction mixture was cooled to 0 °C and 9-fluorenylmethyl 
chloroformate (870 mg, 3.36 mmol) was added in one portion. The solution was allowed to 
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slowly warm up to room temperature and the stirring was continued under N2 atmosphere. The 
reaction progress was monitored by TLC. After the completion of reaction (approximately 2 
days), the reaction mixture was directly absorbed on celite and any residual solvent was removed 
in vacuo. This was followed by automated flash chromatography (40 gm silica columns; Solvent 
A: CHCl3 with 0.1% AcOH, Solvent B: 10% MeOH/ CHCl3 with 0.1% AcOH; Gradient elution: 
0-5 CVs, solvent B 20% followed by 5-45 CVs, solvent B 20% to 100%). The fractions that 
contain the desired product, as indicated by TLC were combined and the solvent was removed by 
rotary evaporation. The resulting viscous oil was dried in vacuo to yield the desired product 13 
(1.16 gm, 91%) as a white foam: [α]23D = -10.6 (c 3.9, CHCl3); IR (film) νmax 3156, 2977, 1737, 
1691, 1583, 1452, 1433, 1405, 1352, 1280, 1226, 1154, 1109, 1012, 697 cm-1; 1H NMR (300 
MHz, 77 °C, DMSO-d6) δ 12.13 (br s, 1H), 7.85 (d, J = 7.5 Hz, 2H), 7.68 (d, J = 7.4 Hz, 2H), 
7.51 (s, 1H), 7.28-7.42 (m, 9H), 5.10 (br s, 2H), 4.65 (d, J = 13.3 Hz, 1H), 4.58-4.62 (m, 1H), 
4.28-4.30 (m, 2H), 4.20 (m, 1H), 2.95 (d, J = 13.3 Hz, 1H), 2.18 (br d, J = 13.5 Hz, 1H), 1.84-
2.04 (m, 2H), 1.56 (ddd, J = 13.1, 13.1, 3.6 Hz, 1H), 1.41 (br s, 9H); 13C NMR (75.4 MHz, 20 
°C, DMSO-d6) δ 172.9, 170.1 and 169.8 (rotamers), 155.0, 155.2 and 154.8 (rotamers), 143.8 
(2C), 140.7 (2C), 136.9 and 136.7 (rotamers), 128.3 (2C), 127.7 (2C), 127.2 (3C), 127.1 (2C), 
125.2 (2C), 120.1 (2C), 81.3, 79.2, 66.3, 65.5, 55.9 and 55.8 (rotamers), 53.9 and 53.7(rotamers), 
46.8 and 46.6 (rotamers), 28.8, 27.6 (3C), 22.5; HRMS-ES (m/z): 623.2373 (C34H36N2O8 + Na+ 
requires 623.2369). 
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(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester 5-methyl ester (14) 
The Fmoc protected amino acid 13 (165 mg, 0.28 mmol) was placed in a 25 mL round bottom 
flask and dissolved in dry MeOH (3 mL) under N2 atomsphere To this clear solution, TMS-
CHN2 was slowly added until no further evolution of N2 was observed and the reaction mixture 
turned yellow. The excess of TMS-CHN2 was quenched by an addition of 10% AcOH/MeOH 
(~1 mL). The reaction mixture was concentrated by rotary evaporation and the residual solvent 
was removed in vacuo to yield 14 (169 mg, >99%) as a white foam. An analytical sample was 
prepared by manual flash chromatography (silica column; solvent: 30% EtOAc/Hexanes, 
Isocratic elution): [α]23D = -12.8 (c 4.8, CHCl3); IR (film) νmax 3322, 2977, 2951, 1731, 1527, 
1449, 1368, 1323, 1252, 1153, 758, 698 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 7.86 (d, J 
= 7.5 Hz, 2H), 7.66-7.69 (m, 3H), 7.29-7.43 (m, 9H), 5.11-5.13 (m, 2H), 4.60-4.69 (m, 2H), 4.34 
(d, J = 6.6 Hz, 2H), 4.20 (t, J = 6.6 Hz, 1H), 3.54 (br s, 3H), 2.96 (d, J = 13.5 Hz, 1H), 2.17 (br d, 
J = 13.5 Hz, 1H), 1.98-2.04 (m, 1H), 1.78-1.88 (m, 1H) 1.57 (ddd, J = 13.1, 13.1, 3.7 Hz, 1H), 
1.42 (br s, 9H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6) δ 171.7, 169.9 and 169.7 (rotamers), 
155.0, 154.8, 143.7 and 143.6 (rotamers, 2C), 140.8 (2C), 136.8 and 136.7 (rotamers), 128.3 
(2C), 127.7 (2C), 127.3 (3C), 127.0 (2C), 125.1 (2C), 120.1 (2C), 81.4, 79.2, 66.4 and 66.3 
(rotamers), 65.4, 56.2 and 56.1 (rotamers), 53.8 and 53.5 (rotamers), 52.0, 46.7, 29.0 and 28.8 
(rotamers), 27.5 (3C), 22.5; HRMS-ES (m/z): 637.2546 (C35H38N2O8 + Na+ requires 637.2526). 
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(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1,5-
dibenzyl ester 2-tert-butyl ester (19) 
The Fmoc protected amino acid 13 (408 mg, 0.67 mmol) was transferred to a 25 mL round 
bottom flask and dissolved in dry DCM (4 mL) under N2 atomsphere. This was followed by 
addition of a catalytic amount of DMAP (8 mg, 0.06 mmol) and then benzyl alcohol (1 mL). The 
resultant solution was cooled in an ice bath and DCC (139 mg, 0.67 mmol) was added in one 
portion. The reaction mixture was allowed to warm up to room temperature and the stirring was 
continued. The reaction progress was monitored by TLC. After the completion of reaction (about 
2 days) the reaction mixture was diluted with DCM and filtered to remove the byproduct DCU 
precipitate. The filtrate was concentrated and absorbed on celite. Any residual solvent was 
removed in vacuo and the crude product on celite was purified by automated flash 
chromatography (40 gm silica columns; Solvent A: Hexanes, Solvent B: EtOAc; Gradient 
elution: 0-5 CVs, solvent A 100% followed by 5-45 CVs, solvent B 0% to 30%). The fractions 
that contain the desired product were combined and the solvent was removed by rotary 
evaporation. The resulting viscous oil was dried in vacuo to yield the desired product 19 (406 
mg, 88%) as a white foam: [α]23D = -15.0 (c 1.8, CHCl3); IR (film) νmax 3322, 2976, 1731, 1526, 
1450, 1321, 1252, 741, 697 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 7.85 (d, J = 7.5 Hz, 
2H), 7.71 (s, 1H), 7.65 (d, J = 7.4 Hz, 2H), 7.26-7.42 (m, 14H), 5.04 (br s, 4H), 4.70 (d, J = 13.3 
Hz, 1H), 4.61 (m, 1H), 4.30 (d, J = 6.6 Hz, 2H), 4.16 (t, J = 6.6 Hz, 1H), 2.97 (d, J = 13.3 Hz, 
1H), 2.20 (br d, J = 13.5 Hz, 1H), 1.98-2.03 (m, 1H), 1.72-1.88 (m, 1H) 1.58 (ddd, J = 12.9, 
12.9, 3.5 Hz, 1H), 1.41 (br s, 9H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6) δ 171.1, 169.9 and 
166.6 (rotamers), 155.1 (2C), 154.7, 143.7 and 143.6 (rotamers, 2C), 140.7 (2C), 136.7, 135.9, 
128.3 (2C), 128.2 (2C), 127.8 (2C), 127.6 (2C), 127.3 (3C), 127.0 (2C), 125.1 (2C), 120.1 (2C), 
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81.4, 79.2, 66.5, 66.0, 65.6, 56.3 and 56.2 (rotamers), 53.7 and 53.5 (rotamers), 46.6, 29.1, 24.5 
(3C) 22.4; HRMS-ES (m/z): 713.2875 (C41H42N2O8 + Na+ requires 713.2839). 
 
General procedure for the hydrolysis of t-butyl esters (14 and 19) 
The t-butyl ester was dissolved in a mixture of 3:7 TFA/DCM (40 mL per mmol of ester) and 
was stirred at room temperature for 2-3 hours. The reaction progress was monitored by TLC. 
After the completion, the reaction mixture was diluted with some toluene (to protect against high 
concentration of TFA during evaporation) and the solvents were removed by rotary evaporation. 
The residual viscous oil was dissolved in DCM and evaporated in vacuo to yield the desired 
product as white foam in quantitative yield. An analytical sample was prepared by manual flash 
chromatography (silica column; solvent: 5% MeOH/CHCl3, Isocratic elution). 
 
(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1,5-
dibenzyl ester (18) 
[α]23D = -16.7 (c 5.1, CHCl3); IR (film) νmax 3317, 3034, 2952, 1717, 1522, 1449, 1315, 1251, 
758, 741, 697 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 12.30 (br s, 1H), 7.85 (d, J = 7.5 
Hz, 2H), 7.69 (s, 1H), 7.65 (d, J = 7.4 Hz, 2H), 7.23-7.42 (m, 14H), 5.03-5.06 (m, 4H), 4.67-4.73 
(m, 2H), 4.28 (d, J = 6.6 Hz, 2H), 4.16 (t, J = 6.6 Hz, 1H), 3.01 (d, J = 13.3 Hz, 1H), 2.22 (br d, J 
= 13.5 Hz, 1H), 2.00-2.06 (m, 1H), 1.85 (m, 1H) 1.59 (ddd, J = 13.2, 13.2, 3.8 Hz, 1H); 13C 
NMR (75.4 MHz, 20 °C, DMSO-d6) δ 172.3 and 172.1 (rotamers), 171.2, 155.1 (2C), 154.7, 
143.7 (2C), 140.8 (2C), 136.7, 135.9, 128.4 (2C), 128.3 (2C), 127.9 (2C), 127.7 (2C), 127.3 
(3C), 127.1 (2C), 125.1 (2C), 120.1 (2C), 79.2, 66.5, 66.1, 65.7, 56.2, 53.2 and 52.9 (rotamers), 
46.6, 29.3, 22.3; HRMS-ES (m/z): 657.2230 (C37H34N2O8 + Na+ requires 657.2213). 
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(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5-methyl ester (3) 
[α]23D = -8.0 (c 0.9, CHCl3); IR (film) νmax 3317, 3033, 2952, 1716, 1523, 1448, 1318, 1237, 758, 
741, 697 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 12.30 (br s, 1H), 7.85 (d, J = 7.5 Hz, 
2H), 7.66 (d, J = 7.4 Hz, 2H), 7.60 (s, 1H), 7.27-7.42 (m, 9H), 5.11 (br s, 2H), 4.67-4.70 (m, 
1H), 4.62 (d, J = 13.3 Hz, 1H), 4.31 (d, J = 6.6 Hz, 2H), 4.19 (t, J = 6.6 Hz, 1H), 3.52 (br s, 3H), 
2.99 (d, J = 13.3 Hz, 1H), 2.17 (br d, J = 13.5 Hz, 1H), 2.00-2.06 (m, 1H), 1.83-1.88 (m, 1H) 
1.57 (ddd, J = 13.1, 13.1, 3.8 Hz, 1H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6) δ 172.3 and 
172.1 (rotamers), 171.7, 155.0, 154.7, 143.7 (2C), 140.8 (2C), 136.8, 128.4 (2C), 127.7 (2C), 
127.3 (3C), 127.1 (2C), 125.1 (2C), 120.3 (2C), 80.3, 78.1, 65.5, 56.1, 52.9, 52.0, 46.7, 29.1, 
22.4; HRMS-ES (m/z): 581.1892 (C31H30N2O8 + Na+ requires 581.1900). 
2.7.3 Solid Phase synthesis 
The Solid phase chemistry was performed on a home-built manual synthesizer. Dry 
dichloromethane used in coupling reactions was obtained from distillation over CaH2. 
Diisopropylethyl amine (DIPEA) was distilled under nitrogen sequentially from ninhydrin and 
potassium hydroxide and stored over molecular sieves (4Å). Rink Acid resin was purchased from 
NovaBiochem. Anhydrous DMF and O-(7-azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium 
hexafluorophosphate (HATU) was obtained from Aldrich. All other reagents used were 
purchased either from Aldrich or Acros and used as such. All solid phase reactions were mixed 
by bubbling argon through the reaction mixture and kept under argon atmosphere. 
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General procedure A: Washing 
In a typical washing sequence, the resin was washed 5 times with DCM and DMF alternately.  
This was followed by a final wash with DCM. 
 
General procedure B: HATU coupling 
In a 1.5 mL polypropylene micro centrifuge vial the amino acid (as given) was dissolved in a 
solution of 10% DCM/ DMF (as given). To this mixture was added DIPEA (as given) followed 
by HATU (as given). The resulting coupling mixture was mixed briefly and immediately added 
to the SPPS reaction vessel carrying the resin. After mixing for the given amount of time, the 
resin was drained and washed according to the general procedure (A). 
 
General procedure C: Fmoc deprotection 
To the SPPS reactor carrying the resin added 1000 μL of a solution of 2% DBU in DMF. After 5 
minutes of mixing, a volume of 40 μL of deprotection mixture was withdrawn and diluted 50 
fold with a solution of 20% piperidine in DMF. A UV-visible spectroscopic analysis of the 
piperidine-fluorenyl adduct was performed and the absorbance at 301 nm (ε = 7800 M-1cm-1) 
was recorded. This value of the absorbance was used to estimate coupling yield. Following the 
Fmoc deprotection, the resin was washed according to general procedure (A). 
 
General procedure D: Capping of the residual free amine 
To the SPPS reactor carrying the resin added 250 μL of a solution of 10% pivalic anhydride in 
pyridine. After 5 minutes of mixing, the resin was drained and washed according to the general 
procedure (A). 
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Solid phase assembly of pip5(2S5S) threemer 
The coupling of Fmoc-glycine to rink acid resin was achieved via a procedure similar to the one 
described in Novabiochem catalogue (2006/07 section 2.17). 18 mg of resin (0.68 mmole/g 
loading) were transferred to a 1 mL polypropylene solid phase peptide synthesis (SPPS) reaction 
vessel and allowed to swell in DMF for 1 hour. 
In a 1.5 mL polypropylene micro centrifuge vial N-α-Fmoc-glycine (18.2 mg, 61.2 
μmol), NMM (1.7 μL, 15.2 μmol), DIPCDI (10.2 μL, 65 μmol) and DMAP (0.1 mg, 0.8 μmol) in 
DCE (306 μL) were mixed for a minute and added to the SPPS reaction vessel carrying the resin. 
After 4 hours of mixing, the solution was drained and the resin was washed according to general 
procedure (A). The terminal Fmoc group was deblocked by general procedure (C). The resin 
loading was determined as 15.1 μmoles and was used for all further calculations of reagents. 
Monomer 18, pip5(2S5S)(OBn) (19.2 mg, 30.2 μmol, 2 equivalent) was dissolved in 20% 
DCM/ DMF solution (151 μL) and coupled for 1.5 hours according to general procedure (B) by 
using DIPEA (10.5 μL, 60.5 μmol) and HATU (11.5 mg, 30.2 μmol). The resin was subjected to 
a second coupling reaction under identical conditions. Any residual free amine was capped 
according to general procedure (D). The terminal Fmoc group was deblocked by general 
procedure (C). The coupling yield was estimated as 85%. 
This coupling sequence was repeated one more time with monomer 18 as above that 
resulted in near quantitative coupling. 
Monomer 3, pip5(2S5S)(OMe) (16.9 mg, 30.2 μmol, 2 equivalent) was dissolved in 20% 
DCM/ DMF solution (151 μL) and coupled for 1.5 hours according to general procedure (B) by 
using DIPEA (10.5 μL, 60.5 μmol) and HATU (11.5 mg, 30.2 μmol). The resin was subjected to 
a second coupling reaction under identical conditions. Any residual free amine was capped 
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according to general procedure (D). The terminal Fmoc group was deblocked by general 
procedure (C). The coupling yield was estimated as near quantitative. 
N-α-Fmoc-O-tert-butyl-L-tyrosine (15.2 mg, 33 μmol, 2.2 equiv) was dissolved in 20% 
DCM/ DMF solution (165 μL) and coupled for 1 hour according to general procedure (B) by 
using DIPEA (11.5 μL, 66 μmol) and HATU (12.6 mg, 33 μmol). The resin was subjected to a 
second coupling reaction under identical conditions. The terminal Fmoc group was deblocked by 
general procedure (C). The coupling yield was estimated as near quantitative. The terminal 
amine was acylated according to general procedure (D). The acylation procedure (D) was 
repeated one additional time to ensure complete acylation. The resin was prepared for cleavage 
by washing with MeOH and DCM alternately followed by drying under reduced pressure. 
The cleavage of the oligomer from resin was affected by treatment of the resin with 10% 
TFA/DCM (0.5 mL) for 5 minute. The cleavage solution was collected after filtration and the 
resin was treated again two more times with TFA solution. All filtered solutions were combined 
and stirred at room temperature for 90 additional minutes to ensure the complete removal of the 
t-butyl group on tyrosine. The solvent was evaporated under a stream of dry nitrogen and any 
residual solvent was removed in vacuo, yielding oligomer 29 as a white residue. 
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HPLC-MS: Column, Waters XTerra MS C18 4.6 mm x 100 mm; mobile phase, MeCN/water 
(0.1% Formic acid), 5% to 95% MeCN over 30 minutes; flow rate, 0.40 mL/min; UV detection 
at 274 nm; tR for 29, 27.1 min; ES-MS: m/z (ion) 1429.3 (M+H+ expected 1429.6) 
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Removal of Cbz groups 
Cbz and benzyl protected oligomer 29 was dissolved in a mixture of 7:2:1 methanol/water/acetic 
acid (2 mL) in a 10 mL round bottom flask. 10 wt.% Pd on activated carbon (~ 5 mg) was added 
to this solution and after degassing under reduced pressure the reaction flask was backfilled with 
H2 gas several times. The process of degassing and backfilling with H2 gas was repeated and the 
stirring was continued overnight. The reaction mixture was filtered through a Spin-X centrifuge 
filter (0.2 micron nylon frit). The residue was washed with methanol (2 x 100 μL) and all filtrates 
were combined. A small volume (10 μL) was set aside for HPLC-MS analysis and rest of the 
solution was dried in vacuo to yield 21 as a white solid. 
HPLC-MS: column, Waters XTerra MS C18 4.6 mm x 100 mm; mobile phase, MeCN/water 
(0.1% Formic acid), 5% to 95% MeCN over 30 minutes; flow rate, 0.40 mL/min; UV detection 
at 274 nm; tR for 21, 10.3 min; ES-MS m/z (ion) 847.3 (M+H+ expected 847.4). 
 
DKP closure via in situ activation methodology 
Oligomer 21 was dissolved in 1.5 mL of dry NMP in a 10 mL round bottom flask and a small 
volume (10 μL) was set aside for HPLC-MS analysis. To the rest of the solution, DIPEA (40 μL, 
230 μmol, 6 equiv per amide bond) was added. This was followed by addition of DCC (25 mg, 
126 μmol, 3 equiv per amide bond, predissolved in 250 μL of NMP) and N-hydroxysuccinimide 
(25mg, 220 μmol, 6 equiv per amide bond, predissolved in 250 μL of NMP). The reaction 
mixture was stirred at room temperature. In order to monitor the reaction progress, a volume of 5 
µL was withdrawn from the reaction mixture and injected into HPLC-MS for analysis. After 24 
hours of stirring the reaction was complete as indicated by HPLC-MS. 
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HPLC-MS: column, Waters XTerra MS C18 column 4.6 mm x 100 mm; mobile phase, 
MeCN/water (0.1% Formic acid), 5% to 95% MeCN over 30 minutes; flow rate, 0.40 mL/min; 
UV detection at 274 nm; tR for 22, 13.9 min; ES-MS m/z (ion) 793.3 (M+H+ expected 793.4). 
The reaction mixture was filtered through a Spin-X centrifuge filter and purified by preparative 
HPLC on a Varian ProStar 500 HPLC system with a Varian Chrompack Micrsorb 100-C18 
column (8 μm packing; 21.5mm x 50mm): mobile phase, MeCN (0.1%TFA)/water (0.05% 
TFA), 5% to 95% MeCN over 30 minutes; flow rate, 15 mL/min; UV detection at 274 nm). The 
product containing fractions were lyophilized to yield the desired rigidified oligomer 22 as a 
fluffy white powder (2.5 mg). HRMS-ES (m/z): 793.3606 (C38H48N8O11 + H+ requires 
793.3521). 
NMR Sample Preparation 
Approximately 2.5 mg of purified oligomer 22 was dissolved in 400 μL of 9:1 H2O/D2O and 
transferred to an advanced microtube matched with D2O purchased from Shigemi, Inc. All 1-D 
and 2-D spectra at room temperature were recorded either on Bruker 500MHz or 600MHz 
instrument. NMR spectra (1D and 2D) and other relevant data are supplied in appendix. 
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3.0  IMPROVED METHODOLOGY FOR DIKETOPIPERAZINE FORMATION AND 
APPLICATION TO THE ASSEMBLY OF HETEROOLIGOMERS 
As described in Chapter 2, we successfully utilized in-situ activation of carboxylic acid for the 
formation of amide bonds for the rigidification of small oligomers, however it was not 
extendable to long sequences. This prompted us to reconsider ester aminolysis for DKP 
formation. 
Diketopiperazine formation has been the subject of several reviews and numerous 
catalysts have been reported for aminolysis.169, 170 A particularly facile reagent and the one that 
we initially used to catalyze an intramolecular aminolysis reaction between an amine and an 
ester, was a 20% (v/v) solution of piperidine in dimethylformamide (Scheme 9).108, 111 We found 
these conditions to be quite effective for pro4 monomers, but they were not ideal for several 
reasons. Occasionally, precipitate would form in the reaction mixture and the yield of fully 
closed product was low. We also discovered that for oligomers containing hin(2S4R7R9R) or 
pip5(2S5S) the DKP formation between monomers under 20% piperidine in dimethylformamide 
was very slow or undetectable. 
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Scheme 9: Diketopiperazine formation in a bis-peptide by 20% piperidine/DMF catalyzed aminolysis  
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The rate of DKP formation is known to be sensitive to the stereochemistry and nature of 
the substituents on the forming DKP ring.171 This would rationalize a big difference observed in 
rates of DKP closure with various monomers. An obvious solution would have been to carry out 
the DKP closure at higher temperature. Unfortunately we couldn’t use high temperatures or long 
reaction times to drive the aminolysis reaction towards completion because DKPs tend to 
epimerize under basic conditions.172 It was for this reason that we undertook this search for an 
appropriate bifunctional catalyst for DKP closure. 
Apart from being a base catalyzed reaction, aminolysis is also known to be catalyzed by 
bifunctional catalysts including carboxylic acids171, 173, 174 as well as neutral compounds,175 such 
as 1,2,4 triazole and 2-pyridone. One advantage of using a bifunctional catalyst is that the 
reaction conditions utilized are either neutral or mildly acidic. These reaction conditions are not 
conducive for epimerization. Thus we could use long reaction time or high temperature to 
accelerate the DKP formation without fear of epimerization. 
There are numerous reports on the use of bifunctional catalysts for aminolysis and a wide 
range of compounds have demonstrated catalytic ability as catalyst. These examples are largely 
for bimolecular reactions and include carboxylate anion,171 2-hydroxypyridine,175-178 DMAP,179 
imidazole,175 nucleosides,180 cyanide,181 1,2,4-triazole175 and catechol.182 There are also some 
reports of intramolecular variant which involve the formation of five- and six-membered 
rings.171, 173, 183 After a careful survey of available options we selected acetic acid for its 
simplicity. Acetic acid has been discovered by Gisin and Merrifield171 to accelerate DKP 
formation in dipeptides. We also selected 2-hydroxypyridine175 because of its catalytic activity in 
a variety of reactions. (Figure 12) 
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Figure 12: Bifunctional catalysts used in present study 
 
As pointed out earlier, another problem with DKP formation was that occasionally 
intermediates precipitated out of the solution that we believe stalled any further DKP formation. 
We reasoned that by closing DKPs on resin, the solubility problem could be avoided. Any 
byproducts of the reaction could be easily washed away, yielding expected rigidified products 
with high purity. Also, the oligomer could be further functionalized while is still attached to the 
resin that would further reduce the number of reaction and purification steps needed. 
3.1 STUDIES ON DKP FORMATION  
In order to explore different solvents, catalyst concentrations and temperatures we chose to close 
the diketopiperazines on solid support and measure the kinetics thereof. As DKP are closed on 
resin an equimolar amount of alcohol is formed that passes into solution in which the resin is 
suspended. We reasoned that if this alcohol was a UV chromophore, the extent of DKP closure 
could be estimated by measuring the amount of released alcohol. p-Nitrobenzylalcohol was 
chosen for these kinetic studies because of high absorbance and ease of ester formation. 
Accordingly, monomer 32 and 33 were obtained from Fmoc amino acid intermediates 29 and 13 
respectively, in a 2-step procedure that involved ester formation via nucleophilic substitution by 
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carboxylate at p-nitrobenzyl bromide followed by unmasking of carboxylic acid functionality 
with TFA as shown in Scheme 10. 
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Scheme 10: Synthesis of pNB ester version of monomers 
 
Also we needed to expose a secondary amine after the solid phase assembly on each 
monomer so that DKP formation could be carried out while the oligomer is still attached to solid 
support. This was accomplished using monomers 35 and 36 that were obtained by exchanging a 
Cbz protecting group with a Boc group184 on pro4(2S4S) and pip5(2S5S) monomers (Scheme 
11). 
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Scheme 11: Cbz to Boc exchange for the synthesis of monomers 35 and 36 
 
We assembled all 4 possible combinations of bis-amino acid dimers 37a-d, using 
monomers 32, 33, 35 and 36 on TFMSA cleavable but TFA stable MBHA185 resin. Our goal was 
to find the combination that gave the slowest reaction rate by measuring the kinetics of DKP 
formation in a flow-cell containing resin bound dimers 37a-d and optimize the reaction 
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conditions for this dimer. This was to make sure that upon using these optimized reaction 
conditions the DKP formation on resin was complete for all monomers. We hypothesized that 
this could be accomplished by quantifying the amount of para-nitrobenzyl alcohol in the effluent 
as different catalyst solutions were flowed over the resin at varying temperatures (Figure 13). 
This was to be followed by optimization of the catalyst solutions against the slowest combination 
and find conditions under which all diketopiperazines close rapidly. 
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Figure 13: On resin diketopiperazine formation reaction with bis-amino acid dimers 
3.1.1 Effect of monomer combination  
A series of diketopiperazine closures experiments was performed using two bifunctional 
catalysts, 2-pyridone and acetic acid, to examine how the nature of the monomers affects the rate 
of intramolecular aminolysis. The kinetic data obtained were used to calculate half-lives for the 
aminolysis reaction in each set of experiments (Table 1). 
Gisin and Merrifield171 found that the maximum rate of acetic acid catalyzed DKP 
formation occurred at an AcOH concentration of 80 mM. We used the same concentration for 
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our experiments as well. Deutero acetic acid was used because epimerization of 38a-d would 
give rise to an increase in molecular weight of at least one Dalton. 
Rony and coworkers175 studied the aminolysis of 4-nitrophenyl acetate by n-butylamine 
in benzene and concluded that 2-pyridone provided the greatest acceleration and the rate of 
reaction increased with the concentration of catalyst. We chose 50 mM as a starting point 
because at this concentration o-xylene becomes nearly saturated with 2-pyridone. Some triethyl 
amine was also added to the catalytic solution to minimize dimerization of 2-pyridone. Addition 
of a base lowers the dimerization constant by preferentially solvating monomeric form of 2-
pyridone.175 
 
Table 1: Half-lives of DKP formation using 2-pyridone and acetic acid as catalysts 
 
Half life t1/2 (min) for DKP closure sequence 
(Figure 13) 50 mM 2-pyridone, 1mM Et3N, 
o-xylene, 130 °C 
80 mM AcOD, DMF, 100 °C 
pro4-pro4(37a?38a) <4 6.5 
pro4-pip5(37b?38b) <4 12 
pip5-pro4(37c?38c) 15 16 
pip5-pip5(37d?38d) 17 78 
 
A comparison of half lives observed for different combinations of monomers showed that 
2-pyridone and acetic acid are both competent bifunctional catalysts under the given conditions 
(Table 1). An 80 mM solution of acetic acid-d in dimethylformamide at 100 °C is a good catalyst 
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for the formation of 38a-c but four times slower for the formation of 38d. This indicated that for 
acetic acid, the rate of DKP formation is dependent on both monomers, leading and trailing.  
A similar trend was observed with 50 mM 2-pyridone in o-xylene at 130 °C as catalyst, 
except that the dependence on the leading monomer, i.e. the one that carries the ester 
functionality was more prominent. When the dimers 38a-d were cleaved from the resin, no 
epimerization was observed in any experiments. 
3.1.2 Effect of temperature and concentration on catalysis by 2-pyridone 
Initially it appeared that 2-pyridone is more effective than acetic acid in accelerating the DKP 
formation and could be a viable solution to our DKP formation problems. In order to confirm 
this we examined the effect of temperature and concentration of 2-pyridone on the rate of 
formation of 38c. (Table 2). 
 
Table 2: The half-life of DKP formation for the formation of 38c 
 
Reaction conditions Half life t1/2 (min) 
10 mM 2-pyridone, 1 mM Et3N, toluene, 100 °C 158 
50 mM 2-pyridone, 1 mM Et3N, toluene, 100 °C 72 
50 mM 2-pyridone, 1 mM Et3N, o-xylene, 130 °C 15 
 
The data showed that 2-pyridone at 10 mM concentration was not an effective catalyst at 
100 °C. Increasing the catalyst concentration 5-fold to 50 mM accelerated the reaction but only 
by a factor of 2. We attributed this moderate increase to the tendency of 2-pyridone to dimerize 
55 
in non-polar solvents.186 Increasing the concentration only helps in pushing the equilibrium 
between its active form (monomer) and inactive form (dimer) towards the dimer. Also, the 
solubility of 2-pyridone was not much higher than 50 mM in o-xylenes and there was little room 
for improvement. 
 
3.1.3 Solvent and temperature effect on catalysis by acetic acid 
To explore more optimal acetic acid catalyzed DKP formations conditions, we investigated the 
effect of solvent and temperature on AcOD catalyzed formation of 38b (Table 3). The 
concentration of acetic acid was kept unchanged throughout the comparative experiments to 
simplify the interpretation of the observed trends. 
 
Table 3: The solvent and temperature effect on DKP formation in 37b for 80 mM AcOD as catalyst 
 
Half life, t1/2 (min) for Temperature 
( T °C) DMF o-xylene 
40 126 n/a 
70 31 115 
100 12 18 
130 <4 <2 
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As anticipated, increasing the temperature accelerates the rate of DKP formation in both 
solvents. However, the temperature effect was stronger in non polar solvent i.e. o-xylene. At 
lower temperatures the reaction was faster in DMF (e.g. 70 °C) but at higher temperatures o-
xylene accelerated reaction more than DMF. Dimethylformamide is not considered a suitable 
reaction medium at elevated temperatures as it decomposes above 100 °C. On the other hand o-
xylene doesn’t have this limitation and can be safely used at temperatures up to 130-135 °C. 
From the above analysis, we concluded that 80 mM AcOD in o-xylene at 130 °C served 
as an effective catalyst. We used these conditions for sequence 37d, that represents a pip5-pip5 
combination, the half-life was found to be 12.5 minutes. This entailed that more than 1.5 hour (7 
half-lives) was needed to ensure > 99 % DKP closure. This prompted us to continue the search 
for even better reaction conditions for aminolysis. 
3.1.4 Effect of added triethyl amine on catalysis by acetic acid 
The work of Capasso and co-workers187 suggested that triethylammonium acetate was at least ten 
times faster at catalyzing DKP formation than acetic acid by itself. Following their lead, we 
examined the effect of adding triethylamine to the catalyst solution and found that DKP 
formation was accelerated by a factor of two to three in the formation of 38d (Table 4) relative to 
when no triethylamine was added. 
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Table 4: The half life of diketopiperazine formation in the reaction 37d→38d exploring different 
concentrations of acetic acid and triethylamine. 
 
Solvent: o-xylene, 
Temperature: 130 °C 
Half life 
t1/2 (min) 
80 mM AcOD 12.5 
50 mM AcOD 9.5 
50 mM AcOD + 50 mM Et3N 5 
100 mM AcOD + 50 mM Et3N 4.3 
1 mM Et3N 266 
 
Giralt and coworkers188 have shown that trifluoroacetic acid inhibited the DKP formation 
via aminolysis reaction. It is likely that in Capasso’s studies187 the triethylamine served to 
neutralize the acidic trifluoroacetate salt of the dipeptides that underwent diketopiperazine 
formation. In our system, we free-base our amines on solid support by washing the deprotected 
resin with triethylamine in dimethylformamide prior to diketopiperazine closure. This could 
explain the moderate increase in the rate of aminolysis observed for our systems. Nonetheless, 
this 2 to 3 fold acceleration provided by addition of triethylamine was sufficient to drive the 
DKP closure reaction in pip5-pip5 dimer to completion in less than 20 minutes. We believe that 
Et3N helps in DKP formation by neutralizing the secondary amines and the carboxylic acid 
catalyzes the aminolysis reaction. 
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3.2 ATTEMPTED ON-RESIN DKP CLOSURE WITH METHYL ESTER 
Next we wanted to test if methyl ester versions of pro4 and pip5 monomers could be used for 
DKP closure as p-nitrobenzyl ester version of monomers (32 and 33) couldn’t be used without 
retooling the monomer synthesis. p-Nitrobenzyl ester is sensitive to hydrogenolysis, that is used 
to exchange the Cbz group with a Boc group during the synthesis of the monomer. For our 
strategy of on-resin DKP to be effective this swapping is highly desired as the Boc group can be 
quantitatively removed on MBHA resin by 1:1 TFA/DCM to free the secondary amine for DKP 
closure. If successful, we could use the existing methyl ester versions of monomers, without a 
need to retool the synthesis of monomers. 
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Figure 14: DKP closure between two pro4 monomers with methyl esters 
 
The answer came from a series of experiments performed in collaboration with Megan 
Macalla, a fellow graduate student in research group. She measured the rate of closure of a pro4-
pro4 dimer using methyl ester bearing monomers (Figure 14). In this case, the intramolecular 
aminolysis reaction was between a secondary amine and a methyl ester rather than a secondary 
amine and a p-nitrobenzyl ester such as 32. The results showed that for pro4-pro4 combinations 
under microwave irradiation and 80 mM AcOD in o-xylene as catalyst, the use of methyl ester in 
place of p-nitrobenzyl ester slows down the rate of DKP formation by a factor of 5.5. 
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By using 5.5 as a scaling factor, we projected that the half-life for pip5-pip5 
combinations with methyl esters using the optimized reaction conditions (100 mM AcOD, 50 
mM Et3N in o-xylene at 130 °C, μwave) should be 20-30 minutes. 
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Figure 15: On-resin DKP closure using μwave for a dimer of pip5 (2S5S) monomers with methyl ester. 
 
To test this prediction we assembled a dimer 41 from two pip5(2S5S)(OMe) monomers 
on MBHA resin and subjected it to microwave irradiation in presence of 100 mM AcOH and 50 
mM Et3N in o-xylene at 130 °C for 1 hr. (Figure 15) The oligomer was then cleaved from the 
resin using TFMSA. The analysis of the product by HPLC-MS revealed complete conversion to 
the expected product 42 without any side product or epimerization. 
Buoyed by this favorable result, we assembled a short oligomer (4-mer) from 
pip5(2S5S)(OMe) monomers 3 and attempted DKP closure under the conditions as utilized for 
dimers. To our surprise, even after 8 hours of microwave heating we obtained a little product 
with mostly a mixture of products that corresponded to one failed DKP formation. 
We hypothesized that this failure to close DKP in an oligomer other than a dimer can be 
attributed to the difference in reaction environment felt by different pairs of monomers 
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undergoing DKP closure. A pair of monomers preceded or followed by a monomer might need 
to overcome a higher energy barrier for DKP formation than the pair without a preceding or 
following monomer. This scenario is further complicated by the statistical probability that DKP 
formation between a pair of monomers could take place in any order thus changing the energy 
landscape for later DKP formations. This result forced us to explore ways to further improve our 
DKP formation methodology that could overcome this probable decrease in rate of DKP 
formation for longer sequences. 
3.3 2,2,3,3 TETRAFLUORO PROPYL ESTERS TO ACCELERATE DKP 
FORMATION 
Bimolecular aminolysis of activated esters has been studied in great detail by Menger et al.189, 190 
They showed that in a non polar medium, the rate determining step is the breakdown of the 
tetrahedral intermediate to yield amide product and an alcohol. This suggested that the rate of 
aminolysis can be accelerated by using a more activated ester i.e. the corresponding alcohol has a 
lower pKa value. That would convert the alcohol into a better leaving group and thus accelerate 
the collapse of tetrahedral intermediate. 
Methyl alcohol has a pKa value of 15.5. On the other hand the pKa value for p-
nitrobenzyl alcohol is only 13.6 and thus it is a better leaving group than methanol. This 
difference of 1.9 units in pKa values is sufficient to account for the observed slower rate of DKP 
formation for methyl ester version of monomers than p-nitrobenzyl ester versions that we used 
for the optimization experiments. This suggested that by using an alcohol of lower pKa value for 
the ester formation we could further enhance the rate of DKP formation. 
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As observed during optimization studies, the rate enhancement provided by p-nitrobenzyl 
esters is good enough to affect DKP closure between two pip5(2S5S) monomer. However p-
nitrobenzyl ester is incompatible with our on-resin DKP formation strategy. This forced us to try 
out other alcohols with lower pKa values for the ester formation. These alcohols with their 
corresponding pKa values are shown in Figure 16. 
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Figure 16: pKa’s of alcohols screened for feasibility of DKP closure (Source: SciFinder Scholar). 
 
We explored trifluoroethyl, trichloroethyl and acetoxy ester versions of the pip5(2S5S) 
monomer and found that they are not suitable for synthesis of the oligomers as they react with 
piperidine and DBU during the assembly of oligomers. After an extensive search we found that 
2,2,3,3-tetrafluoro propyl esters are a good compromise between stability towards piperidine (or 
DBU) and reactivity in DKP formation. 
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3.3.1 Synthesis of TFP ester version of pro4(2S4S) and pip5(2S5S) monomer 
We developed the second generation monomers 47 and 48, TFP ester versions of pro4(2S4S) and 
pip5(2S5S) as a replacement for the methyl esters version of our first generation monomer 35 
and 36. The Fmoc protected amino acid 29 (and 13) was esterified with 2,2,3,3 tetrafluoro 
propanaol using DCC in the presence of catalytic DMAP and the t-Bu group was subsequently 
removed by treatment with 3:7 TFA/DCM to give 45 (and 46), the Cbz protected version of the 
monomer. Then the Cbz group was exchanged with a Boc group under hydrogenolysis 
conditions to yield monomer 47 (and 48) which is suitable for oligomer assembly for on-resin 
DKP formation (Scheme 12). In a similar manner, we have also synthesized 64 and 65, the TFP 
ester versions of pro4(2S4R) and pip5(2S5R) respectively as shown in Scheme 14 (Experimental 
Section). 
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Scheme 12: Synthesis of 2nd generation of pro4(2S4S) and pip5(2S5S) monomers 
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3.3.2 A test of new DKP closure conditions against pip5(2S5S) pentamer 
To test our best catalysis conditions, we assembled a pentamer 49 from pip5(2S5S) monomers 
48 on a MBHA resin by using standard Fmoc solid phase synthesis methodology. We removed 
the Boc protecting group on each monomer and neutralized the amine to form intermediate 49. 
The resin bound open oligomer 49 was suspended in 100 mM AcOD, 50 mM Et3N and exposed 
to microwaves at 130°C for 30 minutes (Scheme 13). The oligomer was cleaved from the resin 
by treatment with TFMSA and the resulting product was characterized by C18 reverse phase 
HPLC with mass spectrometry (Figure 17). The major peak was the desired product 50. Two 
small peaks representing intermediates that had failed to close one diketopiperazine were also 
observed but there was no evidence of epimerization of 50. 
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Figure 17: The unpurified reverse phase C18 HPLC chromatograms of 50 (0.1% HCO2H, 0-25% AcN over 
30 min). The main peak is the desired product (m/z=941). 
 
This result showed that we can simultaneously close five DKP rings in a homooligomer 
consisting of the most difficult combination that is between pip5(2S5S) monomers, in less than 
30 minutes. In later experiments we observed that microwave irradiation was not necessary and 
similar results can be obtained with conventional heating in a flow cell. 
3.4 DKP CLOSURE IN SMALL HETEROSEQUENCES BY ACOH/ET3N 
CATALYSIS 
We then set out to synthesize a small library of structurally diverse bis-peptide oligomers 
containing pip5(2S5S) and pro4(2S4S) monomers and test the efficacy of our newly optimized 
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conditions for diketopiperazine formation. We designed four hetero sequences 51-54 and 
assembled them on hydroxymethyl polystyrene resin191 (Figure 18) by standard Fmoc solid 
phase peptide synthesis methodolgy. This was followed by on resin diketopiperazine formation 
in a flow cell apparatus catalyzed by 100 mM AcOH and 50 mM Et3N in o-xylene at 130 °C. 
 
 
 
Figure 18: Assembly of short hetero oligomers and on resin diketopiperazine formation by continous flow 
method using optimized catalytic conditions. 
 
The resin cleavage products 55-58 were purified by C18 reverse phase preparative HPLC 
characterized by high resolution mass spectrometry. The analysis of the crude products before 
purification by C18 reverse phase HPLC reveals that in all four cases diketopiperazine formation 
was very clean. Only trace amounts of any products with one diketopiperazine ring unclosed 
were detected. A representative chromatogram for oligomer 58 is shown in Figure 19. The 
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oligomers 55, 56, 57 and 58 gave rise to high resolution mass spectra with m/z = 762.2927, 
762.2844, 762.2880 and 762.2865 respectively (calculated 762.2847). 
 
 
Figure 19: The unpurified reverse phase C18 HPLC chromatograms of 58 (0.1% HCO2H, 0-25% AcN over 
30 min). The main peak is the desired product (m/z=762). 
 
These results confirmed that these new AcOD/Et3N catalyzed microwave assisted and 
continuous flow conditions for DKP closure were good for all combinations of monomers 47 and 
48. Now we could close multiple diketopiperazines on solid support with no evidence of 
epimerization. 
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3.5 SUMMARY 
We explored bifunctional catalysts for DKP closure on solid support. A range of reaction 
conditions were screened against combinations of pro4(2S4S) and pip5(2S5S) monomers. As 
observed in previous chapter, pip5-pip5 combination was found to be the slowest one. We 
optimized AcOD/Et3N catalyzed, microwave assisted and continuous flow conditions for 
simultaneously closing multiple diketopiperazines on solid support with no evidence of 
epimerization. By developing the 2nd generation monomers 47 and 48 that carry a TFP ester in 
place of a methyl ester, we further enhanced the rate of DKP formation. As a proof of the 
viability of these new reaction conditions we assembled and performed DKP closure on a 
pentamer 50 made of pip5(2S5S) and small heteroligomers 55-58 consisting of various 
combinations of pro4(2S4S) and pip5(2S5S) monomers in less than 1 hour. 
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3.6 EXPERIMENTAL METHODS 
3.6.1 General procedures 
THF was distilled from Na/benzophenone under nitrogen atmosphere. CH2Cl2 was distilled from 
CaH2. All other reagents were used as received unless otherwise noted. All the reactions were 
carried out in flame-dried or oven-dried glassware under nitrogen atmosphere unless otherwise 
noted. 
Column chromatography was performed either manually using 32-63 D (60 Å particle 
size) grade silica gel or using commercially available normal phase flash chromatography silica 
gel columns on automated purification system. For a typical purification, the compound was 
dissolved in a minimum amount of dichloromethane and after mixing with celite, the solvent was 
removed by rotary evaporation. The resulting solid mixture was transferred to a 10 g or 40 g 
loading column. To obtain best results, any residual solvent was removed by drying under 
reduced pressure. Analytical TLC analysis was performed on Silica Gel plates (250 μm 
thickness). 
NMR experiments were performed on 300 MHz spectrometer. Chemical shifts (δ) are 
reported in parts per million (ppm) relative to DMSO-d6 residual solvent peaks. If possible, 
rotational isomers were resolved by obtaining spectra at 77 °C (350K) in DMSO-d6. IR spectra 
were obtained on a FT-IR instrument. Optical rotations were obtained at ambient temperature (23 
± 2 °C). HPLC-MS analysis was performed on a Waters Xterra C18 column (3.5 μm packing, 4.6 
mm x 150 mm) coupled to a Mass Spectrometer (ESI source). The elemental composition of 
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purified compounds was confirmed by the spectrums obtained on a high resolution mass 
spectrometer with an electrospray ion source (HRESIQTOFMS). Purification by preparative 
HPLC was carried out on a semiprep C18 column (5μm packing, 10 mm x 100 mm). 
Solid phase chemistry was performed on a home-built manual synthesizer. Dry 
dichloromethane used in coupling reactions was obtained from distillation over CaH2. 
Diisopropylethyl amine (DIPEA) was distilled under nitrogen sequentially from ninhydrin and 
potassium hydroxide and stored over molecular sieves (4 Å). Resins for solid phase synthesis 
were purchased from NovaBiochem. All other reagents and dry solvents were obtained from 
various commercial sources and used as such. All solid phase reactions were mixed by bubbling 
argon through the reaction mixture.  
3.6.2 Synthesis of monomers 
(2S,4S)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1-
benzyl ester 4- (p-nitro)benzyl ester 2-tert-butyl ester (30) 
A suspension of 29 (418 mg, 0.71 mmol), KI (119 mg,0.71 mmol, 1 equiv.) and NaHCO3 (57 
mg, 0.67 mmol, 0.9 equiv.) was prepared in anhydrous DMF (5 mL, 7 mL per mmol of 
substrate) in a 25 mL round bottom flask under N2 atmosphere. To this suspension p-nitrobenzyl 
bromide (383 mg, 1.8 mmol, 2.5 equiv.) was added in one portion. The stirring was continued at 
room temperature and the reaction progress was monitored by HPLC-MS. After completion of 
the reaction (about 10 hours), water (15 mL) was added to the reaction mixture and extracted 
with EtOAc (30mL + 2x10 mL). All the organic layers were combined and washed with brine 
(10 mL). This solution was dried over anhydrous Na2SO4, filtered and concentrated by rotary 
evaporation. The crude product was mixed with celite and then purified by automated flash 
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chromatography (10 gm silica column; Solvent A: Hexanes, Solvent B: EtOAc; Gradient elution: 
0-60 CVs, solvent B 5% to 35%). The fractions that contain the desired compound were 
combined and concentrated by rotary evaporation. The residual solvent was removed by 
overnight drying under reduced pressure to yield 30 (411 mg, 5.7 mmol, 80%) as a white foam: 
[α]23D = +11.0 (c 1.15, CHCl3); IR (film) νmax 3317, 2977, 1711, 1523, 1449, 1417, 1347, 1259, 
1156, 749, 740, 697 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 8.07 (d, J = 8.4 Hz, 2H), 
8.00 (s, 1H), 7.85 (d, J = 7.5 Hz, 2H), 7.64 (d, J = 7.5 Hz, 2H), 7.53 (d, J = 8.4 Hz, 2H), 7.26-
7.42 (m, 9H), 5.22 (br s, 2H), 5.08 (br s, 2H), 4.03-4.39 (m, 5H), 3.64 (d, J = 11.4 Hz, 1H), 2.87 
(br m, 1H), 2.33 (br m, 1H), 1.37 (s, 9H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): mixture of 
rotamers δ 171.0, 170.1, 169.8, 155.8, 153.5, 153.2, 146.9, 143.4, 143.1, 140.6, 136.5 and 136.3, 
128.4, 128.1, 127.8, 127.7, 127.5, 127.4, 127.2, 126.9, 125.0, 123.2, 120.0, 81.0, 66.2 (CH2), 
65.8 (CH2), 65.5 (CH2), 63.1 and 62.2, 58.3 and 58.0 (CH), 54.7 and 54.3 (CH2), 46.4 (CH), 38.6 
and 37.6 (CH2), 27.4 and 27.3 (CH3, 3C); HPLC-MS: MeCN (0.05% Formic acid) / water (0.1% 
Formic Acid), 5% to 95% MeCN over 30 min; flow rate 0.80 mL/min; UV detection at 274 nm; 
tR for 30 29.09 min; HRESIQTOFMS calcd for C40H39N3O10Na (M + Na+) 744.2533, found 
744.2532. 
 
(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5-(p-nitro)benzyl ester 2-tert-butyl ester (31) 
129 mg (0.21 mmol) of 13 yielded 112 mg (0.16 mmol, 76%) of 31 as a white foam according to 
the procedure given above for 30: [α]23D = -9.1 (c 1.5, CHCl3); IR (film) νmax 3333, 3030, 2955, 
1716, 1521, 1449, 1347, 1317, 1254, 749, 741, 667 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) 
δ 8.06 (d, J = 8.7 Hz, 2H), 7.85 (d, J = 7.5 Hz, 2H), 7.80 (s, 1H), 7.65 (d, J = 7.5 Hz, 2H), 7.52 
71 
(d, J = 8.4 Hz, 2H), 7.39 (dd, J= 7.5,7.5 Hz, 2H), 7.26-7.31 (m, 7H), 5.17 (br s, 2H), 5.08 (br s, 
2H), 4.71 (br d, J = 13.5 Hz, 1H), 4.64 (m, 1H), 4.30-4.33 (m, 2H), 4.16 (t, J = 6.6 Hz, 1H) 2.99 
(br d, J = 13.2 Hz, 1H), 2.24 (br d, J = 13.5 Hz, 1H), 2.04 (br d, J = 14.1 Hz, 1H), 1.86 ( br m, 
1H), 1.63 (br dd, J = 12.9, 12.9, Hz, 1H), 1.42 (s, 9H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): 
mixture of rotamers δ 170.9, 169.8, 169.5, 155.1, 155.0, 154.7, 146.9, 143.6, 143.5, 140.7, 136.6, 
128.3, 128.2, 127.7, 127.6, 127.2, 126.9, 125.0, 123.3, 120.1, 81.4, 66.4 (CH2), 65.6 (CH2), 64.8 
(CH2), 56.3, 56.2, 53.7 and 53.5(CH), 46.6 (CH2), 46.5 (CH), 29.0 and 28.8 (CH2), 27.5 and 27.4 
(CH3, 3C), 22.4 and 22.3 (CH2); HPLC-MS: MeCN (0.05% Formic acid) / water (0.1% Formic 
Acid), 5% to 95% MeCN over 30 min; flow rate 0.80 mL/min; UV detection at 274 nm; tR for 
31, 29.50 min; HRESIQTOFMS calcd for C41H41N3O10Na (M + Na+) 758.2690, found 758.2698. 
 
(2S,4S)-4-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1-
benzyl ester 4- (p-nitro)benzyl ester (32) 
205 mg (0.28 mmol) of 30 was dissolved in 3:7 mixture of TFA/ DCM (6 mL, 20 mL per mmol 
of substrate) and stirring was continued for 2 hours at room temperature. After confirming the 
disappearance of substrate by TLC (5:1 CHCl3/MeOH, visualized under UV), the reaction 
mixture was diluted with toluene (6 mL) and concentrated by rotary evaporation. This step of 
adding toluene and evaporation in vacuo was repeated one additional time to ensure complete 
removal of TFA. The crude product was mixed with celite and then purified by automated flash 
chromatography (10 gm silica column; Solvent A: CHCl3, Solvent B: 10% CHCl3 in MeOH; 
Gradient elution: 0-60 CVs, solvent B 0% to 100%). The fractions that contain the desired 
compound were combined and concentrated by rotary evaporation. The residual solvent was 
removed by overnight drying under reduced pressure to yield 32 (175 mg, 0.26 mmol, 93%) as a 
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white foam: [α]23D = -18.0 (c 2.4, CHCl3); IR (film) νmax 3307, 3033, 2953, 1709, 1523, 1450, 
1422, 1348, 1263, 749, 741, 697 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 8.05 (d, J = 8.4 
Hz, 3H, overlap with Fmoc-NH-), 7.84 (d, J = 7.5 Hz, 2H), 7.65 (d, J = 7.5 Hz, 2H), 7.52 (d, J = 
8.4 Hz, 2H), 7.27-7.42 (m, 9H), 5.22 (br s, 2H), 5.08 (br s, 2H), 4.13-4.37 (m, 5H), 3.61 (d, J = 
11.4 Hz, 1H), 2.90 (br m, 1H), 2.33 (br m, 1H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): 
mixture of rotamers δ 172.7, 172.4, 171.3, 156.0, 153.7, 153.5, 147.0, 143.6, 143.2, 140.7, 136.6, 
128.5, 128.3, 127.9, 127.6, 127.5, 127.0, 125.2, 123.3, 120.1, 79.2, 66.3 (CH2), 66.0 (CH2), 65.5 
(CH2), 63.0 and 62.2, 57.8 and 57.5 (CH), 54.9 and 54.5 (CH2), 46.5 (CH), 38.7 and 37.6 (CH2); 
HPLC-MS: MeCN (0.05% Formic acid) / water (0.1% Formic Acid), 5% to 95% MeCN over 30 
min; flow rate 0.80 mL/min; UV detection at 274 nm; tR for 32, 25.21 min; HRESIQTOFMS 
calcd for C36H31N3O10Na (M + Na+) 688.1907, found 688.1906. 
 
(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5- (p-nitro)benzyl ester (33) 
112 mg (0.15 mmol) of 31 yielded 95 mg (14.0 mmol, 92%) of 33 as a white foam according to 
the procedure given above for 32: [α]23D = -6.4 (c 0.8, CHCl3); IR (film) νmax 3333, 3030,2955, 
1716, 1521, 1449, 1347, 1317, 1254, 749, 741, 667 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) 
δ 8.05 (d, J = 8.4 Hz, 2H), 7.85 (d, J = 7.2 Hz, 2H), 7.78 (s, 1H), 7.65 (d, J = 7.2 Hz, 2H), 7.52 
(d, J = 8.1 Hz, 2H), 7.27-7.42 (m, 9H), 5.15 (br s, 2H), 5.07 (br s, 2H), 4.70-4.74 (m, 2H), 4.29 
(d, J = 6.6 Hz, 2H), 4.16 (t, J = 6.6 Hz, 1H) 3.05 (br d, J = 13.2 Hz, 1H), 2.25 (br d, J = 13.2 Hz, 
1H), 2.08 (br d, J = 11.4 Hz, 1H), 1.88 ( br m, 1H) 1.63 (br dd, J = 12.9, 12.9, Hz, 1H); 13C NMR 
(75.4 MHz, 20 °C, DMSO-d6): mixture of rotamers δ 172.3, 172.2, 171.0, 155.2, 155.0, 154.7, 
146.9, 143.7, 143.6, 140.7, 136.7, 128.4, 128.3, 127.7, 127.6, 127.2, 127.1, 127.0, 125.1, 123.3, 
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120.1, 79.2, 66.4 (CH2), 65.7 (CH2), 64.8 (CH2), 56.4 and 56.3, 53.0 (CH), 46.5 (CH2), 46.4 
(CH), 29.3 (CH2), 22.5 (CH2); HPLC-MS: MeCN (0.05% Formic acid) / water (0.1% Formic 
Acid), 5% to 95% MeCN over 30 min; flow rate 0.80 mL/min; UV detection at 274 nm; tR for 
33, 25.75 min; HRESIQTOFMS calcd for C37H33N3O10Na (M + Na+) 702.2064, found 702.2042. 
 
(2S,4S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1-
benzyl ester 4-(2,2,3,3-tetrafluoro) propyl ester 2-tert-butyl ester (43) 
Fmoc protected amino acid 29 (9.57 g, 16.3 mmol) was dissolved in dry DCM (163 mL, 10mL 
per mmol) in a 500 mL round bottom flask under N2 atmosphere. To this solution, DMAP (100 
mg, 0.82 mmol, 0.05 equiv.) and 2,2,3,3-tetraflouro propanol (2.93 mL, 32.6 mmol, 2 equiv.) 
were added in one portion. The reaction mixture was cooled in an ice bath under N2 and DCC 
(4.04 g, 19.6 mmol, 1.2 equiv.) was added to the reaction flask in one portion. The reaction 
mixture was allowed to warm up to room temperature and stirring was continued overnight. 
Disappearance of the substrate was confirmed by TLC analysis (5:1 CHCl3: MeOH, observed 
under UV). The reaction was quenched by an addition of 10% acetic acid in DCM (20 mL) and 
solvent was removed via rotary evaporation. The residue was mixed with 1:1 EtOAc / hexanes 
(100 mL) mixture and filtered through sintered funnel to remove insoluble byproduct DCU. The 
filtrate was concentrated, mixed with celite and then purified by automated flash 
chromatography (two separate 40 gm silica columns; Solvent A: Hexanes, Solvent B: EtOAc; 
Gradient elution: 0-5 CVs, solvent B 5% followed by 5-45 CVs, solvent B 5% to 35%). The 
fractions that contain the desired product were combined, concentrated and residual solvent was 
removed by drying overnight under reduced pressure to yield 43 (9.7 g, 13.84 mmol, 85%) as a 
white foam; [α]23D = +2.9 (c 1.09, CHCl3); IR (film) νmax 3307, 2979, 1712, 1525, 1450, 1419, 
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1258, 1157, 1109, 759, 741, 698 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 7.99 (s, 1H), 
7.85 (d, J = 7.8 Hz, 2H), 7.66 (d, J = 7.5 Hz, 2H), 7.31-7.40 (m, 9H), 6.40 (tt, J = 52.2 Hz, J = 
5.1 Hz, -CF2CF2H, 1H) 5.08 (br s, 2H), 4.56 (t, J = 13.8 Hz, -CH2CF2-, 2H), 4.28-4.42 (m, 3H), 
4.19 (t, J = 6.4 Hz, 1H), 4.03 (d, J = 11.4 Hz, 1H), 3.61 (d, J = 11.4 Hz, 1H), 2.82 (br, 1H), 2.32 
(br, 1H), 1.35 (br s, 9H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): mixture of rotamers δ 170.1, 
169.7, 159.2, 143.5, 140.6, 136.5, 136.3, 128.2, 128.1, 127.6, 127.5, 127.2, 126.8, 124.9, 119.9, 
109.0 (tt, 1J = 248 Hz, 2J = 34 Hz, CH), 80.9, 66.2 (CH2), 65.7 (CH2), 63.0 and 62.1, 60.2 (t, 2J = 
28 Hz, CH2), 58.3 and 57.9 (CH), 54.5 and 54.1 (CH2), 46.4 (CH), 38.7 and 37.3 (CH2), 27.4 
(CH3, 3C);  HPLC-MS: MeCN(0.05% Formic acid) / water (0.1% Formic Acid), 5% to 95% 
MeCN over 30 min; flow rate 0.80 mL/min; UV detection at 274 nm; tR for 43, 29.13 min; 
HRESIQTOFMS calcd for C36H36N2O8F4Na (M + Na+) 723.2305, found 723.2295. 
 
(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5- (2,2,3,3-tetrafluoro) propyl ester 2-tert-butyl ester (44) 
4.0 g (6.66 mmol) of 13 yielded 3.97 g (5.55 mmol, 83%) of 44 as a white foam according to the 
procedure given above for 43: [α]23D = -14.7 (c 0.9, CHCl3); IR (film) νmax 3316, 2977, 
1761,1729, 1526, 1450, 1321, 1255, 1118,759,741, 698 cm-1; 1H NMR (300 MHz, 77 °C, 
DMSO-d6) δ 7.84 (d, J = 7.8 Hz, 3H,overlap with Fmoc-NH-), 7.67 (d, J = 7.5 Hz, 2H), 7.30-
7.43 (m, 9H), 6.38 (tt, J = 52.2, 5.1 Hz, -CF2CF2H, 1H) 5.12 (br s, 2H), 4.19-4.70 (m, 4H), 4.35 
(d, J = 6.3 Hz, 2H), 4.21 (t, J = 6.3 Hz, 1H), 2.95 (br d, J = 12.9 Hz, 1H), 2.17 (br d, J = 13.2 Hz, 
1H), 2.05 (br d, J = 12.0 Hz, 1H), 1.82 (m, 1H) 1.62 (br dd, J = 12.9, 12.9, Hz, 1H), 1.42 (br s, 
9H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): mixture of rotamers δ 170.0, 169.6, 169.4, 155.1, 
155.0, 154.7, 143.6, 143.5, 143.4, 140.7, 136.6, 136.5, 128.2, 127.7, 127.5, 127.2, 126.9, 124.9, 
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120.0, 81.4, 79.1, 66.3 (CH2), 65.5 (CH2),59.7 (CH2), 56.3 and 56.2, 53.6 and 53.4 (CH), 46.6 
(CH), 46.5 (CH2), 28.8 (CH2), 27.5 (CH3, 3C), 22.2 (CH2); HPLC-MS: MeCN (0.05% Formic 
acid) / water (0.1% Formic Acid), 5% to 95% MeCN over 30 min; flow rate 0.80 mL/min; UV 
detection at 274 nm; tR for 44, 29.23 min; HRESIQTOFMS calcd for C37H38N2O8F4Na (M + 
Na+) 737.2462, found 737.2423. 
 
(2S,4S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1-
benzyl ester 4- (2,2,3,3-tetrafluoro) propyl ester (45) 
9.7 g (13.84 mmol) of 43 yielded 8.55 g (13.26 mmol, 96%) of 45 as a white foam according to 
the procedure given above for 32: [α]23D = -30.0 (c 0.81, CHCl3); IR (film) νmax 3306, 3034, 
1713, 1526, 1450, 1422, 1260, 1193, 1109, 759, 742, 697 cm-1; 1H NMR (300 MHz, 77 °C, 
DMSO-d6) δ 8.26 (s, 1H), 7.85 (d, J = 7.5 Hz, 2H), 7.66 (d, J = 7.5 Hz, 2H), 7.31-7.40 (m, 9H), 
6.40 (tt, J = 52.2 Hz, J = 5.1 Hz, -CF2CF2H, 1H) 5.09 (br s, 2H), 4.57 (t, J = 13.8 Hz, -CH2CF2-, 
2H), 4.33-4.36 (m, 3H), 4.20 (t, J = 6.6 Hz, 1H), 4.31 (d, J = 11.4 Hz, 1H), 3.57 (d, J = 11.4 Hz, 
1H), 2.85 (br, 1H), 2.31 (br, 1H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): mixture of rotamers δ 
172.5, 172.1, 170.3, 155.7, 153.5, 153.3, 143.5, 140.6, 136.5, 128.2, 128.1, 127.7, 127.5, 127.3, 
126.9, 125.0, 119.9, 109.0 (tt, 1J = 248 Hz, 2J = 34 Hz, CH), 66.2 (CH2), 65.8 (CH2), 62.8 and 
62.0, 60.2 (t, 2J = 28 Hz, CH2), 57.6 and 57.3 (CH), 54.6 and 54.2 (CH2), 46.5 (CH), 38.8 and 
37.5 (CH2); HPLC-MS: MeCN(0.05% Formic acid) / water (0.1% Formic Acid), 5% to 95% 
MeCN over 30 min; flow rate 0.80 mL/min; UV detection at 274 nm; tR for 45, 24.75 min; 
HRESIQTOFMS calcd for C32H28N2O8F4Na (M + Na+) 667.1679, found 667.1681. 
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(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5- (2,2,3,3-tetrafluoro) propyl ester (46) 
3.88 g (5.43 mmol) of 44 yielded 3.17 g (4.81 mmol, 89%) of 46 as a white foam  according to 
the procedure given above for 32: [α]23D = -13.5 (c 1.5, CHCl3); IR (film) νmax 3316, 3037, 1716, 
1523, 1450, 1317, 1255, 1118,759,742, 698 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 7.86 
(d, J = 7.2 Hz, 2H), 7.81 (1H), 7.66 (d, J = 7.2 Hz, 2H), 7.30-7.43 (m, 9H), 6.37 (tt, J = 52.2, 5.1 
Hz, -CF2CF2H, 1H) 5.11 (br s, 2H), 4.42-4.72 (m, 4H), 4.33 (d, J = 6.6 Hz, 2H), 4.20 (t, J = 6.6 
Hz, 1H) 3.00 (br d, J = 13.2 Hz, 1H), 2.19 (br d, J = 13.2 Hz, 1H), 2.08 (br d, J = 14.1 Hz, 1H), 
1.84 (m, 1H) 1.63 (ddd, J = 12.9, 12.9, 3.0 Hz, 1H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): 
mixture of rotamers δ 172.0, 170.0, 155.1, 154.7, 143.6, 143.5 and 143.4, 140.6, 136.7 and 
136.5, 128.2, 127.7, 127.5, 127.1, 127.0, 126.9, 124.9, 120.0, 79.1, 66.4 (CH2), 65.6 (CH2),59.7 
(CH2), 56.3 and 56.2, 53.0 and 52.7 (CH), 46.5 (CH), 46.4 (CH2), 28.9 (CH2), 22.1 (CH2); 
HPLC-MS: MeCN (0.05% Formic acid) / water (0.1% Formic Acid), 5% to 95% MeCN over 30 
min; flow rate 0.80 mL/min; UV detection at 274 nm; tR for 46, 25.47 min; HRESIQTOFMS 
calcd for C32H28N2O8F4Na (M + Na+) 681.1836, found 681.1802. 
 
(2S,4S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1- tert-
butyl ester 4- (2,2,3,3-tetrafluoro) propyl ester (47) 
Intermediate 45 (8.4 g, 13.1 mmol) was dissolved in dry THF (10 mL per mmol of substrate) in a 
250 mL round bottom flask. Boc2O (8.6 g, 39.3 mmol, 3 equiv.) was added to this solution in one 
portion and this was followed by a careful addition of 10 wt % Pd/C (840 mg, 10% by wt. of 
substrate). The reaction mixture was degassed by applying vacuum using an aspirator and 
backfilled with H2 via balloon. This cycle of degassing and backfilling was repeated a few times 
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and stirring was continued under H2 atmosphere (~ 1 atm.) at room temperature. The reaction 
progress was monitored by HPLC. In order to speed up the reaction DIPEA (1.73 mL, 10.8 
mmol, 0.8 equiv.) was added after a few hours and stirring was further continued under H2 
atmosphere. After confirming the disappearance of 45 (about 2 days) by HPLC, the reaction 
mixture was filtered through filter paper under reduced pressure and residual Pd/C was washed 
several times with THF to recover most of the product. The filtrates were combined and 
concentrated by rotary evaporation. The resulting crude product was mixed with celite and then 
purified by automated flash chromatography (120 g silica column; Solvent A: CHCl3 with 0.1% 
AcOH, Solvent B: 10% MeOH/ CHCl3 with 0.1% AcOH; Gradient elution: 0-2 CVs, solvent A 
100% followed by 2-18 CVs, solvent B 0% to 100%). The fractions containing the desired 
product were combined and concentrated. Any residual acetic acid was azeotropically removed 
by mixing with hexane followed by rotary evaporation. Any residual solvent was further 
removed by drying overnight under reduced pressure to yield 47 (7.2 g, 11.8 mmol, 90%) as a 
white foam: [α]23D = -54.3 (c 1.35, CHCl3); IR (film) νmax 3304, 2980, 1760, 1724, 1530, 1451, 
1409, 1369, 1259, 1111, 759, 742 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 8.07 (br s, 1H), 
7.85 (d, J = 7.5 Hz, 2H), 7.66 (d, J = 7.5 Hz, 2H), 7.32-7.41 (m, 4H), 6.40 (tt, J = 52.2 Hz, J = 
5.1 Hz, -CF2CF2H, 1H), 4.57 (t, J = 13.8 Hz, -CH2CF2-, 2H), 4.32-4.37 (m, 2H), 4.18-4.23 (m, 
2H), 4.03 (d, J = 11.4 Hz, 1H), 3.47 (d, J = 11.4 Hz, 1H), 2.82 (br, 1H), 2.20 (br, 1H), 1.38 (br s, 
9H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): mixture of rotamers δ 172.8, 172.5, 170.5, 155.7, 
152.9, 152.5, 143.5, 140.6, 127.5, 126.9, 124.9, 119.9, 109.0 (tt, 1J = 248 Hz, 2J = 34 Hz, CH), 
79.2, 65.7 (CH2), 62.7 and 61.9, 60.1 (t, 2J = 28 Hz, CH2), 57.5 and 57.2 (CH), 54.4 and 54.1 
(CH2), 46.5 (CH), 39.0 and 37.6 (CH2), 27.7 (CH3, 3C); HPLC-MS: MeCN(0.05% Formic acid) 
/ water (0.1% Formic Acid), 5% to 95% MeCN over 30 min; flow rate 0.80 mL/min; UV 
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detection at 274 nm; tR for 47, 24.21 min; HRESIQTOFMS calcd for C29H30N2O8F4Na (M + 
Na+) 633.1836, found 633.1835. 
 
(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1- 
tert-butyl ester 5- (2,2,3,3-tetrafluoro) propyl ester (48) 
3.07 g (4.66 mmol) of 46 yielded 2.03 g (3.25 mmol, 70%) of 48 as a white foam according to 
the procedure given above for 47: [α]23D = -12.5 (c 1.26, CHCl3); IR (film) νmax 3316, 2978, 
1716, 1524, 1450, 1420, 1369, 1319, 1255, 1118, 759, 741 cm-1; 1H NMR (300 MHz, 77 °C, 
DMSO-d6) δ 7.86 (d, J = 7.5 Hz, 2H), 7.77 (s, 1H), 7.67 (d, J = 7.2 Hz, 2H), 7.30-7.44 (m, 4H), 
6.39 (tt, J = 52.2, 5.1 Hz, -CF2CF2H, 1H), 4.46-4.58 (m, 4H), 4.32 (d, J = 6.6 Hz, 2H), 4.33 (t, J 
= 6.6 Hz, 1H) 2.94 (br d, J = 13.5 Hz, 1H), 2.19 (br d, J = 13.8 Hz, 1H), 1.99-2.07 (m, 1H), 1.86 
(m, 1H) 1.63 (ddd, J = 12.9, 12.9, 3.6 Hz, 1H), 1.40 (s, 9H); 13C NMR (75.4 MHz, 20 °C, 
DMSO-d6): mixture of rotamers δ 172.4, 170.2, 170.1, 155.2, 154.1, 143.6, 140.7, 127.6, 127.0, 
125.0, 120.1, 79.4, 79.1, 65.6 (CH2), 59.8 and 59.7 (CH2), 56.4 and 56.3, 53.4 (CH), 46.5 (CH), 
45.8 (CH2), 29.2 (CH2), 27.8 (CH3, 3C), 22.2 (CH2); HPLC-MS: MeCN (0.05% Formic acid) / 
water (0.1% Formic Acid), 5% to 95% MeCN over 30 min; flow rate 0.80 mL/min; UV 
detection at 274 nm; tR for 48, 25.23 min; HRESIQTOFMS calcd for C30H32N2O8F4Na (M + 
Na+) 647.1992, found 647.2028. 
 
(2S,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1- 
tert-butyl ester 5- methyl ester (36) 
280 mg (0.5 mmol) of 3 yielded 198 mg (0.38 mmol, 76%) of 36 as a white foam according to 
the procedure given above for 47: [α]23D = -17.8 (c 0.5, CHCl3); IR (film) νmax 3316, 2977, 1716, 
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1525, 1450, 1421, 1369, 1319, 1255, 1118, 759, 741 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-
d6) 7.86 (d, J = 7.2 Hz, 2H), 7.68 (d, J = 7.2 Hz, 2H), 7.58 (s, 1H), 7.30-7.44 (m, 4H), 4.59 (m, 
1H), 4.49 (d, J = 13.5 Hz, 1H), 4.32 (d, J = 6.6 Hz, 2H), 4.20 (t, J = 6.6 Hz, 1H), 3.59 (br s, 3H), 
2.95 (d, J = 13.5 Hz, 1H), 2.20 (br d, J = 13.5 Hz, 1H), 1.81-2.02 (m, 2H), 1.54 (ddd, J = 12.6, 
12.6, 4.2 Hz, 1H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): mixture of rotamers δ 172.2, 171.7, 
154.9, 153.9, 143.6, 140.6, 127.5, 126.9, 125.0, 120.0, 79.4, 79.2, 65.4 (CH2), 56.2, 52.1 (CH), 
51.8 (CH3), 46.5 (CH), 45.9 (CH2), 29.2 (CH2), 27.8 (CH3, 3C), 22.3 (CH2); HPLC-MS: MeCN 
(0.05% Formic acid) / water (0.1% Formic Acid), 5% to 95% MeCN over 30 min; flow rate 0.80 
mL/min; UV detection at 274 nm; tR for 36, 22.91 min; HRESIQTOFMS calcd for 
C28H32N2O8Na (M + Na+) 547.2056, found 547.2066. 
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Scheme 14: Synthesis of TFP ester version of pro4(2S4R) and pip5(2S5R) monomers 
 
(2S,4R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1-
benzyl ester 4- (2,2,3,3-tetrafluoro) propyl ester 2-tert-butyl ester (60) 
4.0 g (6.82 mM) of 59 yielded 4.28 g (6.11 mM, 89%) of 60 as a white foam according to the 
procedure given for 43; [α]23D = -39.9 (c 0.96, CHCl3); IR (film) νmax 3306, 2979, 1762, 1724, 
1529, 1451, 1414, 1370, 1260, 1152, 1110, 759, 742 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-
d6) δ 8.04 (br s, 1H), 7.85 (d, J = 7.5 Hz, 2H), 7.65 (d, J = 7.5 Hz, 2H), 7.31-7.40 (m, 9H), 6.41 
(tt, J = 52.2 Hz, J = 5.1 Hz, -CF2CF2H, 1H) 5.08 (br s, 2H), 4.56 (t, J = 13.8 Hz, -CH2CF2-, 2H), 
4.36-4.40 (m, 2H), 4.30 (dd, J = 8.3, 8.3 Hz, 1H), 4.21 (t, J = 6.4 Hz, 1H), 4.02 (d, J = 11.4 Hz, 
1H), 3.73 (d, J = 11.4 Hz, 1H), 2.67 (br, 1H), 2.26 (br, 1H), 1.37 (br s, 9H); 13C NMR (75.4 
MHz, 20 °C, DMSO-d6): mixture of rotamers δ 170.2, 169.8, 168.9, 155.4, 153.4, 143.5, 140.6, 
136.4, 136.2, 128.1, 127.7, 127.5, 127.3, 126.8, 124.8, 120.1, 109.0 (tt, 1J = 248 Hz, 2J = 34 Hz, 
CH), 81.1 and 80.9, 66.2 (CH2), 65.6 (CH2), 63.4 and 62.6, 60.2 (t, 2J = 28 Hz, CH2), 58.4 and 
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57.8 (CH), 54.2 and 53.6 (CH2), 46.5 (CH), 38.7 and 37.6 (CH2), 27.3 (CH3, 3C); HPLC-MS: 
MeCN(0.05% Formic acid) / water (0.1% Formic Acid), 5% to 95% MeCN over 30 min; flow 
rate 0.80 mL/min; UV detection at 274 nm; tR for 60, 28.79 min; ES-LRMS m/z (ion) calculated 
723.3 (M + Na+), observed 723.0; 
 
(2S,4R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1-
benzyl ester 4- (2,2,3,3-tetrafluoro) propyl ester (62) 
4.28 g (6.11 mM) of 60 yielded 3.55 g (5.51 mM, 90%) of 62 as a white foam according to the 
procedure as given for 32: [α]23D = -31.0 (c 0.88, CHCl3); IR (film) νmax 3306, 3034, 1761, 1721, 
1529, 1450, 1425, 1262, 1109, 758, 743, 697 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 8.22 
(s, 1H), 7.85 (d, J = 7.5 Hz, 2H), 7.65 (d, J = 7.5 Hz, 2H), 7.31-7.40 (m, 9H), 6.42 (tt, J = 52.2 
Hz, J = 5.1 Hz, -CF2CF2H, 1H) 5.08 (br s, 2H), 4.57 (t, J = 13.8 Hz, -CH2CF2-, 2H), 4.37-4.40 
(m, 3H), 4.21 (t, J = 6.4 Hz, 1H), 4.05 (d, J = 11.4 Hz, 1H), 3.75 (d, J = 11.4 Hz, 1H), 2.71 (br, 
1H), 2.31 (br, 1H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): mixture of rotamers δ 172.5, 172.2, 
168.9, 155.5, 153.9, 153.5, 143.5, 140.6, 136.4, 128.2, 127.9, 127.7, 127.5, 127.2, 127.0, 124.8, 
119.9, 109.0 (tt, 1J = 248 Hz, 2J = 34 Hz, CH), 66.2 (CH2), 65.7 (CH2), 63.5 and 62.8, 60.2 (t, 2J 
= 28 Hz, CH2), 57.7 and 57.2 (CH), 54.1 and 53.7 (CH2), 46.5 (CH), 38.9 and 37.7 (CH2); 
HPLC-MS: MeCN(0.05% Formic acid) / water (0.1% Formic Acid), 5% to 95% MeCN over 30 
min; flow rate 0.80 mL/min; UV detection at 274 nm; tR for 62, 25.87 min; ES-LRMS m/z (ion), 
calculated 667.2 (M + Na+), observed 666.9; 
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(2S,4R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1- tert-
butyl ester 4- (2,2,3,3-tetrafluoro) propyl ester (64) 
3.4 g (5.3 mM) of 62 yielded 2.84 g (4.65 mM, 88%) of 64 as a white foam according to the 
procedure given for 47 : [α]23D = -54.3 (c 1.35, CHCl3); IR (film) νmax 3304, 2980, 1760, 1724, 
1530, 1451, 1409, 1369, 1259, 1111, 759, 742 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 
8.07 (br s, 1H), 7.85 (d, J = 7.5 Hz, 2H), 7.66 (d, J = 7.5 Hz, 2H), 7.32-7.41 (m, 4H), 6.41 (tt, J = 
52.2 Hz, J = 5.1 Hz, -CF2CF2H, 1H), 4.57 (t, J = 13.8 Hz, -CH2CF2-, 2H), 4.37 (d, J = 6.6 Hz, 
2H), 4.18-4.28 (m, 2H), 3.94 (d, J = 11.4 Hz, 1H), 3.66 (d, J = 11.4 Hz, 1H), 2.64 (m, 1H), 2.25 
(m, 1H), 1.40 (br s, 9H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): mixture of rotamers δ 173.0, 
172.5, 169.1, 155.5, 153.4, 152.7, 143.5, 140.6, 127.5, 126.9, 124.8, 119.9, 109.0 (tt, 1J = 248 
Hz, 2J = 34 Hz, CH), 79.4, 65.6 (CH2), 63.4 and 62.7, 60.1 (t, 2J = 28 Hz, CH2), 57.5 and 57.2 
(CH), 53.6 (CH2), 46.5 (CH), 39.0 and 37.7 (CH2), 27.7 (CH3, 3C); HPLC-MS: MeCN(0.05% 
Formic acid) / water (0.1% Formic Acid), 5% to 95% MeCN over 30 min; flow rate 0.80 
mL/min; UV detection at 274 nm; tR for 64, 25.55 min; ES-LRMS m/z (ion), calculated 633.2 
(M + Na+), observed 633.0; 
 
(2S,5R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5- (2,2,3,3-tetrafluoro) propyl ester 2-tert-butyl ester (61) 
3.86 g (5.42 mM) of 24 yielded 3.79 g (5.31 mM, 98%) of 61 as a white foam according to the 
procedure given for 43; [α]23D = -17.9 (c 0.94, CHCl3); IR (film) νmax 3326, 2977, 1729, 1522, 
1450, 1369, 1285, 1155, 1111,741 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 7.85 (d, J = 
7.5 Hz, 2H), 7.74 (s, 1H), 7.65 (d, J = 7.5 Hz, 2H), 7.28-7.42 (m, 9H), 6.38 (tt, J = 52.2 Hz, J = 
5.1 Hz, -CF2CF2H, 1H) 5.12 (br s, 2H), 4.74 (m, 1H), 4.50-4.60 (m, 3H), 4.04-4.27 (m, 3H), 3.30 
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(br, 1H), 1.87-2.15 (m, 3H) 1.65 (m, 1H), 1.41 (br s, 9H); 13C NMR (75.4 MHz, 20 °C, DMSO-
d6): mixture of rotamers δ 171.3, 169.7 and 169.5, 155.6, 143.8, 143.6, 140.7, 136.5, 136.4, 
128.3, 128.1, 127.8, 127.6, 127.3, 127.0, 125.2, 125.0, 120.1, 81.6, 66.5 (CH2), 65.8 (CH2),59.8 
(CH2), 56.9 and 56.7, 53.7and 53.2 (CH), 46.5 and 46.4 (CH), 43.7 (CH2), 28.0 (CH2), 27.5 
(CH3, 3C), 20.7 (CH2); HPLC-MS: MeCN(0.05% Formic acid) / water (0.1% Formic Acid), 5% 
to 95% MeCN over 30 min; flow rate 0.80 mL/min; UV detection at 274 nm; tR for 61, 29.35 
min; ES-LRMS m/z (ion) calculated 737.3 (M + Na+), observed 737.2; 
 
(2S,5R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5- (2,2,3,3-tetrafluoro) propyl ester (63) 
3.7 g (5.2 mM) of 61 yielded 2.94 g (4.47 mM, 86%) of 63 as a white foam according to the 
procedure given for 32: [α]23D = -10.9 (c 1.15, CHCl3); IR (film) νmax 3324, 3034, 1717, 1520, 
1450, 1285, 1190, 759, 742, 697 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 7.87 (d, J = 7.5 
Hz, 2H), 7.80 (s, 1H), 7.66 (d, J = 7.5 Hz, 2H), 7.24-7.42 (m, 9H), 6.42 (tt, J = 52.2 Hz, J = 5.1 
Hz, -CF2CF2H, 1H) 5.05 (br s, 2H), 4.82 (m, 1H), 4.51-4.63 (m, 3H), 4.18-4.28 (m, 3H), 3.39 
(br, 1H), 2.04-2.18 (m, 3H) 1.69 (m, 1H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6): mixture of 
rotamers δ 171.9, 171.3, 155.5, 143.7, 143.5, 140.6, 136.6, 136.4, 128.4, 128.2, 127.8, 127.7, 
127.2, 127.1, 125.3, 125.0, 120.2, 109.2 (tt, 1J = 248 Hz, 2J = 34 Hz, CH), 79.2, 66.6 (CH2), 65.9 
(CH2),59.9 (t, 2J = 28 Hz, CH2), 56.9 and 56.7, 53.2and 52.7 (CH), 46.6 and 46.4 (CH), 44.2 and 
43,8 (CH2), 28.3 and 27.8 (CH2), 20.6 and 20.8 (CH2); HPLC-MS: MeCN(0.05% Formic acid) / 
water (0.1% Formic Acid), 5% to 95% MeCN over 30 min; flow rate 0.80 mL/min; UV 
detection at 274 nm; tR for 63, 25.87 min; ES-LRMS m/z (ion), calculated 681.2 (M + Na+), 
observed 681.0; 
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(2S,5R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1- 
tert-butyl ester 5- (2,2,3,3-tetrafluoro) propyl ester (65) 
2.86 g (4.34 mM) of 63 yielded 2.13 g (3.41 mM, 79%) of 65 as white foamy solid according to 
the procedure given for 47: [α]23D = -7.7 (c 0.83, CHCl3); IR (film) νmax 3317, 2978, 1717, 1519, 
1451, 1369, 1268, 1154, 1113, 759, 742 cm-1; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 7.85 (d, J 
= 7.5 Hz, 2H), 7.78 (d, J = 7.5 Hz, 2H), 7.64 (s, 1H), 7.29-7.43 (m, 4H), 6.40 (tt, J = 52.2 Hz, J = 
5.1 Hz, -CF2CF2H, 1H) 4.71 (br s, 1H), 4.49-4.65 (m, 3H), 4.13-4.28 (m, 3H), 3.26 (br d, J = 
13.0 Hz, 1H), 1.94-2.08 (m, 3H), 1.60-1.69 (m, 1H), 1.34 (s, 9H); 13C NMR (75.4 MHz, 20 °C, 
DMSO-d6): mixture of rotamers δ 172.1, 171.4, 155.4, 154.4, 143.5, 140.5, 127.5, 126.9, 124.9, 
124.8, 119.9, 109.0 (tt, 1J = 248 Hz, 2J = 34 Hz, CH), 79.1, 65.7 (CH2),59.6 (t, 2J = 28 Hz, CH2), 
56.7, 51.6 (CH), 46.4 (CH), 43.6 (CH2), 28.4 and 28.0 (CH2), 27.7 (CH3, 3C) 20.4 (CH2); HPLC-
MS: MeCN(0.05% Formic acid) / water (0.1% Formic Acid), 5% to 95% MeCN over 30 min; 
flow rate 0.80 mL/min; UV detection at 274 nm; tR for 65, 24.91 min; ES-LRMS m/z (ion), 
calculated 647.2 (M + Na+), observed 646.9; 
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3.6.3 Solid phase assembly of dimers for kinetics measurements 
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Figure 20: Assembly of bis-amino acid dimers 
 
General procedure A: Washing 
In a typical washing sequence, the resin was washed 5 times with DCM and DMF alternately. 
This was followed by a final wash with DCM. 
 
General procedure B: HATU coupling 
In a 1.5 mL polypropylene micro centrifuge vial the amino acid (as given) was dissolved in a 
solution of 20% DCM/ DMF (as given). To this mixture was added DIPEA (as given) followed 
by HATU (as given). The resulting coupling mixture was mixed briefly and immediately added 
to the SPPS reaction vessel carrying the resin. After mixing for the given amount of time, the 
resin was drained and washed according to the general procedure (A). 
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General procedure C: Fmoc deprotection by piperidine 
To the SPPS reactor carrying the resin added 1000 μL of a solution of 2% DBU in DMF. After 5 
minutes of mixing, a volume of 40 μL of deprotection mixture was withdrawn and diluted 50 
fold with a solution of 20% piperidine in DMF. A UV-visible spectroscopic analysis of the 
piperidine-fluorenyl adduct was performed and the absorbance at 301 nm (ε = 7800 M-1cm-1) 
was recorded. This value of the absorbance was used to estimate coupling yield. Following the 
Fmoc deprotection, the resin was washed according to general procedure (A). 
 
General procedure D: Capping of the residual free amine 
To the SPPS reactor carrying the resin added 250 μL of a solution of 10% acetiic anhydride in 
pyridine. After 5 minutes of mixing, the resin was drained and washed according to the general 
procedure (A). 
 
General procedure E: Fmoc deprotection by DBU 
To the SPPS reactor carrying the resin added 1000 μL of a solution of 20% piperidine in DMF. 
After 20 minutes of mixing, a volume of 40 μL of deprotection mixture was withdrawn and 
diluted 50 fold with a solution of 20% piperidine in DMF. A UV-visible spectroscopic analysis 
of the piperidine-fluorenyl adduct was performed and the absorbance at 301 nm (ε = 7800 M-
1cm-1) was recorded. This value of the absorbance was used to estimate coupling yield. 
Following the Fmoc deprotection, the resin was washed according to general procedure (A). 
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General procedure F: Boc and t-Bu protecting group removal 
Boc and t-Bu protecting groups were removed by treating the resin with 1mL of 1:1 TFA/DCM 
(2 x 15 minute). The resin was washed with CH2Cl2 and MeOH several times and then 
neutralized by washing a few times with 10% Et3N/CH2Cl2. The resin was washed again with 
CH2Cl2 and MeOH several times, followed by only CH2Cl2. 
 
General procedure G: DKP closure via flow-cell method 
A few beads of resin carrying oligomer sequence were transferred to the PTFE tubing of flow 
cell apparatus and the catalytic solution (as given) was pumped through the resin for the desired 
amount of time at a given temperature. The resin was recovered and transferred to a 1 mL 
polypropylene SPPS reactor. The resin was washed with CH2Cl2, and MeOH several times, 
followed by only CH2Cl2 and then dried under reduced pressure overnight. 
 
General procedure H: DKP closure via microwave irradiation method 
A few beads of resin carrying oligomer sequence were placed in a 10 mL microwave reaction 
vessel (10mL capacity, glass) containing 5 mL of a given solution. The vessel was capped and 
placed in the microwave reactor (CEM Discover) and irradiated (300 W maximum power, T° C, 
5 min ramp) with continuous stirring. After desired time interval the vessel was removed from 
the microwave reactor and the resin was transferred to a 1 mL polypropylene SPPS reactor. The 
resin was washed with CH2Cl2, and MeOH several times, followed by only CH2Cl2 and then 
dried under reduced pressure overnight. 
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General procedure I: Oligomer cleavage from resin via TFMSA method 
The reactor carrying the resin was kept in ice bath and added 25 μL thioanisole, 12.5 μL 1,2-
Ethanedithiol (EDT), and 250 μL TFA. The cleavage mixture was allowed to stir for 5 min and 
25 μL of TFMSA was added. The stirring was continued for 1 h at 0° C followed by 1 h at room 
temperature. The cleavage mixture was dripped into 50 mL of ether in an eppendorf centrifuge 
tube that caused the desired product to precipitate out. This precipitate was converted into pellet 
form by centrifugation for 30 min at 4 °C at 3200 rpm. Ether was decanted, precipitate was 
dissolved in 200 μL of TFA, and product was precipitated a second time from ether. After 
centrifugation Ether was decanted and residual precipitate pellet was prepared for analysis by air 
drying for a few minutes. 
 
Assembly of oligomer 37a 
A quantity of 23 mg of MBHA resin (14.6 μmol free amine, 0.62 mmol loading) was transferred 
to a 1 mL polypropylene solid phase peptide synthesis (SPPS) reaction vessel and allowed to 
swell in DMF for 30 minutes. 
Fmoc-L-Tyr(t-Bu)-OH (13.1 mg, 28.5 μmol) was dissolved in 20% CH2Cl2/DMF (143 
μL) and coupled for 2 hours according to general procedure (B) by using DIPEA (9.9 μL, 57 
μmol) and HATU (10.8 mg, 28.5 μmol). Any residual free amine was capped according to 
general procedure (D). The terminal Fmoc group was deblocked by general procedure (C). The 
coupling yield was estimated as quantitative. 
Monomer 32 (19.4 mg, 28.5 μmol) was dissolved in 20% CH2Cl2/DMF (143 μL) and 
coupled for 2 hours according to general procedure (B) by using DIPEA (9.9 μL, 57 μmol) and 
HATU (10.8 mg, 28.5 μmol). The resin was subjected to a second coupling reaction under 
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identical conditions. Any residual free amine was capped according to general procedure (D). 
The terminal Fmoc group was deblocked by general procedure (C). 
Monomer 35 (19.4 mg, 28.5 μmol) was dissolved in 20% CH2Cl2/DMF (143 μL) and 
coupled for 2 hours according to general procedure (B) by using DIPEA (9.9 μL, 57 μmol) and 
HATU (10.8 mg, 28.5 μmol). The resin was subjected to a second coupling reaction under 
identical conditions. The terminal Fmoc group was deblocked by general procedure (C). The 
coupling yield was estimated as 95%. The terminal amine was acylated according to general 
procedure (D). The acylation procedure (D) was repeated one additional time to ensure complete 
acylation. The resin was prepared for Boc group cleavage by washing with MeOH and DCM 
alternately followed by drying under reduced pressure. 
Boc and t-Bu protecting group were removed by general procedure (F) and resin was 
dried under reduced pressure. Other bis-amino acid oligomers (37b, 37c and 37d) were 
synthesized in the same manner by following general procedures A, B, C and D. 
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Flow Cell Apparatus for DKP closure studies 
 
Figure 21: Schematic Diagram of the flow cell set up for the kinetic measurements. 
 
The above shown simple set up in Figure 21 for the measurement of half-life for DKP 
closure reaction was assembled from the PTFE tubings and connectors. All the connections were 
made by thin tubing with inner diameter 0.75 mm. For flow cell a small piece of tubing (15 mm) 
with inner diameter 1.55 mm was used. This tubing was filled with a few beads of resin (2-5 mg) 
that were held in place by cotton plugs at both ends. The oil bath was maintained at desired 
temperature by using a digital temperature controller. The eluant was prepared by dissolving 
approximately 20 μM of reference compound (9-fluorenemethanol) in the desired catalytic 
solvent mixture. The resin was allowed to swell by pumping blank solvent. After a few minutes 
the flow cell tube carrying the resin was removed from the loop and rest of the system was 
allowed to equilibrate by pumping the eluant. The flow cell was inserted back into the loop, 
lowered into a preheated oil-bath at desired temperature and flow rate was set at 100 μL per 
minute. After a wait of 5 minutes (compensating for the dead volume of tubing from resin to 
collector) the fractions were collected at desired interval by using automatic fraction collector. 
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General procedure for measurement of kinetics of diketopiperazine formation 
A few beads of resin (2-3 mg) carrying desired dimer (e.g. 37c) were loaded in a homemade flow 
cell apparatus and catalysis solution (e.g. 80 mM AcOD in DMF) was flowed over the resin at a 
constant flow rate (100 µL/min) at desired temperature (e.g. 100 °C). The fractions were 
collected at 15 minute interval, and analyzed by analytical HPLC. Areas under the peaks were 
recorded for the reference and the p-nitrobenzyl alcohol that were used to estimate the half lives 
for the corresponding reaction under a given set of conditions as discussed below. 
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Figure 22: Diketopiperazine formation for sequence 37c 
 
Overall aminolysis reaction can be represented as 
 X  ?   Y  +  Z 
Since catalyst is flowed over the resin at a fixed rate, it can be safely assumed that the 
reaction follows first order reaction rate equation 
][/][/][ XkdtXddtYd =−=                                                     (1) 
The quantity being measured in our experiments is the area under the curve (I) for the 
released amount of p-nitrobenzyl alcohol (Y). Hence (I) at any time t represents amount of Y 
released for a time interval t-∆t to t. Thus, 
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Since [X]0 appears as a constant it can be chosen arbitrarily without affecting the 
calculation of half lives. Also we normalized the area under the curve for p-nitrobenzyl alcohol 
(I) by dividing it by the area under the curve for reference, Iref to remove any discrepancies 
arising due to instrumental errors. 
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Table 5: Data obtained from on resin DKP closure for oligomer 37c 
t 
(min) 
I 
(mAU*sec)
Iref 
(mAU*sec)
I'=(I/Iref) lnI' 
15 746.9 1640.7 0.455 -0.787 
30 1877.6 2451.2 0.766 -0.267 
45 896.7 2414.3 0.371 -0.990 
60 460.8 2472.4 0.186 -1.68 
75 238.7 2417.4 0.0987 -2.315 
90 144.2 2464.3 0.0585 -2.838 
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Figure 23: Graph of ln(I’) vs. Time t 
From graph, k = 0.0431 min-1 
Hence half life, t1/2  =  0.693/k 
  t1/2  =  0.693/0.0431 = 16.1 minutes 
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Post DKP closure analysis 
To confirm that the DKP formation was complete and find the evidence of epimerization, the 
resin bound oligomer 38c was recovered and cleaved by TFMSA method according to general 
procedure (I). (Figure 24) The product 66 was recovered in pallet from and dissolved in 200 μL 
of 1:1 acetonitrile/water. A part of this solution (10 μL) was injected into HPLC-MS for analysis. 
HPLC-MS: column, Waters XTerra MS C18 column 4.6 mm x 150 mm; mobile phase, 
MeCN (0.05% Formic acid) / water (0.1% Formic Acid), 5% to 95% MeCN over 30 min; flow 
rate 0.80 mL/min; UV detection at 220 nm; tR for 66, 10.194 min; ES-LRMS m/z (ion), 
calculated 545.2(M + H+) observed 545.0. 
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Figure 24: Cleavage of the product 66 following the DKP formation reaction 
 
 
Figure 25: Chromatogram of the cleaved product 66 at 220 nm. 
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Solid phase assembly of homooligomer 49 on MBHA resin 
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Figure 26: Assembly of homo-oligomer 49 
 
A quantity of 10 mg of MBHA resin (0.62 mmol/g loading, 6.2 μmol free amine) was transferred 
to a 1 mL polypropylene solid phase peptide synthesis (SPPS) reaction vessel and allowed to 
swell in DMF for 30 minutes. 
Monomer 48 (7.7 mg, 12.4 μmol) was dissolved in 20% CH2Cl2/DMF (62 μL) and 
coupled for 2 hours according to general procedure (B) by using DIPEA (4.8 μL, 27.3 μmol) and 
HATU (4.7 mg, 12.4 μmol). The resin was subjected to a second coupling reaction under 
identical conditions. Any residual free amine was capped according to general procedure (D). 
The terminal Fmoc group was deblocked by general procedure (E).  
The above given sequence for coupling of monomer 48 was repeated four times. 
Coupling yields were estimated to be >90% based on Fmoc deprotection step. 
Fmoc-L-Tyr(t-Bu)-OH (8.5 mg, 18.6 μmol) was dissolved in 20% CH2Cl2/DMF (93 μL) 
and coupled for 2 hours according to general procedure (B) by using DIPEA (7.1 μL, 40.9 μmol) 
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and HATU (7.1 mg, 18.6 μmol). Any residual free amine was capped according to general 
procedure (D). 
The terminal Fmoc group was deblocked by general procedure (C). The coupling yield 
was quantitative. 
Boc and t-Bu protecting group were removed by general procedure (F) and resin was 
dried under reduced pressure. The DKP closure was performed by suspending the resin in a 
solution of 100 mM AcOH and 50 mM Et3N in o-xylene in a microwave oven at 130° C 
according to general procedure (G). 
After recovery the resin bound oligomer 49 was cleaved by TFMSA method as given in 
general procedure (I). The product 50 was recovered in pallet from and dissolved in 200 μL of 
1:1 Acetonitrile/water. 10 μL of this solution was injected into HPLC-MS for analysis. HPLC-
MS: column, Waters XTerra MS C18 column 4.6 mm x 150 mm; mobile phase, MeCN(0.05% 
Formic acid) / water (0.1% Formic Acid), 0% to 25% MeCN over 30 min; flow rate 0.80 
mL/min; UV detection at 274 nm; tR for 50, 16.03 min; ES-LRMS m/z (ion), Calculated 941.4 
(M + H+), observed 941.2; 
 
Assembly of heterooligomers 51-54 and DKP closure 
Each of the hetero oligomers 51-54 was assembled on hydroxymethyl polystyrene resin (0.98 
mmol/g loading) on 20 mg scale. Monomer X1 was attached to the hyroxymethylpolystyrene 
resin using MSNT/MeIm method, as described in Novabiochem catalogue. 
The resin was transferred to a 1 mL polypropylene SPPS reaction vessel and allowed to 
swell in dry CH2Cl2 for 10 minutes. In case of oligomer 54, 25 mg of 48 (40 μmol, 2 equiv.) 
were dissolved in 300 μL of dry CH2Cl2. To this solution 2.3 μL of MeIm (28 μmol, 1.4 equiv.) 
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and 12 mg of MSNT (40 μmol) were added. This coupling solution was mixed briefly and added 
to the pre swelled resin. After mixing for 30 minutes, the coupling solution was drained and the 
resin was washed several times with MeOH and CH2Cl2 alternately. Any unreacted alcohol 
groups were capped by treatment with 500 μL of 10% Ac2O in pyridine for 5 minutes. The resin 
was drained and washed several times with MeOH and CH2Cl2, followed by only CH2Cl2. 
Other monomers, X2-4 followed by Fmoc-L-Tyr(t-Bu)OH were coupled sequentially 
using HATU following a procedure similar to the one as described for oligomer 49. After the 
removal of terminal Fmoc group, residual Boc and t-Bu protecting groups were removed by 
general procedure (F) and resins were dried under reduced pressure prior to DKP closure. 
The resins carrying desired sequence 51-54 were subjected to DKP closure at 130 °C by 
flow cell method (200 µL/min) according to general procedure (G) by flowing catalytic solution 
of 100 mM AcOH and 50 mM Et3N in o-xylene over the resin for 2 hours. 
After recovery, the resin bound oligomer 51 (and 52-54) was cleaved by TFMSA method 
as given in general procedure (I). After single precipitation the product 55 (and 56-58) was 
obtained in a pallet from and immediately dissolved in ~ 1mL of 10% acetonitrile in water. 10 
μL of this solution was injected into analytical HPLC-MS for analysis and rest was purified by 
preparative reverse phase HPLC on a Varian ProStar 500 HPLC system with a Varian 
Chrompack Micrsorb 100-C18 column (8 μm packing; 21.5mm x 50mm): mobile phase 
MeCN(0.05% Formic acid) / water (0.1% Formic Acid), 0% to 25% MeCN over 30 min; flow 
rate 15 mL/min; UV detection at 274 nm). The product containing fractions were combined and 
lyophilized to yield the desired rigidified oligomers 55-58 as fluffy white powders. 
HRESIQTOFMS calcd for C35H40N9O11 (M + H+) 762.2847, found 762.2927 for 55, found 
762.2844 for 56, found 762.2880 for 57, found 762.2865 for 58. 
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Analytical HPLC-MS (before purification): column, Waters XTerra MS C18 column 4.6 
mm x 150 mm; mobile phase, MeCN(0.05% Formic acid) / water (0.1% Formic Acid), 0% to 
25% MeCN over 30 min; flow rate 0.80 mL/min; UV detection at 220 and 274 nm; tR for 55, 9.7 
min; tR for 56, 8.6 min; tR for 57, 10.1 min; tR for 58, 9.3 min; ES-LRMS calcd for C35H40N9O11 
(M + H+) 762.3, found 762.2 for 55, 56, 57, 58. 
3.6.4 HPLC chromotograms for the oligomers before purification. 
 
Figure 27: HPLC chromatogram for homo-oligomer 50 at 220 nm 
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Figure 28: HPLC chromatogram for hetero-oligomer 55 at 220 nm 
 
 
 
Figure 29: HPLC chromatogram for hetero-oligomer 56 at 220 nm 
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Figure 30: HPLC chromatogram for hetero-oligomer 57 at 220 nm 
 
 
 
Figure 31: HPLC chromatogram for hetero-oligomer 58 at 220 nm 
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4.0  SYNTHESIS OF A CARBOXYLATE FUNCTIONALIZED BIS-AMINO ACID 
MONOMER 
Oligomers that adopt well-defined three-dimensional structures have attracted a great deal of 
interest in the past decade.10-12 Functionalized oligomers that present proteogenic and 
nonproteogenic functional groups from a structurally defined backbone have found many 
applications.192 Functionalized amphipathic β-peptides have demonstrated antifungal and 
antimicrobial activities and mixed β-peptide foldamers have been developed that bind protein 
surfaces.193-195 Functionalized peptoids have also demonstrated antimicrobial activity and are 
being developed as mimics of lung surfactant proteins.196, 197 Phenylene ethynylene foldamers 
have demonstrated molecular recognition of small molecules.198 In our own laboratory, we have 
developed a functionalized oligomer that acts as a molecular switch under the control of metal 
exchange.199 An essential requirement toward the development of more sophisticated 
applications for shape-persistant oligomers is the development of monomers that carry 
proteogenic and nonproteogenic chemical functionality. 
As described previously in chapters 1 and 2, in our laboratory, we have developed a 
synthetic approach to a unique class of oligomers called bis-peptides.200 We synthesize 
stereochemically pure, cyclic bis-amino acid monomers and couple them through pairs of amide 
bonds to create spiro-ladder oligomers (bis-peptides) with programmable three-dimensional 
shapes. Bis-peptides are assembled by using solid phase peptide synthesis and they are trivially 
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functionalized on their two ends through the incorporation of amino acids at the beginning or the 
end of a bis-peptide synthesis. 
To enable the development of more highly functionalized bis-peptides we need to 
develop synthetic approaches to incorporate functionality into the bis-peptide backbone. The 
approach that we have described in this chapter is to create the functionalized bis-amino acid 
“proAc(2S3S4R)”114 that carries a protected carboxylic acid functional group on its cyclic core. 
This approach is general and can be easily extended to incorporate other functional groups. 
We chose carboxylic acid group for our first synthesis as it is a very versatile proteogenic 
functional group found in aspartic acid and glutamic acid. It plays an essential role in enzyme 
catalysis such as part of the Asp-His-Ser catalytic triad in proteases and esterases.201 Miller and 
co-workers have demonstrated that carboxylic acids on chiral scaffolds can carry out asymmetric 
epoxidation of alkenes.202, 203 It is a polar group that is solvated well by water and it can be 
activated and further functionalized through the formation of amides and esters. 
In this chapter we describe the synthesis of the first functionalized bis-amino acid 
monomer proAc(2S3S4R) 67 that carries an acetyl side chain. This monomer was incorporated 
into oligomer 84 to assess the monomer’s amenability for Fmoc-SPPS. Finally, two-dimensional 
NMR and computational experiments were performed to determine the conformational 
preference of this new functionalized monomer 67. 
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4.1 SYNTHESIS OF FUNCTIONALIZED MONOMER 
4.1.1 Approaches to alkylation 
Our synthesis of proAc series of monomers starts from trans-4-hydroxy-(S)-proline 6 the same 
starting material used in the synthesis of pro4 and pip5 monomers. The simplest approach would 
have been to alkylate the ketone intermediate 5 used for the synthesis of pro4108, 109 and pip5112 
monomers at β−carbon and follow subsequent synthetic steps to the final monomer (Figure 32). 
Numerous methods are available for ketone alkylation and two approaches that are most 
prevalent are via enolate formation or via enamine formation. 
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Figure 32: Retrosynthetic approach to a functionalized monomer 
 
Enamine based approaches do not require strong acidic or basic conditions and are 
generally performed at ambient temperature or with mild heating. However, strongly activated 
104 
electrophiles are required for alkylation. Initially we tried a few approaches for alkylation based 
on enamine chemistry204 but without any success. 
Enolates are easily formed by treating a ketone with strong bases such as organolithium 
compounds and are easily alkylated with an electrophile. This approach could be utilized to 
access a large number of alkylated bis-amino acids as a variety of electrophiles are commercially 
available. Unfortunately we could not utilize ketone 5 for enolate based alkylations. A major 
concern for us was that the strong bases used could cause epimerization at α-carbon (C-2) of 
amino-acid moiety in 5. Furthermore, the secondary amine of ketone 5 is protected with a Cbz 
protecting group that reacts with organolithiums. Another convenient N-protecting group, the 
Boc group is stable under alkylation conditions, but offers little protection against epimerization. 
Also, amino ketones protected with carbamates show poor regioselectivity towards alkylation 
(C-3 vs C-5).205 
4.1.2 The Pf protecting group 
This prompted us to find an effective substitute for Cbz protecting group that not only is stable to 
alkylation conditions but also protects against any racemization. We built on the work of 
Rapoport and Lubell,206-210 who have made extensive use of the 9-phenylfluoren-9-yl (Pf) as a 
nitrogen protecting group for regio- and stereoselective alkylation of various amino acid, amino 
aldehyde and amino ketone derivatives. The phenylfluorenyl group offered us several advantages 
over other protecting group (such as carbamates): It simulatenously masked the secondary 
amine, prevented enolization at carbon next to nitrogen (C-5), protected the stereochemical 
configuration of the α-carbon, and protected the adjacent benzyl ester from attack by 
nucleophiles and base hydrolysis (Figure 33). Furthermore, the Pf protecting group is very stable 
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to solvolysis and can withstand mild acids unlike the trityl protecting group and is easily 
removed by hydrogenolysis. We found that the introduction of Pf protecting group also 
facilitated NMR analysis because it did not produce amide rotamers associated with carbamate 
protecting groups. We noted that all the intermediates isolated during the synthesis that carried 
Pf protecting group were easy to crystallize. Since Pf protecting group is an excellent UV 
chromophore, we could utilize RP-HPLC very effectively for the monitoring and optimization of 
reactions. 
 
 
Figure 33: The steric bulk of 9-phenylfluoren-9-yl (pf) group provides protection to functional groups in 
its periphery including α-proton (2H) of ketone 70 
 
4.1.3 Alkylation of ketone 70 via enolate formation 
We used the Rapoport and Lubell’s chemistry to convert trans-4-hydroxy-L-proline 6 into 
ketone 70 through a three-step procedure that included the conversion of 6 to its benzyl ester,210, 
211 protection of the secondary amine with a phenylfluorenyl group,208 and oxidation of the 
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alcohol by using Swern oxidation212, 213 to produce the ketone 70. We deliberately chose benzyl 
ester for the protection of carboxylic acid functionality as it can be simultaneously deprotected in 
a single step while swapping a Pf group with a Boc group under hydrogenolysis conditions as 
described later. 
α-Bromo acetic acid protected with t-butyl group was chosen as the electrophile so that 
the carboxylic acid functionality could be unmasked by treatment with TFA after the monomer 
has been incorporated into an oligomeric sequence. For alkylation, we used a protocol similar to 
the one reported by Poisson et al. 214 The ketone 70 was treated with n-BuLi in THF:HMPA at -
78 ºC and the resulting enolate was added to a suspension of BrCH2CO2t-Bu and NaI in THF at -
40 ºC. The enolate was formed exclusively at the 3-position of the pyrrolidine ring consistent 
with previous reports.214 We obtained a diastereomeric mixture of ketones 72a and 72b in a 10:1 
ratio as determined by C18 reverse phase (RP) HPLC-MS analysis and 1D proton NMR. After 
separation of the diastereomers by silica gel chromotography, the stereochemistry of each 
diastereomer was tentatively assigned by comparing the coupling constants between Hα and Hβ 
for the respective ketones (J = 6.1 Hz for 72a and J = 8.2 Hz for 72b) with those reported 
previously for similar alkylated ketone derivatives (Scheme 15).214, 215 
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Scheme 15: Synthesis of diastereomeric alkylated ketones 72a and 72b 
 
We noted that the diasteromeric ratio was very sensitive to the reaction temperature 
employed and the order of addition of reactants as observed generally with enolate alkylations. 
Upon reversing the order of addition i.e. adding the solution of the electrophile at -40 ºC to the 
preformed enolate at -78 ºC followed by warming the reaction to -40 ºC a ratio of 3:2 for 72a and 
72b was obtained albeit in lower yields. Moreover, flash chromatography purification of crude 
product did not result in good separation. 
The alkylation of enolate with BrCH2CO2t-Bu at -40 ºC represents a bottleneck in the 
overall process of synthesizing monomer 67.We found that the combined yield of 72a and 72b 
decreased significantly when we carried the reaction out on scales larger than 100 mmol and in 
particular in round-bottomed flasks larger than 100 mL. We believe that this is because of poor 
temperature control in larger volumes. 
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4.1.4 Reduction of alkylated ketones with trichloromethylanion 
Both diastereomers 72a and 72b could lead to useful carboxylate functionalized bis-amino acids 
with different stereochemistry. Our attempts to use the Bucherer-Bergs reaction142, 143 reaction to 
convert alkylated ketones 72a or 72b to their corresponding hydantoins failed. However, 
unalkylated ketone 70 easily reacted under similar reaction conditions to yield corresponding 
hydantoins. This led us to conclude that the steric hinderance from the alkyl side chain is the 
reason for this inertness of alkylated ketones toward the Bucherer-Bergs reaction and an 
alternative method was needed for the installation of the second amino acid functionality. 
In 1992 Corey and Link216 reported a mild protocol for the conversion of a ketone to 
trichlorocarbinols, that on treatment with a basic solution of azide undergoe a Jocic 
rearrangement217 to yield a carboxylic acid. Later Pedregal et al.218 reported an efficient method 
for the synthesis of trichlorocarbinols that involved reduction of a ketone with a trichloromethyl 
anion. This trichloromethyl anion is formed by the reaction of chloroform with LiHMDS in THF 
at -78 ºC. This methodology has been previously used by us111 to synthesize quarternary amino 
acid derivatives. 
On reduction with trichloromethyl anion, the major ketone 72a yielded two 
diastereomeric products 73a and 73b in a ratio of 3:2 as determined by RP-HPLC-MS analysis 
and 1D proton NMR (Scheme 16). Unfortunately, this mixture of two diastereomeric 
trichlorocarbinols was very difficult to separate by silica chromotography. We succesfully 
isolated these trichlorocarbinols 73a and 73b by flash chromotography at mg scale to obtain pure 
analytical samples, but our attempts to isolate two diastereomeric products in useful gram 
quantities failed repeatedly. This limitation turned our attention towards the minor ketone 72b. 
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Scheme 16: Reduction of major ketone 72b with trichloromethyl anion 
 
We hypothesized that because of the relative cis orientation of substituents at C2 and C3, 
the Re face of the ketone will be highly shielded against approach of an anion towards the 
trigonal carbon C4 along the Burgi-Denitz trajectory (Figure 34b). The incoming bulky trichloro 
anion would preferably attack from the Si face which could translate into very high 
diastereoselectivity. As envisioned, the reaction of ketone 72b with trichlormethyl anion yielded 
only the single diasteremer 74 as evidenced by RP-HPLC-MS and 1D proton NMR. 
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Figure 34: (a) Reduction of minor ketone 72b with trichloromethyl anion leads to a single product 74. (b) 
Incoming anion can add from the Si face only as approach from the Re face (shown by an arrow) is blocked. 
 
4.1.5 Enrichment of minor alkylated ketone 
As described earlier, the alkylation of ketone 70 yields ketone 72b only as a minor diastereomer. 
We explored a deprotonation-protonation protocol for reversing the stereochemistry of an 
alkylated ketone previously developed by Sardina et al.215 This involved the treatment of an 
alkylated ketone with n-BuLi at -78 ºC followed by quenching with acetic acid. This method was 
very effective but only at mg scale. Upon scaling up to gram scale, it resulted in poor yields as a 
significant amount of the alkylated ketone 72a was being converted to an unknown side product. 
We attributed this to the high strength of n-BuLi base that could wreak havoc if the reaction 
(a) (b)
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mixture warms above -78 ºC because of the poor temperature control as is generally the case 
with large scale reactions. We searched for a milder organolithium base for deprotonation that 
has the capacity to deprotonate the alkylated ketone but is mild enough to tolerate slight variation 
in temperature. We found that the combination of LiHMDS for deprotonation and saturated 
NH4Cl solution for quenching worked best. 
To increase the amount of ketone intermediate 72b that we could produce, we carried out 
a controlled epimerization at carbon 3 by treating the 10:1 mixture of 72a and 72b with lithium 
bis(trimethylsilyl)amide (LiHMDS) at -78 ºC for 1 h followed by quenching by rapidly adding 
saturated ammonium chloride to the reaction mixture at -78 ºC. The resulting diastereomeric 
mixture had a more useful ratio of 72a and 72b of 1:2. The two diastereomers were then 
separated by silica gel chromatography. 
We believe that this poor stereoselectively of the enolate protonation process was due to 
the small size of incoming electrophile that was proton. Because of its small size, incoming 
proton does not see much steric interaction from either of the faces. This was in contrast to initial 
alkylation by BrCH2CO2t-Bu, a bulky nucleophile, which proceeded with high stereoselectivity. 
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Scheme 17: Deprotonation-protonation protocol for the enrichment of minor ketone 72b 
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Toward the synthesis of carboxyl functionalized bis-amino acid 67 we converted the 
ketone 72b to a protected amino ester. We achieved this by reducing the ketone 72b to 
trichloromethylcarbinol 74. In Pedregal et al.’s procedure,218 LiHMDS was added to a precooled 
solution of the ketone and chloroform in THF. The base that is being added to chloroform in the 
presence of a ketone, has two chemical species to react with (Scheme 18). It can either 
deprotonate chloroform or deprotonate at C3 on the alkylated ketone 72b to give enolate 75. The 
fraction of the ketone that is converted to an enolate cannot be reduced with trichloromethyl 
anion and upon quenching gives rise to both diasteromeric ketones 72a and 72b thus reducing 
the recovered yield of the desired trichlorocarbinol 74. This was supported by the observation 
that the addition of more LiHMDS after the reaction had stopped (as observed by HPLC) did not 
result in more product. One way to avoid this competitive deprotonation would have been to 
preform the trichlomethyl anion and add the ketone to this solution. Indeed, we saw no 
epimerization at C3 indicating no enolization occurred, but yields could not be improved beyond 
20% even though 5 fold initial excess of anion was used. We concluded that the trichloromethyl 
anion is very unstable and needs to react with ketone immediately upon its formation. 
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Scheme 18: Two reaction pathways during the reduction of alkylated ketone 72b by trichloromethyl anion 
and their end products 
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We optimized the reaction conditions and found that the best yields are obtained by a 
slow addition of 2 equiv of LiHMDS solution to a precooled solution of alkylated ketone in a 1:2 
mixtures of chloroform and THF. We also determined that the reaction stops after first few 
minutes by that time most of the ketone has been reduced to trichlorocarbinol. Unreacted ketone 
was easily recovered by silica gel column chromatography. Alternatively, the crude product was 
taken to the next step without any interference from unreacted ketones. 
4.1.6 Synthesis of the amino acid intermediate 79 
N
OBn
O
O
Ot-Bu
Pf
HO
Cl3C
N OBn
O
O
Ot-Bu
Pf
HO2C
N3
N OBn
O
O
Ot-Bu
Pf
HO2C
HN
Fmoc N
OBn
O
O
Ot-Bu
Pf
HN
Fmoc
O
O
74 78
80
NaN3, NaOH,
H2O:Dioxane (1:1)
0 °C to rt
Fmoc-OSu, Na2CO3,
H2O:Dioxane (1:3)
CF2HCF2CH2OH, DCC,
cat. DMAP, CH2Cl2
 
           0 °C to rt81% from 74
89%
79
N OBn
O
O
Ot-Bu
Pf
HO2C
H2N
Zn, AcOH:THF (1:1)
79
CF2
HF2C
81  
Scheme 19: Synthesis of a fully protected ester intermediate 81 
 
Upon treatment with a basic aqueous solution of sodium azide, the trichlorocarbinol 74 
underwent a Jocic rearrangement to yield azido acid 78 with an inversion of configuration. The 
best results were obtained when an ice-cooled solution of sodium azide and sodium hydroxide 
was added to an ice-cooled solution of trichlorocarbinol in dioxane. If any of the two solutions 
were added at room temperature, an undesired hydroxyacid 82 was formed in varying amounts 
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(Scheme 18). Also, an excess of sodium azide and sodium hydroxide (5 equiv each) was required 
to ensure that the reaction is complete within a day and has no side products. We couldn’t use 
strong mineral acids e.g. HCl, to quench the reaction as they are incompatible with azides. A 
simple aqueous workup minus quenching step led to the partition of the product azido-acid 78 
into organic as well as into aqueous layer. After experimenting with a series of quenching 
conditions, we found that upon quenching the reaction mixture with a small volume of saturated 
NH4Cl solution, the entire product could be forced into organic layer as desired. The crude 
product 78 thus obtained could be taken to next step without any complication. 
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Figure 35: Mechanism of a Jocic Reaction: Formation of azide intermediate 78 and undesired hydroxyl-
acid side product 82 
 
The azide 78 was then reduced to the amine 79 using Zn/AcOH. We determined that to 
achieve quantitative reduction within a day, 20-30 wt% (with respect to 78) of Zn was optimum. 
When we tried to speed up the reaction by adding more Zn, a significant amount of over-reduced 
product i.e. complete removal of azide was observed. In one such optimization experiment where 
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we used 45 wt% of Zn, the reaction was complete within 1.5 h. However, 23% of the azide 78 
was lost as over-reduced undesired product (as determined by RP-HPLC). The crude amino-acid 
product 79 obtained after the removal of acetic acid could be used for next step without any 
further purification. 
4.1.7 Synthesis of fully protected intermediate 81 
We protected amine functionality of 79 with 9-fluorenylmethyl N-succinimidyl carbonate 
(Fmoc-Su) to form 80. It was necessary to keep the reaction mixture homogenous throughout the 
course of the reaction by adjusting the ratio of water and dioxane. The Fmoc protected amino 
acid 80 was purified by silica gel chromatography and a portion was crystallized from 
hexanes/ethyl acetate. The X-ray determined structure revealed that the stereochemistry was as 
shown for compound 80 and consistent with our tentative assignment using NMR. 
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Figure 36: X-ray crystallographic structure of intermediate 80 
 
Compound 80 was then treated with 1,3-dicyclohexylcarbodiimide (DCC)/4-
(dimethylamino)pyridine (DMAP) and 2,2,3,3-tetrafluoropropanol to yield ester 81. We found 
that the yield of this reaction was moderately affected by the purity of 80. When the 
esterification was performed on crude intermediate 80, obtained after Fmoc protection step, the 
reaction was incomplete (~ 14% unreacted 80 as determined by HPLC) and the isolation of the 
desired product 81 was difficult. 
4.1.8 Pf to Boc group exchange 
Finally the Pf protecting group was exchanged for a Boc protecting group while simultaneously 
removing the benzyl protecting group to unmask the carboxylic acid for coupling. Use of N,N-
117 
diisopropylethylamine (DIPEA) as an additive in this reaction reduced the reaction time from a 
week to less than a day. The best result was obtained when the reaction mixture was allowed to 
equilibrate for 2-3 h before the addition of DIPEA. If DIPEA was added to the reaction mixture 
at the onset of the reaction with other reagents, a significant amount of a side product (~ 30%) 
formed. This was a result of an incomplete Boc protection of the secondary amine and could not 
be converted into monomer 67 without isolating it from the crude product. After final 
purification we obtained the desired monomer 67 as a white foam in an overall 38% yield from 
the ketone 72b (Scheme 20). 
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Scheme 20: Conversion of intermediate 81 into the functionalized monomer 67 
 
Only three purification columns are required through the synthesis from ketone 70. The 
synthesis we describe is well optimized and highly reproducible for the scale of 850 mg of 
monomer 67. All the reactions have been well optimized and are individually scalable to 
multigram synthesis. The synthesis of 67 identified that the enolate alkylation (to form 72a and 
72b) alongwith the subsequent purification, and the trichloromethyl anion reduction (to form 74) 
are potential bottlenecks. 
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4.2 SYNTHESIS OF THREE-MER INCORPORATING A PROAC(2S3S4R) 
MONOMER 
4.2.1 Solid phase assembly of a short oligomer 
We incorporated 67 into a heterosequence of three bis-amino acid monomers using solid phase 
synthesis protocols that we have previously developed for synthesizing bis-peptides.108, 112 The 
oligomeric sequence (L)Leu-pro4(2S4S)-proAc(2S3S4R)-pro4(2S4S)-(L)Tyr was assembled on 
2-chlorotritylchloride resin219 (50 mg scale). The leucine residue was used to enhance the 
lipophilicity of the oligomer and the tyrosine residue provides a UV-chromophore to facilitate 
purification and characterization. After the attachment of leucine to the resin, each subsequent 
residue was activated as the 1-hydroxy-7-azabenzotriazole (-OAt) ester149 for coupling to the 
growing oligomer on solid support. Quantitative coupling of the first pro4(2S4S) monomer was 
achieved through double coupling of 2 equiv with respect to the resin loading. The next coupling 
of proAc(2S3S4R) to the pro4(2S4S) monomer proved to be difficult. After screening a range of 
coupling methods and reagents we concluded that our general coupling method that involves 
activating monomer as the -OAt ester gives the best results (up to 45% after double coupling 
with 3 equiv for 4 h). This may be due to the additional hindrance of the t-Bu protected acetyl 
side chain. Recently, our group has reported acyl transfer based coupling methodology for the 
coupling of sterically hindered amino acids that could be utilized to overcome this problem.220 
The subsequent coupling of pro4(2S4S) monomer to proAc(2S3S4R) monomer was 
quanititaive. After coupling tyrosine and removal of the terminal Fmoc group, the oligomer was 
cleaved from the resin with trifluoroacetic acid (TFA)/CH2Cl2. After removal of TFA, the 
oligomer 83 was lypholized to remove any traces of TFA (Scheme 21). 
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Scheme 21: Solid phase assembly of a short oligomer 84 with proAc(2S3S4R) monomer 
(The hydrogens on compound 84 are labeled with the number of the heavy atom to which they are attached. The 
hydrogens of methylenes are labeled “α” if they go into the page and “β” if they come out.) 
 
To form the remaining two diketopiperazine (DKP) rings, 83 was dissolved in an 80 mM 
solution of ammonium acetate in 20% acetonitrile/water and heated in an oven at 55 °C. The 
reaction progress was monitored by RP-HPLC-MS. After 26 h, analysis of the reaction mixture 
revealed a major peak for the desired product 84 and no trace of 83 or any intermediates. The 
crude oligomer was purified by preparative C18 RP-HPLC and after lypholization, 84 was 
obtained as a white powder that we used for NMR studies and high-resolution mass spectrometry 
(Scheme 21). 
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Figure 37: The AMBER94 energy minimized structure of bis-peptide 84 that is most consistent with the 
superimposed ROESY correlations. 
(The sequence is (L)-Leu-pro4(2S4S)-proAc(2S3S4R)-pro4(2S4S)-(L)-Tyr and the pyrrolidine rings are shaded 
green, red, and green, respectively. The inset figures are a close-up of the second monomer (proAc(2S3S4R), red). 
The colors of the ROESY correlation lines are color-coded based on their intensity (red = strong, yellow = medium, 
green = weak).) 
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4.2.2 Solution phase NMR structure and conformational analysis 
For NMR experiments, the oligomer 84 was dissolved in 350 µL dimethyl sulfoxide-d6 and 5 µL 
trifluoroacteic acid was added to protonate all basic groups. We carried out a series of two-
dimensional NMR experiments (COSY, TOCSY, ROSEY, HMQC, and HMBC) and assigned 
the hydrogen and carbon chemical shifts using SPARKY.166 The NMR data confirmed the 
expected connectivity and stereochemistry. 
We carried out a stochastic conformational144 search in vacuo using the AMBER94145 
force field within the molecular mechanics package MOE.146 The lowest energy conformation is 
shown in Figure 37; ROESY correlations between non-J-coupled protons are superimposed on 
the structure sorted by intensity, classified as strong, medium, and weak. The conformational 
search revealed two closely spaced lowest energy conformers (separated by 0.22 kcal/mol) 
differing in conformation of the pyrolidine ring A. The ROESY correlations for pyrolidine ring 
A were consistent with this in that they did not support a single conformation. 
In the case of pyrolidine ring C, amide proton H18 shows a strong correlation with H13 
but only a medium correlation with H15α. There is a medium intensity correlation between 
H15α and H12. We also observe a medium strength correlation between H20 and H15β. These 
correlations are in agreement with the structure shown. 
The ROESY correlations of pyrrolidine ring E are consistent with the envelop 
conformation shown. It is identical with the envelop conformation that we have previously seen 
for a pro4(2S4S) monomer followed by an (S)-tyrosine.108, 110 The amide proton H26 shows a 
strong correlation with H21β and a medium correlation with H23β. A weak correlation of H20 
with H23α further supports this conformation. We did not observe ROESY correlations between 
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the tyrosine aromatic hydrogens and H23α and H23β as seen in previous structures;108, 110 this 
may be because this structure was determined in DMSO rather than water, which would promote 
a hydrophobic interaction between the aromatic tyrosine and the methylene 23. 
 
H
H
CO2HH
C34
C14C12
H
H
HHO2C
C34
C14C12
∇ E = 3.2 kCal/mole
 
Figure 38: Two probable conformations of the acetyl group that are consistent with ROESY correlations seen for 
oligomer 84 
 
The acetyl side chain appears to prefer a single rotamer because we observe a 3 Hz 
(gauche) and 11.5 Hz (anti) J1,3 coupling constant between H13 to H34α and H13 to H34β. We 
cannot absolutely assign the chemical shift of H34α and H34β and so there are two possible 
conformations consistent with these chemical shifts. The conformation shown in Figure 37 is the 
lower energy rotamer by 3.2 kcal/mol. 
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4.3 CONCLUSION 
In conclusion, we have developed a synthesis for a carboxylate functionalized bis-amino acid, 
proAc(2S3S4R). We demonstrated that it can be incorporated into bis-peptides, determined the 
structure of a short bis-peptide oligomer that contains it, verified its stereochemical 
configuration, and determined its conformational preference. The synthesis of this monomer is 
general and can be used to incorporate other functional groups. 
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4.4 EXPERIMENTAL METHODS 
4.4.1 General methods 
All the reagents, including dry solvents, were obtained from various commercial sources and 
used as such. All the moisture sensitive reactions were carried out in flame-dried or oven-dried 
glassware under an argon atmosphere unless otherwise noted. 
Analytical TLC analysis was performed on silica gel plates (250 μm thickness). Flash 
chromatography was performed using custom made columns (50 g, I.D. 26 mm or 170g, I.D. 47 
mm) packed with 32-63 D (60 Å particle size) grade silica gel on an automated purification 
system. For difficult separations, oven-dried silica (kept in oven for 2 days at 120-130 °C and 
immediately used after cooling inside a desiccator) was used as indicated in preparative methods. 
For a typical purification, the compound was dissolved in a minimum amount of 
dichloromethane and mixed with celite. Dichloromethane was removed by rotary evaporation. 
The resulting solid mixture was transferred to a 40 g empty loading column and further dried 
overnight under reduced pressure to remove any residual solvent. In the case of purifications 
where multiple columns connected in series were used, CVs are reported with respect to the size 
of an individual column not the entire series. 
NMR experiments were performed on a 500 MHz spectrometer. In the case of oligomer 
84, a special 5 mm Shigemi tube matched for DMSO was used. For all other experiments, 
standard 5 mm NMR tubes were used. Chemical shifts (δ) are reported in parts per million (ppm) 
relative to CDCl3, DMSO-d6 or acetone-d6 residual solvent peaks. If required, rotational isomers 
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were resolved by obtaining spectra at 77 °C (350K) in DMSO-d6. Analysis of 1D NMR spectra 
was performed using commercially available processing software NUTS. IR spectra were 
obtained on an FT-IR instrument. Optical rotations were obtained at ambient temperature (26 ± 1 
°C). 
The elemental composition of purified compounds was confirmed by spectra obtained on 
a high resolution mass-spectrometer with an electrospray ion source (HRESIQTOFMS). The 
elemental composition of oligomer 84 was confirmed by spectra obtained on a LTQ Orbitrap – 
Hybrid FT mass spectrometer (HRLTQ-Orbitrap). 
 
4.4.2 HPLC-MS procedures 
HPLC-MS analysis was performed on a C18 reverse-phase column (3.5 μm packing, 4.6 mm x 
150 mm) coupled to a mass spectrometer (ESI source). Purification by preparative HPLC was 
carried out on a semiprep C18 column (5μm packing, 19 mm x 100 mm). HPLC mobile phase: 
Solvent A “water (0.1% formic acid)”, Solvent B “acetonitrile (0.05% formic acid)”. Method 
05_95 indicates that a gradient was run with initial composition of solvent A 95% and B 5% to 
solvent A 5% and B 95% over 30 min. Method 05_100xx indicates that a gradient was run with 
initial composition of solvent A 95% and B 5% to solvent B 100% over 32 min and solvent B 
100% was continued for an additional 8 min. The analytical HPLC-MS was run at a flow rate of 
0.8 mL/min while the preparative HPLC was run at 18 mL/min of mobile phase. 
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4.4.3 Monomer synthesis 
(2S,3R)-Benzyl-3-((tert-butoxycarbonyl)methyl)-4-oxo-1-(9-phenyl-9H-fluoren-9-
yl)pyrrolidine-2-carboxylate (72a) and (2S,3S)-Benzyl 3-((tert-butoxycarbonyl)methyl)-4-
oxo-1-(9-phenyl-9H-fluoren-9-yl)pyrrolidine-2-carboxylate (72b). 
The ketone 70 (4.6 g, 10 mmol) was placed in an oven-dried 50-mL round-bottomed flask and 
dissolved in dry THF (20 mL) under argon. HMPA (4 mL) was added and the solution was 
cooled to -78 °C in an acetone/dry ice bath. After equilibrating for 15 min, a 1.6 M solution of n-
BuLi in hexanes (6.3 mL, 1 equiv) was slowly added to the reaction mixture via syringe pump 
(0.5 mL/min). The stirring was continued for an additional 30 min to ensure the complete 
conversion of ketone 70 to the corresponding enolate. 
In the meantime, a solution of the electrophile was prepared as follows: NaI (0.75 g, 5 
mmol, 0.5 equiv) was suspended in dry THF (20 mL) under argon flow in an oven-dried 100-mL 
round-bottomed flask. t-Butyl bromoacetate (4.4 mL, 30 mmol, 3 equiv) was added and the 
reaction mixture was stirred at rt for 5 min. The resulting milky suspension was further cooled to 
-40 °C in an acetonitrile/dry ice bath for 15 min. 
The preformed enolate (at -78 °C) was transferred to the reaction flask containing the 
electrophile suspension (at -40 °C) via cannula and the reaction mixture was stirred for an 
additional 3 hours at -40 °C. The reaction was quenched by a quick addition of 10 % (v/v) 
phosphoric acid solution (10 mL, at rt) to the reaction mixture at -40 °C. The quenched reaction 
mixture was allowed to warm to room temperature. The resulting suspension was further diluted 
with water (50 mL) and extracted with EtOAc (500 mL). The organic layer was washed with 1:1 
brine/water (50 mL) followed by brine (25 mL). After drying over anhydrous Na2SO4 for 30 
min, the organic layer was decanted and concentrated to dryness by rotary evaporation under 
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reduced pressure. The crude product was purified via automated flash chromatography (2 x 50 g 
columns connected in series with silica; solvent A: hexanes; solvent B: EtOAc; gradient elution: 
0-5 CVs “solvent A 100%” followed by 5-45 CVs “solvent B 0% to 50%”). All the fractions that 
showed UV absorbance at 301 nm were pooled together and concentrated by rotary evaporation. 
The resulting oil was further dried under reduced pressure overnight to yield a mixture of 
diastereomeric products 72a and 72b in a ratio of 10:1 (on the basis of 1H NMR spectrum and 
HPLC chromatogram at 301 nm) as a white foam (5.3 g, 9.2 mmol, 92%). 
HPLC-MS. Method: 05_100xx; UV detection at 301 nm; 72a tR = 30.9 min, m/z (ion) 
596.3 (M + Na+, expected 596.2), 72b tR = 31.1 min, m/z (ion) 596.3 (M + Na+, expected 596.2). 
A portion of the mixture of compounds 72a and 72b (2.1 g, 3.7 mmol) obtained from the 
purification step above was placed in an oven-dried 50-mL round-bottomed flask and dissolved 
in dry THF (18 mL) under argon. The solution was cooled to -78 °C in an acetone/dry ice bath. 
After equilibrating for 15 min, a 1 M solution of LiHMDS in THF (4.4 mL, 1.2 equiv) was 
slowly added to the reaction mixture via syringe pump (1 mL/min). The stirring was continued 
for an additional 1 h after which the reaction was quenched by a quick addition of saturated 
NH4Cl solution (5 mL, at room temperature) to the reaction mixture at -78 °C. The quenched 
reaction mixture was allowed to warm to room temperature. The resulting suspension was further 
diluted with water (50 mL) and extracted with EtOAc (250 mL). The organic layer was washed 
with 1:1 brine/water (50 mL) followed by brine (25 mL). After drying over anhydrous Na2SO4 
for 30 min, the organic layer was decanted and concentrated by rotary evaporation under reduced 
pressure. The resulting oil was further dried under reduced pressure overnight to yield a mixture 
of diastereomeric products 72a and 72b in a ratio of 1:2 (as determined by HPLC chromatogram 
at 301 nm) as a yellow foam. 
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HPLC-MS: Method: 05_100xx; UV detection at 301 nm; 72a tR = 30.9 min, m/z (ion) 
596.3 (M + Na+, expected 596.2), 72b tR = 31.1 min, m/z (ion) 596.3 (M + Na+, expected 596.2). 
The crude product was purified by automated flash chromatography (4 x 50 g columns 
connected in series packed with oven-dried silica; solvent A: hexanes; solvent B: EtOAc; 
gradient elution: 0-5 CVs “solvent A 100%” followed by 5-75 CVs “solvent B 0% to 40%”). The 
fractions were analyzed by HPLC. On the basis of the analysis, the relevant fractions were 
divided into three parts (pure 72a, pure 72b and mixture) and pooled together separately. The 
three pools were concentrated by rotary evaporation and the resulting oils were further dried 
under reduced pressure overnight to yield pure 72a (0.54 g, 0.9 mmol, 26%), pure 72b (1.15 g, 
2.0 mmol, 55%), and a mixture of 72a and 72b (0.14 g, 0.2 mmol, 7%), all as white foams 
(overall recovery 88%). 
 
More polar 72a: 
1H NMR (500.1 MHz, CDCl3): δ 7.66–7.13 (m, 18H), 4.60 (d, J = 12.5 Hz, 1H), 4.36 (d, J = 
12.5 Hz, 1H), 3.82 (d, J = 17.6 Hz, 1H), 3.49 (d, J = 17.6 Hz, 1H), 3.49 (d, J = 5.9 Hz, 1H), 2.82 
(m, 1H), 2.40–2.31 (m, 2H), 1.260 (s, 9H). 13C NMR (125.8 MHz, CDCl3): δ 212.0, 172.4, 
169.7, 146.1, 144.7, 141.6, 141.1, 140.6, 135.4, 129.0, 128.6, 128.5, 128.2, 128.1, 127.9, 127.9, 
127.8, 127.5, 127.1, 126.1, 120.4, 120.1, 81.5, 75.9, 66.4 (CH2), 63.8 (CH), 55.8 (CH2), 49.3 
(CH), 34.4 (CH2), 27.9 (CH3, 3C). IR(thin film): 3031, 1760, 1717, 1584, 1261, 959, 735. [α]27D 
-68.0 (c 0.53, CHCl3). HRMS-ES (m/z): calcd for C37H35NO5Na+ (M + Na+) 596.2413, found 
596.2407. 
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Less polar 72b: 
1H NMR (500.1 MHz, CDCl3): δ 7.63 (dd, J = 17.2, 7.5 Hz, 2H), 7.41–7.20 (m, 14H), 7.13 (m, 
2H), 4.61 (d, J = 12.4 Hz, 1H), 4.55 (d, J = 12.4 Hz, 1H), 4.07 (d, J = 8.2 Hz, 1H), 3.83 (d, J = 
17.8 Hz, 1H), 3.57 (dd, J = 17.8, 1.0 Hz, 1H), 3.05 (dddd, J = 9.1, 8.2, 5.0, 1.0 Hz, 1H), 2.54 (dd, 
J = 17.6, 5.0 Hz, 1H), 1.81 (dd, J = 17.6, 9.1 Hz, 1H), 1.27 (s, 9H). 13C NMR (125.8 MHz, 
CDCl3): δ 212.4, 171.3, 170.3, 147.1, 145.6, 141.9, 141.2, 139.9, 135.3, 128.9, 128.7, 128.5, 
128.3, 128.2, 127.8, 126.9, 126.8, 125.4, 120.4, 120.3, 81.1, 75.7, 66.2 (CH2), 62.1 (CH), 54.1 
(CH2), 48.2 (CH), 31.0 (CH2), 27.9 (CH3, 3C). IR(thin film): 3035, 1761, 1717, 1584, 1264, 
1164, 959, 737. [α]27D -110 (c 0.55, CHCl3). HRMS-ES (m/z): calcd for C37H35NO5Na+ (M + 
Na+) 596.2413, found 596.2397. 
 
(2S,3S,4S)-Benzyl-3-((tert-Butoxycarbonyl)methyl)-4-(trichloromethyl)-4-hydroxy-1-(9-
phenyl-9H-fluoren-9-yl)pyrrolidine-2-carboxylate (74). 
The pure alkylated ketone 72b (1.06 g, 1.85 mmol) was placed in an oven-dried 50-mL round-
bottomed flask and dissolved in dry THF (18.5 mL) under argon. Dry CHCl3 (9.2 mL) was 
added and the solution was cooled to -78 °C in an acetone/dry ice bath. After equilibrating for 30 
minutes, 1M solution of LiHMDS in THF (3.7 mL, 2 equiv) was slowly added to the reaction 
mixture via syringe pump (0.5 mL/min). The stirring was continued for an additional 2 h after 
which the reaction was quenched by a quick addition of saturated NH4Cl solution (5 mL, at room 
temperature) to the reaction mixture at -78 °C. The quenched reaction mixture was allowed to 
warm to room temperature. The resulting suspension was further diluted with water (20 mL) and 
extracted with EtOAc (250 mL). The organic layer was washed with 1:1 brine/water (25 mL) 
followed by brine (25 mL). After drying over anhydrous Na2SO4 for 30 min, the organic layer 
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was decanted and concentrated to dryness by rotary evaporation under reduced pressure. The 
crude product was purified by automated flash chromatography (3 x 50 g columns connected in 
series packed with oven-dried silica; solvent A: hexanes; solvent B: EtOAc; gradient elution: 0-5 
CVs “solvent A 100%” followed by 5-75 CVs “solvent B 0% to 40%”). The fractions were 
analyzed by HPLC. On the basis of the analysis, the relevant fractions were divided into three 
parts (pure 74, pure 72b, and mixture of 74, 72b and 72a) and pooled together separately. The 
three pools were concentrated by rotary evaporation and the resulting oils were further dried 
under reduced pressure overnight to yield pure product 74 (0.81 g, 1.17 mmol, 63%), recovered 
ketone 72b (0.15 g, 0.26 mmol, 14%), and the mixture of 74, 72b, and isomerized ketone 72a 
(0.17 g, ~15%), all as white foams (overall recovery ~92%). The stereochemistry for 74 was 
back-assigned after the determination of the stereochemistry at the quaternary center of 
intermediate 80 by X-ray crystallography. 
HPLC-MS: Method: 05_100xx; UV detection at 301 nm; 74 tR = 32.8 min, m/z (ion) 692.2 
(100%), 694.2 (95.9%) (M + H+ expected 692.2 and 694.2, characteristic for the –CCl3 group). 
1H NMR (500.1 MHz, CDCl3): δ 7.62 (dd, J = 7.0, 7.0 Hz, 2H), 7.52–7.18 (m, 14H), 7.09 (m, 
2H), 5.31 (s, 1H), 4.78 (d, J = 12.4 Hz, 1H), 4.51 (d, J = 12.4 Hz, 1H), 3.83 (d, J = 9.4 Hz, 1H), 
3.81 (d, J = 10.5 Hz, 1H), 3.62 (d, J = 10.5 Hz, 1H), 3.34 (ddd, J = 9.4, 8.2, 5.0, Hz, 1H), 2.89 
(dd, J = 18.0, 5.0 Hz, 1H), 1.91 (dd, J = 18.0, 9.1 Hz, 1H), 1.16 (s, 9H). 13C NMR (125.8 MHz, 
CDCl3): δ 176.1, 170.1, 146.3, 146.1, 141.5, 140.6, 140.3, 134.5, 128.9, 128.9, 128.6, 128.6, 
128.5, 128.4, 128.3, 128.2, 127.8, 127.6, 127.2, 127.0, 125.9, 120.4, 120.2, 103.1, 88.2, 80.9, 
75.5, 67.3 (CH2), 65.2 (CH), 59.5 (CH2), 42.8 (CH), 31.8 (CH2), 27.8 (CH3, 3C). IR(thin film): 
3391, 3062, 2976, 2936, 2877, 1727, 1451, 1368, 1257, 1156, 1065, 909, 794, 735. [α]27D -97.3 
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(c 0.42, CHCl3). HRMS-ES (m/z): calcd for C38H36Cl3NO5Na+ (M + Na+) 714.1557, found 
714.1564. 
 
(2S,3S,4R)-2-((Benzyloxy)carbonyl)-3-((tert-butoxycarbonyl)methyl)-4-azido-1-(9-phenyl-
9H-fluoren-9-yl)pyrrolidine-4-carboxylic Acid (78). 
The pure intermediate 74 (0.83 g, 1.2 mmol) was placed in a 50-mL round-bottomed flask and 
dissolved in dioxane (12 mL). The reaction flask was cooled in an ice bath for 2 min and a 
solution (precooled to 0 °C) of NaN3 (390 mg, 6 mmol, 5 equiv) and NaOH (240 mg, 6 mmol, 5 
equiv) in water was added drop by drop. Additional dioxane (3–4 mL) was added to dissolve any 
starting material that precipitates out upon addition of aqueous solution. The stirring was 
continued and the reaction progress was monitored by HPLC: a small volume (5 µL) was 
withdrawn from the reaction flask, diluted with MeOH (45 µL), and filtered through a Spin-X 
centrifuge filter. We injected a portion of this solution (5 µL) into HPLC-MS for analysis 
(method: 05_100xx, UV detection at 301 nm; 78 tR = 30.4 min, m/z (ion) 645.2 and 667.2 (M + 
H+ expected 645.3 and M + Na+ expected 667.3), 74 tR = 32.7 min). After completion (ca. 9 h, as 
indicated by the absence of the peak corresponding to 74), the reaction was quenched by the 
addition of saturated NH4Cl solution (10 mL). The resulting mixture was further diluted with 
water (50 mL) and extracted with EtOAc (500 mL). The organic layer was washed with 1:1 
brine/water (50 mL) followed by brine (25 mL). After drying over anhydrous Na2SO4 for 30 
min, the organic layer was decanted and concentrated to dryness by rotary evaporation under 
reduced pressure. Any residual solvent was removed by drying under reduced pressure to yield 
crude product 78 as a yellow foam (0.81 g). This crude product was taken to the next step 
without any further purification. For characterization, the above reaction was repeated at 0.30 
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mmol scale and the resulting crude product was purified by automated flash chromatography (50 
g silica column; solvent A: hexanes with 0.1% AcOH, solvent B: EtOAc with 0.1% AcOH; 
gradient elution: 0–5 CVs “solvent B 10%” followed by 5–45 CVs “solvent B 10% to 60%”). 
The desired fractions were pooled together and concentrated by rotary evaporation. To remove 
residual acetic acid, the purified product was redissolved in EtOAc (200 mL) and washed with 
water (2 x 20 mL). The organic layer was further washed with brine (20 mL) and after drying 
over anhydrous sodium sulfate for 20 min, solvent was removed by rotary evaporation under 
reduced pressure. The resulting oil was further dried under reduced pressure overnight to yield 
the desired product 78 (172 mg, 0.26 mmol, 87%) as a white foam. 
1H NMR (500.1 MHz, CDCl3): δ 7.75 (d, J = 7.6 Hz, 1H), 7.57 (d, J = 7.4 Hz, 1H), 7.50–7.06 
(m, 16H), 4.69 (d, J = 12.4 Hz, 1H), 4.49 (d, J = 12.4 Hz, 1H), 3.86 (d, J = 9.6 Hz, 1H), 3.55 (d, 
J = 10.0 Hz, 1H), 3.22 (d, J = 10.0 Hz, 1H), 2.78 (ddd, J = 10.2, 9.6, 4.0 Hz, 1H), 2.44 (dd, J = 
17.5, 4.0 Hz, 1H), 2.16 (dd, J = 17.5, 10.2 Hz, 1H), 1.17 (s, 9H). 13C NMR (125.8 MHz, 
CDCl3): δ 173.8, 170.1, 169.7, 145.4, 143.5, 141.6, 140.6, 140.0, 134.5, 129.5, 129.2, 128.9, 
128.5, 128.4, 128.3, 128.1, 128.1, 128.0, 127.3, 127.1, 126.9, 120.7, 120.1, 81.5, 76.2, 70.9, 67.5 
(CH2), 61.6 (CH), 55.9 (CH2), 46.3 (CH), 32.9 (CH2), 27.8 (CH3, 3C). IR (thin film): 3061, 
3034, 2978, 2936, 2107, 1730, 1451, 1368, 1255, 1157, 909, 737. [α]27D +124 (c 0.47, CHCl3). 
HRMS-ES (m/z): calcd for C38H36N4O6Na+ (M + Na+) 667.2533, found 667.2458. 
 
(2S,3S,4R)-2-((Benzyloxy)carbonyl)-3-((tert-butoxycarbonyl)methyl)-4-amino-1-(9-phenyl-
9H-fluoren-9-yl)pyrrolidine-4-carboxylic Acid (79). 
The crude product 75 obtained in the preceding step (0.81 g, all of it) was transferred to a 50-mL 
round-bottomed flask and dissolved in dry THF (12 mL). AcOH (12 mL) was added to this 
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solution followed by 0.16 g of Zn dust (20 wt % of 78). The reaction mixture was stirred at rt and 
the reaction progress was monitored by HPLC: a small volume (10 µL) was withdrawn from the 
reaction flask, diluted with MeOH (250 µL), and filtered through a Spin-X centrifuge filter. We 
injected a portion of this solution (5 µL) into HPLC for analysis (method: 05_100xx, UV 
detection at 301 nm; 79 tR = 20.2 min, m/z (ion) 619.2 and 641.2 (M + H+ expected 619.3 and M 
+ Na+ expected 641.3), 78 tR = 30.4 min). After completion (ca. 3 hours, as indicated by the 
absence of a peak corresponding to 78) the reaction mixture was filtered through a filter paper, 
using a Buchner funnel under reduced pressure. The residual zinc was washed 2-3 times with a 
THF/AcOH (1:1) mixture to extract any trapped product. All the filtrates were combined and 
concentrated by rotary evaporation under reduced pressure. To remove residual acetic acid, the 
residual solid was dissolved in CH2Cl2 (5 mL) and diluted with hexanes (20 mL), then the 
solvent was removed by rotary evaporation under reduced pressure. This process was repeated 
one more time to ensure complete removal of acetic acid. The resulting glue-like solid was 
further dried under reduced pressure overnight to yield crude product 79 as a white foam (0.75 g) 
that was taken to the next step as such. For characterization, a small part of this crude product 79 
(35 mg) was dissolved in 1:1 acetonitrile/water (500 µL) and purified by preparative HPLC 
(method: 05_95, UV detection at 254 nm, tR = 18.1 min). The products containing fractions from 
all three injections were pooled and the solvent was removed by lyophilization to yield pure 
product 79 as fluffy white powder (ca. 30 mg), which was used for the characterization tests. 
1H NMR (500.1 MHz, (CD3)2CO): δ 7.80-7.15 (m, 18H), 4.61 (d, J = 12.6 Hz, 1H), 4.57 (d, J = 
12.6 Hz, 1H), 3.93 (d, J = 10.6 Hz, 1H), 3.74 (d, J = 8.2 Hz, 1H), 3.49 (d, J = 10.6 Hz, 1H), 2.79 
(ddd, J = 8.8, 8.2, 6.6 Hz, 1H), 2.59 (dd, J = 18.0, 8.8 Hz, 1H), 2.34 (dd, J = 18.0, 6.6 Hz, 1H), 
1.302 (s, 9H). 13C NMR (125.8 MHz, (CD3)2CO): δ 206.5, 206.3, 206.2, 206.0, 176.1, 172.4, 
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171.7, 148.5, 147.9, 144.4, 141.4, 141.1, 137.1, 129.6, 129.3, 129.1, 129.1, 129.1, 128.7, 128.5, 
128.2, 128.2, 127.9, 126.8, 121.1, 120.7, 81.0, 76.3, 70.3, 66.4 (CH2), 64.1 (CH), 60.3 (CH2), 
48.5 (CH), 32.7 (CH2), 28.2 (CH3, 3C). IR (thin film): 3414, 2978, 1720, 1501, 1256, 1155, 909, 
735. [α]27D +19.6 (c 0.28, CHCl3). HRMS-ES (m/z): calcd for C38H39N2O6+ (M + H+) 619.2808, 
found 619.2825. 
 
(2S,3S,4R)-2-((Benzyloxy)carbonyl)-3-((tert-butoxycarbonyl)methyl)-4-((9H-fluoren-9-
yl)methoxycarbonylamino)-1-(9-phenyl-9H-fluoren-9-yl)pyrrolidine-4-carboxylic Acid (80). 
The crude amino acid 79 obtained in the preceding step (0.71 g) was transferred to a 50-mL 
round-bottomed flask and dissolved in dioxane (about 12 mL). This was followed by the addition 
of water (6 mL) and sodium carbonate (0.25 g, 2.4 mmol, 2 equiv assuming 100% conversion in 
the previous 2 steps). More dioxane (5-6 mL) was added to ensure that any precipitated starting 
material goes back into the solution. To this reaction mixture was added Fmoc-Su in one portion. 
At this stage the reaction mixture was inhomogeneous. The reaction progress was monitored by 
HPLC: a small volume (10 µL) was withdrawn from the reaction flask, diluted with MeOH (200 
µL), and filtered through a Spin-X centrifuge filter. We injected a portion of this solution (5 µL) 
into HPLC for analysis (method: 05_100xx, UV detection at 301 nm; 80 tR = 32.4 min, m/z (ion) 
842.3 (M + H+ expected 842.3), 79 tR = 22.4 min). After completion (ca. 17 h, as indicated by the 
absence of a peak corresponding to 79), the reaction mixture was quenched by the dropwise 
addition of 2 N HCl solution until the reaction mixture was at pH ~ 4 as monitored by pH paper. 
The resulting clear solution was extracted with EtOAc (200 mL + 50 mL). The combined organic 
layer was washed with 1:1 brine/water (50 mL) followed by brine (25 mL). After drying over 
anhydrous Na2SO4 for 30 min, the organic layer was decanted and concentrated by rotary 
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evaporation under reduced pressure. The crude product was purified by automated flash 
chromatography (50 g silica column; solvent A: hexanes with 0.1% AcOH, solvent B: EtOAc 
with 0.1% AcOH; gradient elution: 0-5 CVs “solvent B 10%” followed by 5-55 CVs “solvent B 
10% to 60%”). The desired fractions were pooled and concentrated by rotary evaporation. To 
remove the traces of acetic acid, the residual solid was dissolved in CH2Cl2 (5 mL) and diluted 
with hexanes (20 mL), then the solvent was removed by rotary evaporation under reduced 
pressure. This process was repeated one more time to ensure the complete removal of acetic acid. 
The resulting oil was further dried under reduced pressure overnight to yield pure product 80 
(0.78 g, 0.93 mmol, 81% over three steps, based on 74) as a white foam. A portion of this 
product was then recrystallized from ethyl acetates/hexanes to yield small, colorless granular 
crystals of 80 which were used for NMR and other analyses. X-ray structure determination of 
these crystals revealed that the stereochemistry of the intermediate 80 is S at position 3 and R at 
position 4 (Figure 36, see APPENDIX for crystallographic data in cif format). 
1H NMR (500.1 MHz, CDCl3): δ 12.470 (br s, 1H), 7.81 (d, J = 7.6 Hz, 1H), 7.73 (d, J = 7.3 Hz, 
2H), 7.61-7.17 (m, 22H), 7.128 (t, J = 7.4 Hz, 1H), 6.938 (s, 1H), 4.78 (d, J = 12.0 Hz, 1H), 4.42 
(m, 1H), 4.34 (d, J = 12.0 Hz, 1H), 4.22 (t, J = 7.1 Hz, 1H), 4.16 (d, J = 8.8 Hz, 1H), 4.10 (m, 
1H), 3.57 (d, J = 10.5 Hz, 1H), 3.35 (d, J = 10.5 Hz, 1H), 3.09 (m, 1H), 2.11 (dd, J = 18.0, 10.5 
Hz, 1H), 1.91 (br d, J = 17.6 Hz, 1H), 1.331 (s, 9H). 13C NMR (125.8 MHz, CDCl3): δ 172.0, 
171.2, 170.8, 155.8, 145.2, 144.1, 143.9, 142.4, 141.9, 141.3, 139.9, 139.7, 134.6, 129.8, 129.3, 
129.1, 129.0, 128.8, 128.7, 128.6, 128.3, 128.0, 127.9, 127.7, 127.7, 127.3, 127.2, 127.1, 126.9, 
125.5, 125.3, 120.6, 120.0, 82.2, 76.7, 67.2 (CH2), 67.1 (CH2), 65.0, 60.6 (CH), 55.8 (CH2), 47.1 
(CH), 42.2 (CH), 33.3 (CH2), 27.9 (CH3, 3C). IR (thin film): 3339, 3063, 3034, 2978, 1728, 
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1503, 1450, 1256, 1156, 1056, 909, 737. [α]27D +143 (c 0.54, CHCl3). HRMS-ES (m/z): calcd 
for C53H49N2O8+ (M + H+) 841.3489, found 841.3497. 
 
(2S,3S,4R)-2-Benzyl 4-(2,2,3,3-tetrafluoropropyl) 3-((tert-butoxycarbonyl)methyl)-4-(9H-
fluoren-9-yl)methoxycarbonylamino)-1-(9-phenyl-9H-fluoren-9-yl)pyrrolidine-2,4-
dicarboxylate (81). 
To a solution of 80 (0.88 g, 1.05 mmol) in dry CH2Cl2 (21 mL, 20 mL per mmol) in a 50-mL 
round-bottomed flask was added DMAP (13 mg, 0.1 mmol, 0.1 equiv) and 2,2,3,3-
tetraflouropropanol (283 µL, 3.15 mmol, 3 equiv). The resulting solution was cooled in an ice 
bath under argon. To this cooled solution was added DCC (433 mg, 2.1 mmol, 2 equiv) in one 
portion. The reaction mixture was allowed to warm to room temperature and the stirring was 
continued overnight. The reaction progress was monitored by HPLC: a small volume (10 µL) 
was withdrawn from the reaction flask, diluted with MeOH (200 µL), and filtered through a 
Spin-X centrifuge filter. We injected a portion of this solution (10 µL) into HPLC for analysis 
(method: 05_100xx, UV detection at 301 nm; 81 tR = 34.4 min, 80 tR = 32.4 min). After 
completion (ca. 18 h, as indicated by the absence of a peak corresponding to 80), the reaction 
was quenched by the addition of acetic acid (200 µL) and concentrated to dryness by rotary 
evaporation. The residual solid was dissolved in 30% EtOAc/hexanes (100 mL) and filtered 
through a sintered funnel to remove the dicyclohexylurea byproduct. The filtrate was 
concentrated by rotary evaporation to yield the crude product 81 as a yellow foam. The crude 
product was purified by automated flash chromatography (2 x 40 g silica columns connected in 
series; solvent A: hexanes, solvent B: EtOAc; gradient elution: 0-5 CVs “solvent A 100%” 
followed by 5-45 CVs “solvent B 0% to 30%”). The desired fractions were pooled and 
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concentrated by rotary evaporation. The resulting oil was further dried under reduced pressure 
overnight to yield 81 as a white foam (0.89 g, 0.93 mmol, 89%). 
1H NMR (500.1 MHz, CDCl3): δ 7.79 (d, J = 7.6 Hz, 1H), 7.73 (d, J = 7.6 Hz, 2H), 7.64-7.17 
(m, 23H), 7.06 (t, J = 7.4 Hz, 1H), 6.16 (br t, J = 52.6 Hz, -CF2CF2H, 1H), 4.81 (d, J = 12.0 Hz, 
1H), 4.72-4.64 (m, 1H), 4.59 (d, J = 9.1 Hz, 1H), 4.43 (d, J = 12.0 Hz, 1H), 4.35-4.28 (m, 2H), 
4.17-4.12 (m, 2H), 3.12 (d, J = 10.0 Hz, 1H), 3.06 (d, J = 10.0 Hz, 1H), 2.66-2.61 (m, 1H), 2.34 
(dd, J = 18.3, 11.4 Hz, 1H), 2.05 (br d, J = 17.5 Hz, 1H), 1.384 (s, 9H). 13C NMR (125.8 MHz, 
CDCl3): δ 172.9, 169.6, 156.0, 148.0, 144.1, 143.9, 142.3, 141.4, 141.2, 139.3, 135.2, 129.1, 
128.9, 128.8, 128.6, 128.6, 127.9, 127.8, 127.5, 127.3, 127.3, 127.1, 127.1, 125.3, 125.2, 120.4, 
120.1, 120.0, 109.0 (tt, 1J = 249 Hz, 2J = 33 Hz, CH), 82.4, 76.1, 67.2 (CH2), 66.7 (CH2), 64.2, 
61.5 (CH), 60.6 (t, 2J = 30 Hz, CH2), 56.7 (CH2), 47.1 (CH), 44.6 (CH), 32.4 (CH2), 28.0 (CH3, 
3C). IR (thin film): 3325, 3061, 3034, 2978, 1741, 1509, 1260, 1164, 909, 737. [α]27D +123 (c 
0.37, CHCl3). HRMS-ES (m/z): calcd for C56H50F4N2O8Na+ (M + Na+) 977.3401, found 
977.3438. 
 
(2S,3S,4R)-4-((2,2,3,3-Tetrafluoropropoxy)carbonyl)-1-(tert-butoxycarbonyl)-3-((tert-
butoxycarbonyl)methyl)-4-(9H-fluoren-9-yl)methoxycarbonylamino)pyrrolidine-2-
carboxylic Acid (67). 
Ester 81 (1.36 g, 1.42 mmol) was transferred to a 100-mL round-bottomed flask and dissolved in 
dry THF (28 mL). Solid Boc2O (1.0 g, 4.3 mmol) was added to this solution followed by careful 
addition of 10 wt % Pd/C (136 mg, 10 wt % of 81) in one portion. The reaction flask was 
degassed under reduced pressure and backfilled with H2 gas several times. After 1 h of stirring, a 
catalytic amount of DIPEA (25 µL, 10 mol% of 81) was added to speed up the reaction. The 
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process of degassing and backfilling with H2 gas was repeated and the stirring was continued 
overnight. The reaction progress was monitored by HPLC: a small volume (10 µL) was 
withdrawn from the reaction flask, diluted with MeOH (200 µL) and filtered through a Spin-X 
centrifuge filter. We injected a portion of this solution (10 µL) into HPLC for analysis (method: 
05_100xx, UV detection at 301 nm; 67 tR = 27.7 min, 81 tR = 34.4 min). After completion (ca. 23 
h, as indicated by the absence of the peaks corresponding to 81 or other intermediates), the 
reaction mixture was mixed with Celite and the solvent was removed by rotary evaporation 
under reduced pressure. The resulting solid mixture was transferred to a 40 g empty loading 
column and further dried overnight under reduced pressure to remove any residual solvent. This 
was followed by purification by automated flash chromatography (2 x 40 g silica columns 
connected in series; solvent A: CH2Cl2 with 0.1% AcOH, solvent B: 5% MeOH in CH2Cl2 with 
0.1% AcOH; gradient elution: 0-10 CVs “solvent A 100%” followed by 10-50 CVs “solvent B 
0% to 100%”). The desired fractions were pooled and concentrated by rotary evaporation. To 
remove residual acetic acid, the purified product was dissolved in EtOAc (200 mL) and washed 
with water (2 x 20 mL). The combined organic layer was further washed with brine (20 mL) and 
after drying over anhydrous sodium sulfate for 20 min, the solvent was removed by rotary 
evaporation under reduced pressure. The resulting oil was further dried under reduced pressure 
overnight to yield 67 as a white foam (0.85 g, 1.17 mmol, 83%). 
1H NMR (500.1 MHz, 77 °C (CD3)2SO): δ 12.32 (br s, 1H) 8.141 (s, 1H), 7.87 (d, J = 7.6 Hz, 
2H), 7.67 (d, J = 7.6 Hz, 2H), 7.42 (t, J = 7.6 Hz, 2H), 7.33 (m t, J = 7.6, Hz, 2H), 6.39 (tt, J = 
52.2, 5.1 Hz, -CF2CF2H, 1H), 4.58-4.40 (m, 3H), 4.36-4.30 (m, 2H), 4.21 (t, J = 6.8 Hz, 1H), 
4.10 (d, J = 11.5 Hz, 1H), 3.68 (d, J = 11.5 Hz, 1H), 3.24 (m, 1H), 2.52 (dd, J = 17.5, 4.7 Hz, 
1H), 2.31 (dd, J = 17.5, 9.6 Hz, 1H), 1.42 (s, 9H), 1.38 (s, 9H). 13C NMR (125.8 MHz, 20 °C 
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(CD3)2SO): mixture of rotamers δ 171.1 and 170.6, 169.6 and 169.5, 168.7 and 168.6, 155.8, 
153.5 and 152.9, 143.7 and 143.5, 140.7, 127.7, 127.1, 125.1, 120.2, 109.0 (t, J = 249 Hz, CH), 
80.4 and 80.3, 79.6, 79.5, 65.9 (CH2), 60.3 and 60.0 (CH), 60.3 (CH2), 53.6 and 53.0 (CH2), 46.5 
(CH), 43.5 and 42.8 (CH), 32.2 and 32.1 (CH2), 28.0 and 27.8 (CH3, 3C), 27.7 (CH3, 3C). IR 
(thin film): 3318, 3061, 3034, 2978, 1742, 1519, 1260, 1156, 909, 737. [α]27D +75.9 (c 0.34, 
CHCl3). HRMS-ES (m/z): calcd for C35H40F4N2O10Na+ (M + Na+) 747.2517, found 747.2444. 
 
4.4.4 Solid phase synthesis 
Solid phase chemistry was performed manually. All solid phase reactions were mixed by 
bubbling argon through the reaction mixture and stirring with a magnetic stir bar at the same 
time. All the couplings (except the first coupling to resin) were performed in 0.8 M LiCl in 10% 
dry dichloroethane (DCE)/dry DMF solution. 
 
General procedure A: Washing 
In a typical washing sequence, the resin was washed 3 times with DCM and DMF alternately. 
This was followed by 3 times washing with DCM and IPA alternately and a final wash with 
DCM. 
 
General procedure B: HATU coupling 
In a 1.5 mL polypropylene micro centrifuge vial the amino acid (as given) was dissolved in a 
solution of 0.8M LiCl in 10% DCE/ DMF (as given). To this mixture was added DIPEA (as 
given) followed by HATU (as given). The resulting coupling mixture was mixed briefly and 
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immediately added to the SPPS reaction vessel carrying the resin. After mixing for the given 
amount of time, the resin was drained and washed according to the general procedure (A). 
 
General procedure C: Fmoc deprotection 
To the SPPS reactor carrying the resin a solution of 20% piperidine in DMF (2000 μL) was 
added. After 15 min of mixing, a known volume of deprotection mixture (40 μL) was withdrawn 
and diluted 100 fold with DMF. A UV-visible spectroscopic analysis of the piperidine-fluorenyl 
adduct was performed and the absorbance at 301 nm (ε = 7800 M-1cm-1) was recorded. This 
value of the absorbance was used to estimate coupling yield. Following the Fmoc deprotection, 
the resin was washed according to general procedure (A). 
 
General procedure D: Capping of the residual free amine 
To the SPPS reactor carrying the resin a solution of 10% acetic anhydride in pyridine (0.5 mL) 
was added. After 5 min of mixing, the resin was drained and washed according to the general 
procedure (A). 
 
Assembly of the oligomer 83 
The coupling of leucine to 2-chloro-trityl chloride resin was achieved via a procedure similar to 
the one described in Novabiochem catalogue (2006/07 section 2.17). The resin (50 mg, 1.1 
µmole/g loading) were transferred to a 10 mL polypropylene solid phase peptide synthesis 
(SPPS) reaction vessel and allowed to swell in DMF for 30 min. 
In a 1.5 mL polypropylene micro centrifuge vial N-α-Fmoc-L-leucine (38.9 mg, 110 
μmol) was dissolved in DCE (550 μL). To this mixture DIPEA (76.7 μL, 440 μmol) was added 
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and mixed briefly. The resulting coupling mixture was added to the SPPS reaction vessel 
carrying the resin. After 2 h of mixing, the solution was drained and the resin was washed 
according to general procedure (A). The terminal Fmoc group was deblocked by general 
procedure (C). The resin loading was determined as 22 μmoles and was used for all further 
calculations of reagents.  
Monomer 47, pro4(2S4S) (26.9 mg, 44 μmol, 2 equivalents) was dissolved in 0.8M LiCl 
in 10% DCE/ DMF solution (220 μL) and coupled for 2 h according to general procedure (B) by 
using DIPEA (16.9 μL, 97 μmol) and HATU (16.8 mg, 44 μmol). Any residual free amine was 
capped according to general procedure (D). The terminal Fmoc group was deblocked by general 
procedure (C). The coupling yield was estimated as 94%.   
Monomer 67, proAc(2S3S4R) (16 mg, 22 μmol, 1 equivalent) was dissolved in 0.8M LiCl 
in 10% DCE/ DMF solution (110 μL) and coupled for 3 h according to general procedure (B) by 
using DIPEA (8.5 μL, 48 μmol) and HATU (8.4 mg, 22 μmol). The resin was subjected to a 
second coupling reaction under identical conditions. Any residual free amine was capped 
according to general procedure (D). The terminal Fmoc group was deblocked by general 
procedure (C). The coupling yield was estimated as 32%. 
Monomer 47, pro4(2S4S) (26.9 mg, 44 μmol, 2 equivalents) was dissolved in 0.8M LiCl 
in 10% DCE/ DMF solution (220 μL) and coupled for 1.5 h according to general procedure (B) 
by using DIPEA (16.9 μL, 97 μmol) and HATU (16.8 mg, 44 μmol). The resin was subjected to 
a second coupling reaction under identical conditions. Any residual free amine was capped 
according to general procedure (D). The terminal Fmoc group was deblocked by general 
procedure (C). The coupling yield was estimated as 100%. 
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N-α-Fmoc-O-tert-butyl-L-tyrosine (20.3 mg, 44 μmol, 2 equivalents) was dissolved in 
0.8M LiCl in 10% DCE/ DMF solution (220 μL) and coupled for 1.5 h according to general 
procedure (B) by using DIPEA (16.9 μL, 97 μmol) and HATU (16.8 mg, 44 μmol). The resin 
was subjected to a second coupling reaction under identical conditions. Any residual free amine 
was capped according to general procedure (D). The terminal Fmoc group was deblocked by 
general procedure (C). The coupling yield was estimated as 96%. The resin was prepared for 
cleavage by drying under reduced pressure. 
The cleavage of the oligomer from resin was affected by treatment of the resin with 10% 
TFA/DCM (1 mL) for 5 min. The cleavage solution was collected after filtration and the resin 
was treated again three more times with TFA solution. All filtered solutions were combined in a 
flask. Additional TFA (3 mL, so that overall composition is 50% TFA by volume) was added 
and the solution was stirred at room temperature for 30 additional minutes to ensure the complete 
removal of the Boc and t-butyl groups. After dilution with toluene (10 mL), the solvent was 
removed in vacuo. The residual solid was dissolved in 1:1 acetonitrile/water (2 mL). We injected 
a portion of this solution (5 μL) into HPLC-MS for analysis (Method: 05_95, UV detection at 
274 nm; 83 tR = 8.58 min, m/z (ion) 1031.2 (M + H+ expected 1031.3). The rest of the solution 
was lypholized to yield crude product 83 as white fluffy powder.  
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Rigidification of the oligomer 83 
The crude oligomer 83 was dissolved in a 100 mM solution of ammonium acetate (1.6 mL). To 
help the dissolution, some acetonitrile (0.4 mL) was added so that the final concentration of 
ammonium acetate was 80 mM. The reaction mixture was incubated inside an oven and stirred at 
55 °C. In order to monitor the reaction progress, a small volume (5 µL) was withdrawn from the 
reaction mixture and injected into HPLC-MS for analysis. After 26 h of stirring the reaction was 
complete as indicated by the absence of 83 and any other intermediates by HPLC-MS (Method: 
00_50, UV detection at 274 nm; 84 tR = 11.2 min, m/z (ion) 767.2 (M + H+ expected 767.3)). 
The desired rigidified oligomer 84 was isolated from the reaction mixture by C18 reverse 
phase preparative HPLC chromatography (Method: 00_50, UV detection at 274 nm; 84 tR = 9.9 
min). The fractions containing the desired peak were analyzed by analytical HPLC. All the pure 
fractions were combined and lypholized to give the desired rigidified oligomer 84 as white fluffy 
powder (2 - 3 mg). 
To ensure the purity, a small quantity of 84 was dissolved in water and analyzed by 
analytical HPLC-MS (Method: 00_50, UV detection at 274 nm; 84 tR = 11.2 min, m/z (ion) 
767.2 (M + H+ expected 767.3) (Figure 39). HRMS (LTQ-Orbitrap) (m/z): calcd for 
C35H43N8O12+ (M + H+) 767.2995, found 767.2992. 
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Figure 39: (a) Absorbance (mAU) at 274 nm versus time and (b) corresponding total ion current (TIC) 
versus time plots from HPLC-MS analysis of purified oligomer 84. 
a) 
b) 
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5.0  FURTHER PROGRESS TOWARDS SYNTHESIS OF FUNCTIONALIZED BIS-
AMINO ACID MONOMER 
In chapter 4, we described the synthesis of a functionalized monomer proAc(2S3S4R) from 
alkylated ketone 72b. Here, we discuss advances that have been made towards the synthesis of 
other two stereoisomers, proAc(2S3R4R) and proAc(2S3R4S) that are accessible from alkylated 
ketone 72a. 
We also report on preliminary experiments towards the synthesis of a functionalized 
monomer that carries an N-methyl imidazolyl side chain. N-methyl imidazole (NMI).221 Small 
peptides containing N-alkyl histidine derivatives are efficient nucleophilic catalysts in 
enantioselective acylation and phosphorylation reactions.222 Miller and coworkers223 have 
published a comprehensive study where they screened peptide libraries and identified an 
octapeptide carrying two alkyl imidazole groups that acts as a highly enantioselective acylation 
catalyst. We believe that we can employ simliar principles of catalytic selectivity and design 
functionalized bis-peptides that catalyze a variety of chemical reactions. The advantage of 
bispeptides in studying bifunctional catalysis is that we can alter the distance and relative 
orientation between functional groups and study the relationship between catalytic function and 
structure. 
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Synthetic access to an N-methyl imidozolyl carrying monomer will not only add a highly 
versatile, catalytically useful monomer to our molecular toolkit but also validate the assertion 
that our synthetic methodology is general. 
5.1 SYNTHESIS OF STEREOISOMERS OF PROAC(2S3S4R) MONOMER 
5.1.1 Separation of diasteromeric trichlorocarbinols 
As illustrated earlier in chapter 4 Scheme 15, ketone 72a when reduced with trichloromethyl 
anion yielded a mixture of diastereomeric trichlorocarbinols 73a and 73b that were very difficult 
to separate. To obtain these trichlorocarbinols in useful gram quantities that could be converted 
to the corresponding monomers, we needed to develop efficient conditions for chromatographic 
separation. 
We attempted several combinations of solvents (e.g. cyclohexanes/EtOAc, hexanes/ether, 
hexanes/THF) but no separation was observed even after multiple elutions. Hexanes/EtOAc was 
the only combination that gave any separation of the products upon TLC analysis (minimum 3 
elutions are needed). This solvent system was the most economical and convenient as well. We 
deduced that the most effective and general method will be to improve the separation capacity of 
silica gel. 
When exposed to atmospheric moisture, silica gel gets hydrated and its separation 
capacity is affected negatively. We hypothesized that if we could re-activate those hydrated sites 
in silica gel, the separation power could be restored back. To test this, we dried commercially 
available silica gel in a conventional oven for a given length of time and cooled it in a dessicator 
147 
for 2-3 h before loading onto the chromatographic column. We immediately noticed a great 
improvement in the separation of diasteremoeric trichlorocarbinols. We observed that the best 
results are obtained for silica gel that has been dried for 2 days in a conventional oven at 130 °C. 
Further drying does not result in any visible improvement in the separation capacity. 
Alkylated ketone 72a (2.3 g, 4 mmol) was reduced with trichloro anion to yield a mixture 
of diastereomeric trichlorocarbinols 73a and 73b in a ratio of 3:2 as determined by RP-HPLC-
MS and NMR. This crude mixture was purified by automated flash chromatography. Four 50g 
columns connected in series and loaded with pre-dried silica gel were utilized for purification 
(see experimental section). 
We found that upon using dried silica gel, a useful quantity of 1.15 g for 73a and 0.32 g 
for 73b could be recovered. This was in sharp contrast to earlier separation when use of regular 
silica gel yielded only 22 mg of 73a and 6 mg of 73b for a similar scale reaction. This 
experiment proved that the separation capacity of silica gel can be greatly enhanced by drying. 
Later we determined that this use of oven dried silica gel improved other difficult separations as 
well. 
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Scheme 22: Use of dry silica gel to improve separation of diasteromeric trichlorocarbinols 
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5.1.2 Determination of stereochemistry of trichlorocarbinol diastereomers 
We used an approach that utilizes the difference in the proximities of the alcoholic –OH to α, β 
and δ protons of the pyrrolidine ring which is detectable by ROESY or NOESY spectra.108 This 
method could not be utilized for the determination of stereochemistry of trichlorocarbinol 74 as 
only one diastereomer was available. We hypothesized that since ketone 72a yields both 
diastereomeric trichlorocarbinols, we could assign stereochemistry based on the differences 
observed in ROESY spectra. 
 
 
Figure 40: Stereochemistry of tricarbinols 73a and 73b: ROESY correlation projected upon corresponding 
lowest energy conformations as determined by MOE. 
 
2D ROESY spectra were recorded for 73a and 73b in CDCl3 at ambient temperature on a 
500MHZ NMR instrument. Spectral analysis showed a correlation of alcoholic hydrogen 6OH 
with 3Hβ and 5Hβ for trichlorocarbinol 73a. However, for 73b of the the alcoholic hydrogen 
6OH showed a correlation with 5Hα and 2Hα. We also observed correlations of 6OH with side 
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chain -CH2 hydrogens (8H1 and 8H2). These correlations are justified only if the side chain acyl 
group, tertiary alcohol and α hydrogen of pyrolidine ring are on the same face for 73b. Thus we 
assigned S and R stereochemistry respectively to 73a and 73b at quarternary center 4C. 
5.1.3 Attempted synthesis of azido-acids 
In previous chapter we reported a clean Jocic rearrangement for the trichlorocarbinol 74 that 
yielded azido acid 78 with an inversion of configuration. We subjected trichlorocarbinol 73a to 
the same reaction conditions. To our surprise we received no desired product 85a. Two major 
peaks in a ratio of ~5:2 were observed in HPLC chromatogram. The peak at 28.6 min 
corresponded to hydroxy acid 85b (m/z = 620 for M + H+) while the peak at 23.5 min indicated 
hydroxy acid sans t-Bu ester 86b (m/z = 564 for M + H+ and m/z = 586 for M + Na+). 
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Scheme 23: Products obtained from a Jocic rearrangement on trichlorocarbinol 73a 
 
We had previously encountered this formation of hydroxy acid side product 82 in the 
case of the rearrangement of trichlorocarbinol 74 as well but hydrolysis of side chain t-butyl 
ester was surprising. We tried to change the course of this reaction by decreasing NaOH 
equivalents from 5 to 2. It slowed down the formation of hydroxyl acid 86a and subsequent 
hydrolysis product 86b significantly but no desired azido-acid 85a could be produced. Also, we 
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didn’t detect any hydrolyzed trichlorocarbinol 87a that would have indicated that the hydrolysis 
of side chain t-butyl group occurs before the rearrangement. Increasing the equivalents of azide 
from 5 to 8 did not cause any noticeable change in reaction rate. 
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Scheme 24: Products obtained from a Jocic rearrangement on trichlorocarbinol 73b 
 
Next we performed a Jocic reaction on the minor trichlorocarbinol 73b. We observed 
desired azido acid product but the formation of hydroxy acid and the hydrolysis of t-butyl ester 
was competitive. In one such experiment that was performed at 0.6 mmol scale of 73b by 
utilizing a combination of 4 equiv of NaOH and 8 equiv of NaN3 we found that after 2 days, 4% 
of 73b remained unreacted. We detected 7 major peaks of which 6 could be accounted for. The 
peak at 31 min corresponded to desired product 88a (30%) while the peak at 28.4 min indicated 
hydroxyl acid side product 88b (10%). We also see corresponding hydrolyzed product for 
trichlorocarbinol 87b (16%), azido acid 89a (11%), and hydroxy acid 89b (13%). 
The product distribution observed with three trichlorocarbinols 74, 73a and 73b can be 
justified based on the relative stereochemistry of the functional groups. We compare hypothetical 
reaction pathways for Jocic reaction for these stereoisomers in Figure 41. In all three cases 
overall reaction takes place at the same time scale if similar reaction conditions are utilized. This 
indicates that the rate determining step i.e. the formation of dichloroepoxides is not influenced by 
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a change in stereochemistry. This is further supported by the observation that a decrease in 
NaOH equiv, slows down the reaction but product distribution remains unchanged. 
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Figure 41: A comparison of pathways that lead to the observed product formations in stereoisomeric 
trichlorocarbinols 
 
Once dichloroepoxide intermediate is formed the product distribution is governed by the 
stereochemical factors. In the case of 74 nucleophile attacks from a face that is sterically 
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unhindered and the desired azido acid is primarily formed. However, for 73a and 73b incoming 
nucleophile encounters steric hindrance to different extent. In this scenario, a smaller hydroxide 
anion becomes a better nucleophile than larger azide anion. For trichlorocarbinol 73a, 
nucleophile sees steric hindrance from neigbouring acetyl side chain that is greater than the steric 
hindrance by benzyl ester for trichlorocarbinol 73b. This translates into a complete formation of 
hydroxy acid 85b from 73a but only a partial formation of hydroxy acid 88b from 73b. 
Even though we can rationalize the formation of azido and hyroxy acids in the light of 
stereochemical differences, the hydrolysis of t-butyl ester remains perplexing. We do not see any 
hydrolysis of trichlorocarbinol 74 or azido acid 78. In the case of 73a we observe hydrolysis only 
after the hydroxy acid has formed. For 73b the hydrolysis occurs before the Jocic reaction takes 
place. We are unable to explain these observations and a detailed study is needed to completely 
understand the true mechanism of various product formations. 
We believe that by enhancing the nucleophilicity of azide and/or decreasing the 
nucleophilicity of hydroxides we could force the reaction to go on a desired pathway and efforts 
are on in this direction. 
5.2 SYNTHESIS OF A MONOMER WITH METHYLIMIDAZOLE SIDE CHAIN 
Synthesis of a monomer with methylimidazolyl side chain required an electrophile such as 5-
bromomethyl-1-methyl-1 H-imidazole 92. Unlike t-butyl bromoacetate this electrophile needs to 
be synthesized. Easiest approach would have been to convert commercially available alcohol 91 
to the corresponding bromide electrophile. However this alcohol is very expensive and since we 
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needed gram quantities of the electrophile to start this project, we decided to synthesize it from 
available literature methods. 
As shown in Scheme 25 the imidazole alcohol 91 was prepared in 48% yield in two steps 
from 1, 3-dihydroxyacetone 89 using Collman et. al.’s224 modification of Rapoport et. al.’s225 
procedure. Next we tried to brominate this alcohol 91 to obtain bromomethyl imidazole 92. We 
dissolved the alcohol (obtained in powder form) in a solution of HBr in acetic acid and left it to 
stir for a couple of days. The reaction mixture was evaporated to dryness by rotary evaporation 
under reduced pressure leaving behind a red-brown crystalline residue. Unfortunately we were 
unable to characterize this bromomethyl imidazole 92. Later, we determined that this bromo 
derivative was very sensitive to moisture and upon storing decomposed in a few days. 
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Scheme 25: Synthesis of 5-bromomethyl-1-methyl-1 H-imidazole electrophile 
 
We hypothesized that the best way to confirm the success of this conversion would be to 
use this as an electrophile for alkylation of ketone 70 and search for the expected products. The 
ketone 70 (2.3 g, 5mmol) was treated with n-BuLi in THF:HMPA at -78 ºC and the resulting 
enolate was added to a suspension of crude electrophile 92, n-BuLi (1 equiv) and NaI in THF at -
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40 ºC. It was necessary to add n-BuLi to neutralize the HBr salt of the electrophile suspension. 
We obtained a diastereomeric mixture of ketones 93a (less polar, tR = 17.5 min, m/z = 554 for M 
+ H+) and 93b (more polar, tR = 17.0 min, m/z = 554 for M + H+) in a 2:1 ratio as determined by 
RP-HPLC-MS analysis (Figure 44). We also found that the alkylation stalled after 2 h of reaction 
leaving 34% of ketone 70 unreacted. 
We tried to separate two diastereomeric ketones 93a and 93b by silica gel FC. Although 
we could remove unreacted ketone 70 from the crude mixture by using EtOAc/hexanes as eluant, 
ketones 93a and 93b remained inseparable even after repeated attempts. We decided to use this 
mixture of ketone for next step as such and attempt purification at that stage. 
Upon reduction with trichloromethyl anion this mixture of alkylated ketone (93a and 
93b) yielded a mixture of diastereomeric trichlorocarbinol. RP-HPLC-MS chromatogram (Figure 
45) of the crude reaction mixture showed two nearly overlapping peaks (tR = 17.9 min and 18.0 
min, m/z (ion) 692.2 (100%), 694.2 (95.9%) for M + H+, characteristic for the –CCl3 group). We 
were able to purify this mixture by silica gel FC by using dichloromethane/MeOH solvent 
gradient. Although two diastereomers couldn’t be separated fully, we were able to obtain a 
nearly pure sample (78 mg) of trichlorocarbinol 94b (more polar) as indicated by HPLC-MS 
(Figure 46). 
Next we subjected this trichlorocarbinol 94b to same sequence of steps that were used for 
the synthesis of proAc(2S3S4R) monomer from corresponding trichlorocarbinol 74 (Scheme 26). 
Each reaction was monitored by RP-HPLC-MS and the crude products formed were taken to the 
next step without any purification. 
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Scheme 26: Synthesis of a methylimidazole functional group bearing bis-amino acid 
 
Trichlorocarbinol 94b was subjected to Jocic rearrangement reaction conditions that 
yielded desired azido acid 95 (tR = 17.7 min, m/z = 625 for M + H+). This azido acid upon 
reduction with Zn/AcOH gave amino acid 96 (tR = 13.7 min, m/z = 621 for M + Na+) that was 
protected with an Fmoc protecting group by Fmoc-OSu to yield the desired protected amino acid 
97 (tR = 19.3 min, m/z = 821 for M + H+). We could not continue beyond this step as the product 
97 was lost during purification.  
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5.3 CONCLUSION AND FUTURE DIRECTIONS 
In this chapter we showed that the development of other stereoisomers of proAc(2S3S4R) was 
not straightforward. Trichlorocarbinol 73b gave some azido acid 88a upon Jocic rearrangement 
but 73a yielded hydroxy acid only. We also observed unexpected hydrolysis of side chain t-butyl 
ester. We are working in the direction of optimizing the formation of azido acids in these cases 
so that they could be converted to useful monomers. 
We also demonstrated a preliminary synthesis of a new monomer that carries a methyl 
imidazolyl side chain. Although the final monomer could not be obtained we were able to 
perform all the key steps. We showed that silica gel FC could be used to separate the mixture of 
trichlorocarbinols 94a and 94b and a series of reaction steps can be carried out without any need 
of purification. 
In future we plan to pursue the synthesis of this monomer and other functionalized 
monomers with various side chains. We will also optimize purification protocol and determine 
the stereochemistry of trichlorocarbinols 94a and 94b. Our group has recently developed a 
methodology that allows us to incorporate a different functional group on every bis-amino acid 
monomer within a bis-peptide.220 We believe that by combining this new approach with the 
methodology for the synthesis of a functionalized monomer that has been described in chapter 4 
and 5, we shall be able to access any desired orientation of functional groups. This will enable us 
to develop bis-peptides for applications such as multi-functional catalysts, binding and disruption 
of protein-protein interactions and sophisticated nanodevices. 
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5.4 EXPRIMENTAL METHODS 
For general methods and RP-HPLC-MS methods see chapter 4, experimental section. 
5.4.1 Monomer synthesis 
(2S,3R,4S)-Benzyl 3-((tert-butoxycarbonyl)methyl)-4-(trichloromethyl)-4-hydroxy-1-(9-
phenyl-9H-fluoren-9-yl)pyrrolidine-2-carboxylate (73a) and (2S,3R,4R)-Benzyl 3-((tert-
butoxycarbonyl)methyl)-4-(trichloromethyl)-4-hydroxy-1-(9-phenyl-9H-fluoren-9-
yl)pyrrolidine-2-carboxylate (73b). 
The alkylated ketone 72a (2.3 g, 4 mmol) was subjected to reduction by trichloromethyl anion as 
described for the synthesis of trichlorocarbinol 74 from ketone 72b in the experimental section of 
chapter 3. The crude product was purified by automated flash chromatography (4 x 50 g columns 
connected in series packed with oven-dried silica; solvent A: hexanes; solvent B: EtOAc; 
gradient elution: 0-5 CVs “solvent A 100%” followed by 5-75 CVs “solvent B 0% to 40%”). The 
fractions were analyzed by HPLC. On the basis of the analysis, the relevant fractions were 
divided into three parts (pure 73a, pure 73b and mixture of 73a, 73b, 72a and 72b) and pooled 
together separately. The three pools were concentrated by rotary evaporation and the resulting 
oils were further dried under reduced pressure overnight to yield pure 73a (1.15 g, 42%), pure 
73b (0.32 g, 12%), and a mixture (0.69 g) all as white foams. 
 
Less polar 73a: 
HPLC-MS: Method: 05_100xx; UV detection at 301 nm; 73a tR = 33.2 min, m/z (ion) 692.2 
(100%), 694.2 (95.9%) (M + H+ expected 692.2 and 694.2, characteristic for the –CCl3 group). 
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1H NMR (500.1 MHz, CDCl3): δ 7.77 (d, J = 7.3 Hz, 1H), 7.76-7.08 (m, 17H), 6.33 (s, 1H), 4.91 
(d, J = 12.3 Hz, 1H), 4.42 (d, J = 12.3 Hz, 1H), 3.77 (d, J = 9.8 Hz, 1H), 3.56 (d, J = 9.8 Hz, 1H), 
2.85 (d, J = 2.2 Hz, 1H), 2.73 (br d, J = 12.3 Hz, 1H), 2.64 (dd, J = 15.0, 3.8 Hz, 1H), 1.68 (dd, J 
= 15.0, 12.3, Hz, 1H), 1.134 (s, 9H). 13C NMR (125.8 MHz, CDCl3): δ 177.2, 170.0, 147.1, 
144.7, 142.0, 140.9, 139.5, 134.8, 129.3, 129.0, 128.8, 128.4, 128.3, 128.2, 128.1, 127.9, 127.6, 
127.5, 127.2, 126.5, 120.6, 120.0, 101.4, 87.9, 81.2, 75.9, 67.7 (CH2), 65.2 (CH), 55.3 (CH2), 
51.0 (CH), 38.0 (CH2), 27.8 (CH3, 3C). IR (thin film): 3392, 3062, 2978, 2936, 2877, 1725, 
1452, 1368, 1256, 1156, 1065, 909, 793, 735. [α]27D +44.1 (c 0.59, CHCl3). HRMS-ES (m/z): 
calcd for C38H36Cl3NO5Na+ (M + Na+) 714.1557, found 714.1542. 
 
More polar 73b: 
HPLC-MS: Method: 05_100xx; UV detection at 301 nm; 73b tR = 31.6 min, m/z (ion) 692.2 
(100%), 694.2 (95.9%) (M + H+ expected 692.2 and 694.2, characteristic for the –CCl3 group). 
1H NMR (500.1 MHz, CDCl3): δ 7.66-7.14 (m, 18H), 5.19 (s, 1H), 4.56 (d, J = 12.3 Hz, 1H), 
4.28 (d, J = 12.3 Hz, 1H), 4.00 (d, J = 11.5 Hz, 1H), 3.39 (d, J = 8.9 Hz, 1H), 3.27 (m, 1H), 3.17 
(d, J = 11.5 Hz, 1H), 2.68 (dd, J = 16.7, 4.4 Hz, 1H), 2.40 (dd, J = 16.7, 5.7 Hz, 1H), 1.23 (s, 
9H). 13C NMR (125.8 MHz, CDCl3): δ 173.1, 172.7, 146.0, 145.6, 142.5, 140.8, 140.6, 135.6, 
128.9, 128.7, 128.5, 128.4, 128.2, 128.2, 128.1, 127.8, 127.7, 127.3, 127.2, 126.8, 120.0, 119.9, 
105.2, 87.1, 82.5, 76.2, 66.7 (CH), 66.5 (CH2), 60.4 (CH2), 45.7 (CH), 33.9 (CH2), 27.8 (CH3, 
3C). IR (thin film): 3391, 3063, 2977, 2936, 2876, 1727, 1451, 1368, 1259, 1156, 1067, 909, 
794, 737. [α]27D -37.8 (c 0.50, CHCl3). HRMS-ES (m/z): calcd for C38H36Cl3NO5Na+ (M + Na+) 
714.1557, found 714.1572. 
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Figure 42: Unpurified RP-HPLC chromatogram at 274 nm for the products obtained after Jocic reaction on 
73a. (Method 05_100xx) 
 
 
Figure 43: Unpurified RP-HPLC chromatogram at 274 nm for the products obtained after Jocic reaction on 
73a. (Method 05_100xx) 
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5.4.2 HPLC chromatograms of intermediates toward the synthesis of a monomer with 
methylimidazole side chain 
 
 
Figure 44: RP-HPLC chromatogram of the crude mixture of products (93a + 93b) obtained after the 
alkylation of ketone 70 with electrophile 92 at 254 nm. (Method 05_100xx) 
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Figure 45: RP-HPLC chromatogram of the crude mixture of products (94a + 94b) obtained after the 
trichloromethyl anion reduction of mixture of ketones 93a and 93b at 254 nm. (Method 05_100xx) 
 
 
Figure 46: RP-HPLC chromatogram of the pure trichlorocarbinol 94b at 254 nm. (Method 05_95) 
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Figure 47: RP-HPLC chromatogram of the unpurified azido acid 95 at 254 nm. (Method 05_95) 
 
 
 
Figure 48: RP-HPLC chromatogram of the unpurified amino acid 96 at 254 nm. (Method 05_95) 
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Figure 49: RP-HPLC chromatogram of the unpurified Fmoc protected amino acid 97 at 254 nm.  
(Method 05_95) 
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APPENDIX A 
1D NMR SPECTRA 
The spectra illustrated in this appendix are 1D NMR spectra of the pip5(2S5S)(OBn) 18, 
pro4(2S4S)(OTFP) 47, pip5(2S5S)(OTFP) 48, and proAc(2S3S4R) 67 monomers and oligomers 
22 and 84 that contain them. 
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Figure 50: 1H spectrum of compound 18, 300 MHz, DMSO-d6, 350K 
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Figure 51: Proton decoupled 13C spectrum of compound 18, 75.4 MHz, DMSO-d6 rt
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Figure 52: 1H spectrum of compound 47, 300 MHz, DMSO-d6, 350K 
N
Boc
O
OH
HN
OTFPO
Fmoc
168 
ppm (f1)
50100150
0
50000
10000
15000
20000
1
7
2
.
7
6
1
1
7
2
.
3
6
4
1
7
0
.
3
7
8
1
5
5
.
6
4
2
1
5
2
.
8
1
0
1
5
2
.
4
3
4
1
4
3
.
4
4
5
1
4
3
.
3
9
0
1
4
0
.
5
2
9
1
2
7
.
3
9
4
1
2
6
.
8
0
1
1
2
4
.
8
5
8
1
2
4
.
6
2
3
1
1
9
.
8
4
1
1
1
7
.
3
4
5
1
1
4
.
3
8
5
1
1
4
.
0
3
3
1
1
2
.
6
5
6
1
1
2
.
2
1
2
1
1
1
.
7
6
7
1
1
0
.
7
2
6
1
0
9
.
3
5
7
1
0
8
.
9
2
0
1
0
8
.
4
7
6
1
0
6
.
0
7
0
1
0
5
.
6
2
9
7
9
.
1
4
7
6
5
.
6
9
5
6
2
.
6
4
7
6
1
.
8
1
2
6
0
.
4
2
6
6
0
.
0
6
4
5
9
.
7
0
7
5
7
.
4
4
9
5
7
.
0
8
6
5
4
.
3
2
6
5
4
.
0
1
6
4
6
.
4
1
8
4
0
.
2
6
3
3
9
.
9
8
6
3
9
.
7
0
7
3
9
.
4
3
0
3
9
.
1
5
1
3
8
8
7
4
3
8
5
9
5
 
Figure 53: Proton decoupled 13C spectrum of compound 47, 75.4 MHz, DMSO-d6 rt 
N
Boc
O
OH
HN
OTFPO
Fmoc
169 
ppm (f1)
50100150
-50000
0
50000
10000
15000
20000
25000
1
2
7
.
3
9
1
1
2
6
.
7
9
9
1
2
4
.
8
7
1
1
1
9
.
8
4
5
1
1
2
.
1
9
5
1
1
1
.
7
5
8
1
0
9
.
3
4
9
1
0
8
.
9
0
1
1
0
8
.
4
6
1
1
0
5
.
6
2
2
1
0
5
.
1
8
1
6
5
.
6
8
2
6
0
.
4
2
2
5
7
.
4
1
5
5
7
.
0
6
3
5
4
.
3
2
5
5
3
.
9
8
0
4
6
.
3
9
5
3
8
.
5
1
2
2
7
.
7
4
6
2
7
.
6
0
5
 
Figure 54: DEPT135 spectrum of compound 47, 75.4 MHz, DMSO-d6, rt 
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Figure 55: 1H spectrum of compound 48, 300 MHz, DMSO-d6, 350K 
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Figure 56: Proton decoupled 13C spectrum of compound 48, 75.4 MHz, DMSO-d6, rt 
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Figure 57: DEPT135 spectrum of compound 48, 75.4 MHz, DMSO-d6, rt 
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Figure 58: 1H spectrum of compound 67, 500 MHz, DMSO-d6, 350K 
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Figure 59: Proton decoupled 13C spectrum of compound 67, 125 MHz, DMSO-d6, rt 
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Figure 60: DEPT135 spectrum of compound 67, 125 MHz, DMSO-d6, rt 
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Figure 61: 1H spectrum of oligomer 22, 600 MHz, 90% H2O / 10% D2O at rt 
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Figure 62: 1H spectrum of oligomer 84, 500 MHz, DMSO-d6, rt 
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APPENDIX B 
RESONANCE ASSIGNMENT FOR OLIGOMERS 
The NMR resonances derived from the 2D-NMR spectra of the oligomers 22 and 84 are 
tabulated in supplemental tables 1, 2 and 3. 
Group: the number corresponding to the place of the residue in the sequence 
Heavy atom number: the numerical designation of the atoms in the structures shown in the text. 
Atom: the first letter (C or H) designates the nucleus. The following letters are coded as follows; 
A = alpha, B = beta, C = gamma, D = delta, E = epsilon 
AC = carbonyl carbon adjacent to alpha carbon 
CC = carbonyl carbon adjacent to gamma carbon 
DC = carbonyl carbon adjacent to gamma carbon 
N = amide nitrogen 
Shift: chemical shift (on the δ scale) 
StDev: the standard deviation of the mean chemical shift for each resonance 
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Table 6: Chemical shift assignment and dissertation to Sparky atom name conversion chart for oligomer 22 
(# = number of cross-peaks in COSY/ROESY/HMBC/HMQC spectra involving this nucleus). 
 
Heavy  
Atom  Group 
Atom 
name Nuc Shift SDev # 
Heavy 
Atom  Group 
Atom 
name Nuc Shift SDev # 
C10 1 CA 13C 44.806 0.002 3 C22 4 CA 13C 58.332 0.045 2 
C9 1 CAC 13C 166.03 0.04 4 C21 4 CAC 13C 169.019 0.067 2 
H10α 1 HA1 1H 3.974 0.003 4 C23 4 CB 13C 26.331 0.083 3 
H10β 1 HA2 1H 4.03 0.002 5 C24 4 CC 13C 31.73 0.006 2 
H1 1 HN 1H 8.075 0.018 7 C25 4 CD 13C 57.969 0.02 2 
C3 2 CA 13C 57.471 0.011 2 C36 4 CDC 13C 174.506 0.014 2 
C2 2 CAC 13C 166.207 0 1 C26 4 CE 13C 45.386 0 1 
C4 2 CB 13C 24.108 0.095 2 C38 4 CF 13C 54.046 0 1 
C5 2 CC 13C 35.16 0 1 H22 4 HA 1H 4.098 0.002 11 
C6 2 CD 13C 57.214 0 1 H23α 4 HB1 1H 2.198 0.003 4 
C19 2 CDC 13C 167.688 0.02 2 H23β 4 HB2 1H 1.803 0.006 6 
C7 2 CE 13C 49.687 0 1 H24α 4 HC1 1H 2.005 0.004 5 
H3 2 HA 1H 4.033 0.002 10 H24β 4 HC2 1H 2.128 0.001 4 
H4α 2 HB1 1H 2.127 0.002 3 H26α 4 HE1 1H 3.126 0.003 4 
H4β 2 HB2 1H 1.807 0.003 4 H26β 4 HE2 1H 4.998 0.002 7 
H5α 2 HC1 1H 2.07 0.004 5 H38 4 HF 1H 3.629 0.001 2 
H5β 2 HC2 1H 1.945 0.002 3 H29 4 HN 1H 8.368 0.025 9 
H7α 2 HE1 1H 3.114 0.004 5 C31 5 CA 13C 54.671 0 3 
H7β 2 HE2 1H 2.507 0 1 C30 5 CAC 13C 174.446 0.038 3 
H11 2 HN 1H 8.477 0.02 6 C39 5 CB 13C 37.457 0.028 4 
C13 3 CA 13C 57.047 0 1 C40 5 CC 13C 128.989 0.053 3 
C12 3 CAC 13C 168.762 0 1 C41 5 CD 13C 131.307 0.062 4 
C14 3 CB 13C 24.474 0.024 2 C42 5 CE 13C 116.204 0.028 3 
C15 3 CC 13C 32.586 0 1 C43 5 CF 13C 155.177 0.054 2 
C16 3 CD 13C 57.278 0 1 C34 5 CP 13C 39.105 0 1 
C28 3 CDC 13C 166.685 0.046 3 C33 5 CPC 13C 182.555 0.013 2 
C17 3 CE 13C 51.906 0 1 C35 5 CQ 13C 27.124 0 2 
H13 3 HA 1H 4.065 0.002 11 H31 5 HA 1H 4.611 0 4 
H14α 3 HB1 1H 2.181 0.002 3 H39α 5 HB1 1H 2.647 0.003 10 
H14β 3 HB2 1H 1.84 0.005 5 H39β 5 HB2 1H 2.893 0.002 10 
H15α 3 HC1 1H 2.256 0.001 5 H41 5 HD 1H 7.011 0.001 8 
H15β 3 HC2 1H 1.941 0.002 4 H42 5 HE 1H 6.689 0.001 5 
H17α 3 HE1 1H 2.811 0.003 5 H32 5 HN 1H 7.306 0.017 9 
H17β 3 HE2 1H 4.314 0.004 6 H35 5 HQ 1H 0.884 0.001 4 
H20 3 HN 1H 8.506 0.022 7 
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Figure 64: Naming scheme for oligomer 84 used for assigning 2D NMR spectra by SPARKY and corresponding heavy atom numbering scheme used 
in dissertation 
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Table 7: Dissertation to Sparky atom name conversion chart and chemical shift assignments for compound 
84. (# = number of cross-peaks in COSY/ROESY/HMBC/HMQC spectra involving this nucleus) 
 
Group Atom name 
Heavy 
atom # Nuc Shift SDev # 
 Group Atom name 
Heavy 
atom # Nuc Shift SDev # 
1 CA 2 13C 50.819 0.003 2  3 Ha 12 1H 4.684 0 11 
1 CAC 1 13C 172.943 0.003 2  3 Hb 13 1H 3.119 0 7 
1 CB 31 13C 39.676 0.001 4  3 Hd1 15α 1H 3.001 0 8 
1 CC 32 13C 24.254 0.007 4  3 Hd2 15β 1H 4.414 0 7 
1 CD1 33 13C 22.708 0 1  3 He1 34β  1H 2.933 0 7 
1 CD2 33 13C 21.129 0 1  3 He2 34α 1H 2.158 0.001 8 
1 Ha 2 1H 4.237 0 14  3 NH 18 1H 8.498 0.002 7 
1 Hb12 32 1H 1.541 0 9  4 CA 20 13C 57.897 0.002 2 
1 Hc 32 1H 1.637 0.001 7  4 CAC 19 13C 167.891 0.006 3 
1 Hd1 33 1H 0.906 0 5  4 CB 21 13C 42.048 0 2 
1 Hd2 33 1H 0.865 0 5  4 CC 22 13C 58.943 0.011 4 
1 NH 3 1H 8.736 0 8  4 CCC 30 13C 169.041 0.012 4 
2 CA 5 13C 58.316 0 1  4 CD 23 13C 55.182 0.003 3 
2 CAC 4 13C 166.265 0.002 2  4 Ha 20 1H 4.534 0 7 
2 CC 7 13C 62.505 0 2  4 Hb1 21α 1H 2.46 0 5 
2 CB 6 13C - - -  4 Hb2 21β 1H 1.939 0 5 
2 CCC 17 13C 165.331 0 1  4 Hd1 23α 1H 2.703 0 4 
2 CD 8 13C 50.829 0 3  4 Hd2 23β 1H 2.816 0 5 
2 Ha 5 1H 4.31 0 10  4 NH 26 1H 8.362 0.001 4 
2 Hb1 6α 1H 3.006 0 6  5 CA 28 13C 55.398 0.01 3 
2 Hb2 6β 1H 1.938 0 11  5 CAC 27 13C 165.745 0.001 2 
2 Hd1 8α 1H 3.635 0 7  5 CB 36 13C 37.69 0 3 
2 Hd2 8β 1H 3.36 0 8  5 CC 37 13C 156.052 0 2 
2 NH 10 1H 8.31 0.002 6  5 CD 38 13C 131.064 0.02 4 
2 NH1 9 1H 9.748 0 6  5 CE 39 13C 114.914 0.005 3 
2 NH2 9 1H 8.995 0 6  5 CF 40 13C 125.305 0.015 2 
3 CA 12 13C 56.018 0.003 4  5 Ha 28 1H 4.181 0 7 
3 CAC 11 13C 166.231 0 1  5 Hb1 36α 1H 2.753 0 11 
3 CB 13 13C 44.792 0.01 5  5 Hb2 36β 1H 3 0.001 5 
3 CC 14 13C 62.622 0.003 4  5 Hd 38 1H 6.912 0 9 
3 CCC 25 13C 163.241 0.002 3  5 He 39 1H 6.672 0.001 5 
3 CD 15 13C 52.424 0.001 2  5 NH 29 1H 8.389 0 6 
3 CE 34 13C 29.719 0 1  
3 CEC 35 13C 173.227 0.004 2  
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Table 8: ROESY correlations list for compound 84. 
Assignment w1 w2 Volume Intensity 
     
1Hb12-NH 1.531 8.726 ‐3.87E+05 Medium 
1Hc-Ha 1.627 4.227 ‐1.11E+06 Strong 
1Hc-NH 1.637 8.73 ‐2.95E+05 Medium 
1Hd2-Ha 0.87 4.239 ‐7.01E+05 Medium 
2Hb1-1NH 3.006 8.73 ‐2.25E+05 Weak 
2Hb2-Hd2 1.937 3.36 ‐1.75E+05 Weak 
2Hb2-NH 1.938 8.315 ‐8.86E+05 Strong 
4Hb2-4NH 1.931 8.359 ‐9.94E+05 Strong 
2Hd1-Ha 3.626 4.31 ‐2.05E+05 Weak 
2Hd2-NH 3.363 8.31 ‐1.24E+06 Strong 
3Ha-2NH 4.684 8.309 ‐5.47E+04 Weak 
3Hb-NH 3.115 8.495 ‐1.96E+06 Strong 
3Hd1-Ha 3.004 4.68 ‐4.53E+05 Medium 
3Hd1-NH 2.993 8.5 ‐5.69E+05 Medium 
2Ha-1NH 4.304 8.725 ‐8.97E+05 Strong 
3Hd2-4Ha 4.414 4.53 ‐6.70E+05 Medium 
3He1-Ha 2.923 4.689 ‐2.61E+05 Weak 
3He2-NH 2.165 8.5 ‐1.45E+05 Weak 
4Hd1-Ha 2.699 4.531 ‐1.39E+05 Weak 
4Hd2-NH 2.806 8.355 ‐8.34E+05 Medium 
5Hb1-NH 2.749 8.391 ‐5.34E+05 Medium 
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APPENDIX C 
2D NMR SPECTRA FOR OLIGOMERS 
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Figure 65: DQF-COSY spectrum of oligomer 22, 600 MHz, 90% H2O / 10% D2O rt 
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Figure 66: TOCSY spectrum of oligomer 22, 600 MHz, 90% H2O / 10% D2O rt 
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Figure 67: HMBC spectrum (1 of 4) of oligomer 22, 500 MHz, 90% H2O / 10% D2O rt 
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Figure 68: HMBC spectrum (2 of 4) of oligomer 22, 500 MHz, 90% H2O / 10% D2O rt 
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Figure 69: HMBC spectrum (3 of 4) of oligomer 22, 500 MHz, 90% H2O / 10% D2O rt 
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Figure 70: HMBC spectrum (4 of 4) of oligomer 22, 500 MHz, 90% H2O / 10% D2O rt 
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Figure 71: ROESY spectrum (1 of 2) of oligomer 22, 600 MHz, 90% H2O / 10% D2O rt 
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Figure 72: ROESY spectrum (2 of 2) of oligomer 22, 600 MHz, 90% H2O / 10% D2O rt 
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Figure 73: COSY spectrum (1 of 2) of oligomer 84, 500 MHz, DMSO-d6, rt 
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Figure 74: COSY spectrum (2 of 2) of oligomer 84, 500 MHz, DMSO-d6, rt 
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Figure 75: TOCSY spectrum (1 of 2) of oligomer 84, 500 MHz, DMSO-d6, rt 
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Figure 76: TOCSY spectrum (2 of 2) of oligomer 84, 500 MHz, DMSO-d6, rt 
197 
 
Figure 77: HMQC spectrum (1 of 2) of oligomer 84, 500 MHz, DMSO-d6, rt 
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Figure 78: HMQC spectrum (2 of 2) of oligomer 84, 500 MHz, DMSO-d6, rt 
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Figure 79: HMBC spectrum (1 of 4) of oligomer 84, 500 MHz, DMSO-d6, rt 
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Figure 80: HMBC spectrum (2 of 4) of oligomer 84, 500 MHz, DMSO-d6, rt 
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Figure 81: HMBC spectrum (3 of 4) of oligomer 84, 500 MHz, DMSO-d6, rt 
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Figure 82: HMBC spectrum (4 of 4) of oligomer 84, 500 MHz, DMSO-d6, rt 
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Figure 83: ROESY spectrum (1 of 2) of oligomer 84, 500 MHz, DMSO-d6, rt 
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Figure 84: ROESY spectrum (2 of 2) of oligomer 84, 500 MHz, DMSO-d6, rt
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APPENDIX D 
SPPS SHEMATICS 
 
Figure 85: A schematics for solid phase peptide synthesis (SPPS) reactor assembly. Three configurations 
utilized for the synthesis and corresponding flow directions are shown. 
206 
BIBLIOGRAPHY 
1. Goodman, C. M.; Choi, S.; Shandler, S.; DeGrado, W. F. Foldamers as versatile 
frameworks for the design and evolution of function. Nature Chemical Biology 2007, 3, 
252-262. 
2. Horne, W. S.; Price, J. L.; Gellman, S. H. Interplay among side chain sequence, backbone 
composition, and residue rigidification in polypeptide folding and assembly. Proceedings 
of the National Academy of Sciences of the United States of America 2008, 105, 9151-
9156. 
3. Yoo, B.; Kirshenbaum, K. Peptoid architectures: elaboration, actuation, and application. 
Current Opinion in Chemical Biology 2008, 12, 714-721. 
4. Robson, B.; Vaithilingam, A., Protein Folding Revisited. In Molecular Biology of Protein 
Folding, Pt B, 2008; Vol. 84, pp 161-202. 
5. DeBartolo, J.; Colubri, A.; Jha, A. K.; Fitzgerald, J. E.; Freed, K. F.; Sosnick, T. R. 
Mimicking the folding pathway to improve homology-free protein structure prediction. 
Proceedings of the National Academy of Sciences of the United States of America 2009, 
106, 3734-3739. 
6. Voelz, V. A.; Shell, M. S.; Dill, K. A. Predicting Peptide Structures in Native Proteins 
from Physical Simulations of Fragments. Plos Computational Biology 2009, 5. 
7. DeGrado, W. F.; Summa, C. M.; Pavone, V.; Nastri, F.; Lambardi, A. De novo design 
and structural charcaterization of proteins and metalloproteins. Annu. Rev. Biochem. 
1999, 68, 779-819. 
8. Baker, D. Prediction and design of macromolecular structures and interactions. Phil. 
Trans. R. Soc.Lond.B 2006, 361, 459-463. 
9. Alexandrova, A. N.; Rothlisberger, D.; Baker, D.; Jorgensen, W. L. Catalytic Mechanism 
and Performance of Computationally Designed Enzymes for Kemp Elimination. J. Am. 
Chem. Soc. 2008, 130, 15907-15915. 
10. Gellman, S. H. Foldamers: A manifesto. Acc. Chem. Res. 1998, 31, 173-180. 
207 
11. Hill, D. J.; Mio, M. J.; Prince, R. B.; Hughes, T. S.; Moore, J. S. A Field Guide to 
Foldamers. Chem. Rev. 2001, 101, 3893-4011. 
12. Kirshenbaum, K.; Zuckermann, K.; Dill, K. A. Designing Polymers that Mimic 
Biomolecules. Curr. Opin. Struc. Biol. 1999, 9, 530-535. 
13. Rueping, M.; Mahajan, Y.; Sauer, M.; Seebach, D. Cellular uptake studies with beta-
peptides. Chembiochem 2002, 3, 257-259. 
14. Harker, E. A.; Schepartz, A. Cell-Permeable beta-Peptide Inhibitors of p53/hDM2 
Complexation. Chembiochem 2009, 10, 990-993. 
15. Kritzer, J. A.; Lear, J. D.; Hodsdon, M. E.; Schepartz, A. Helical beta-peptide inhibitors 
of the p53-hDM2 interaction. J. Am. Chem. Soc. 2004, 126, 9468-9469. 
16. Hardcastle, I. R. Inhibitors of the MDM2-p53 interaction as anticancer drugs. Drugs of 
the Future 2007, 32, 883-896. 
17. Baldauf, C.; Pisabarro, M. T. Stable hairpins with beta-peptides: Route to tackle protein-
protein interactions. Journal of Physical Chemistry B 2008, 112, 7581-7591. 
18. Horne, W. S.; Boersma, M. D.; Windsor, M. A.; Gellman, S. H. Sequence-based design 
of alpha/beta-peptide foldamers that mimic BH3 domains. Angewandte Chemie-
International Edition 2008, 47, 2853-2856. 
19. Harker, E. A.; Daniels, D. S.; Guarracino, D. A.; Schepartz, A. beta-Peptides with 
improved affinity for hDM2 and hDMX. Bioorganic & Medicinal Chemistry 2009, 17, 
2038-2046. 
20. Hintersteiner, M.; Kimmerlin, T.; Garavel, G.; Schindler, T.; Bauer, R.; Meisner, N. C.; 
Seifert, J. M.; Uhl, V.; Auer, M. A Highly Potent and Cellularly Active beta-Peptidic 
Inhibitor of the p53/hDM2 Interaction. Chembiochem 2009, 10, 994-998. 
21. Gelman, M. A.; Richter, S.; Cao, H.; Umezawa, N.; Gellman, S. H.; Rana, T. M. 
Selective binding of TAR RNA by a tat-derived beta-peptide. Org. Lett. 2003, 5, 3563-
3565. 
22. Bonnard, V.; Azoulay, S.; Di Giorgio, A.; Patino, N. Polyamide amino acids: a new class 
of RNA ligands. Chemical Communications 2009, 2302-2304. 
23. Epand, R. F.; Raguse, T. L.; Gellman, S. H.; Epand, R. M. Antimicrobial 14-helical beta-
peptides: Potent bilayer disrupting agents. Biochemistry 2004, 43, 9527-9535. 
24. Som, A.; Vemparala, S.; Ivanov, I.; Tew, G. N. Synthetic mimics of antimicrobial 
peptides. Biopolymers 2008, 90, 83-93. 
25. Miller, C. A.; Abbott, N. L.; de Pablo, J. J. Surface Activity of Amphiphilic Helical beta-
Peptides from Molecular Dynamics Simulation. Langmuir 2009, 25, 2811-2823. 
208 
26. Fischer, P. M. Peptide, peptidomimetic, and small-molecule antagonists of the p53-
HDM2 protein-protein interaction. International Journal of Peptide Research and 
Therapeutics 2006, 12, 3-19. 
27. Aina, O. H.; Liu, R. W.; Sutcliffe, J. L.; Marik, J.; Pan, C. X.; Lam, K. S. From 
combinatorial chemistry to cancer-targeting peptides. Molecular Pharmaceutics 2007, 4, 
631-651. 
28. Fear, G.; Komarnytsky, S.; Raskin, I. Protease inhibitors and their peptidomimetic 
derivatives as potential drugs. Pharmacology & Therapeutics 2007, 113, 354-368. 
29. Huther, A.; Dietrich, U. The emergence of peptides as therapeutic drugs for the inhibition 
of HIV-1. Aids Reviews 2007, 9, 208-217. 
30. Li, S.; Xu, W. F. Peptidomimetics and metalloprotease inhibitors as anticancer drugs. 
Science in China Series B-Chemistry 2009, 52, 535-548. 
31. Karle, I. L.; Handa, B. K.; Hassall, C. H. Conformation of cyclic tetra peptide-L-Ser (O-t-
Bu)-β-Ala-Gly-L-β-Asp(Ome) containing a 14 membered ring. Acta Crystallogr. B 1975, 
31, 555-560. 
32. Zuckermann, R. N. The chemical synthesis of peptidomimetic libraries. Curr. Opin. 
Struc. Biol. 1993, 580-584. 
33. Seebach, D.; Overhand, M.; KÃ¼hnle, F. N. M.; Martinoni, B.; Oberer, L.; Hommel, U.; 
Widmer, H. Helv. Chim. Acta 1996, 79, 913. 
34. Cheng, R. P.; Gellman, S. H.; DeGrado, W. F. Chem. Rev. 2001, 101, 3219. 
35. Appella, D. H.; Christianson, L. A.; Karle, I. L.; Powell, D. R.; Gellman, S. H. J. Am. 
Chem. Soc. 1996, 118, 13071. 
36. Seebach, D.; Beck, A. K.; Bierbaum, D. J. Chem. Biodiversity 2004, 1. 
37. Zega, A. Azapeptides as pharmacological agents. Current Medicinal Chemistry 2005, 12, 
589-597. 
38. Loser, R.; Frizler, M.; Schilling, K.; Gutschow, M. Azadipeptide nitriles: Highly potent 
and proteolytically stable inhibitors of papain-like cysteine proteases. Angewandte 
Chemie-International Edition 2008, 47, 4331-4334. 
39. Violette, A.; Averlant-Petit, M. C.; Semetey, V.; Hemmerlin, C.; Casimir, R.; Graff, R.; 
Marraud, M.; Briand, J. P.; Rognan, D.; Guichard, G. N,N '-linked oligoureas as 
foldamers: Chain length requirements for helix formation in protic solvent investigated 
by circular dichroism, NMR spectroscopy, and molecular dynamics. J. Am. Chem. Soc. 
2005, 127, 2156-2164. 
209 
40. Fischer, L.; Didierjean, C.; Jolibois, F.; Semetey, V.; Lozano, J. M.; Briand, J. P.; 
Marraud, M.; Poteau, R.; Guichard, G. Propensity for local folding induced by the urea 
fragment in short-chain oligomers. Organic & Biomolecular Chemistry 2008, 6, 2596-
2610. 
41. Fischer, L.; Lena, G.; Briand, J. P.; Didierjean, C.; Guichard, G. In Mixing Urea and 
Amide Bonds: Synthesis and Self-Organization of New Hybrid Oligomers, 2009; 
DelValle, S.; Escher, E.; Lubell, W. D., Eds. 2009; pp 39-40. 
42. Baldauf, C.; Gunther, R.; Hofmann, H. J. Helices in peptoids of alpha- and beta-peptides. 
Physical Biology 2006, 3, S1-S9. 
43. Sharma, G. V. M.; Babu, B. S.; Ramakrishna, K. V. S.; Nagendar, P.; Kunwar, A. C.; 
Schramm, P.; Baldauf, C.; Hofmann, H. J. Synthesis and Structure of alpha/delta-Hybrid 
Peptides-Access to Novel Helix Patterns in Foldamers. Chemistry-a European Journal 
2009, 15, 5552-5566. 
44. Li, X.; Wu, Y.-D.; Yang, D. α-Aminoxy Acids: New Possibilities from Foldamers to 
Anion Receptors and Channels. Acc. Chem. Res. 2008, 41, 1428. 
45. Prest, P. J.; Prince, R. B.; Moore, J. S. Supramolecular organization of oligo(m-
phenylene ethynylene)s in the solid-state. J. Am. Chem. Soc. 1999, 121, 5933-5939. 
46. Prince, R. B.; Barnes, S. A.; Moore, J. S. Foldamer-based molecular recognition. J. Am. 
Chem. Soc. 2000, 122, 2758-2762. 
47. Bum, U. H. F. Poly(aryleneethynylene)s. Macromolecular Rapid Communications 2009, 
30, 772-805. 
48. Kang, Y. K.; Lee, O. S.; Deria, P.; Kim, S. H.; Park, T. H.; Bonnell, D. A.; Saven, J. G.; 
Therien, M. J. Helical Wrapping of Single-Walled Carbon Nanotubes by Water Soluble 
Poly(p-phenyleneethynylene). Nano Letters 2009, 9, 1414-1418. 
49. Hamuro, Y.; Geib, S. J.; Hamilton, A. D. Oligoanthranilamides. Non-peptide subunits 
that show formation of specific secondary structure. J. Am. Chem. Soc. 1996, 118, 7529-
7541. 
50. Hamuro, Y.; Geib, S. J.; Hamilton, A. D. Novel folding patterns in a family of 
oligoanthranilamides: Non-peptide oligomers that form extended helical secondary 
structures. J. Am. Chem. Soc. 1997, 119, 10587-10593. 
51. Ziener, U. Self-Assembled Nanostructures of Oligopyridine Molecules. Journal of 
Physical Chemistry B 2008, 112, 14698-14717. 
52. Mutai, T.; Araki, K. Fluorescent oligopyridines and their photo-functionality as tunable 
fluorophores. Current Organic Chemistry 2007, 11, 195-211. 
210 
53. Seebach, D.; Ciceri, P. E.; Overhand, M.; Jaun, B.; Rigo, D.; Oberer, L.; Hommel, U.; 
Amstutz, R.; Widmer, H. Probing the helical secondary structure of short-chain beta-
peptides. Helvetica Chimica Acta 1996, 79, 2043-2066. 
54. Seebach, D.; Overhand, M.; Kuhnle, F. N. M.; Martinoni, B.; Oberer, L.; Hommel, U.; 
Widmer, H. beta-peptides: Synthesis by Arndt-Eistert homologation with concomitant 
peptide coupling. Structure determination by NMR and CD spectroscopy and by X-ray 
crystallography. Helical secondary structure of a beta-hexapeptide in solution and its 
stability towards pepsin. Helvetica Chimica Acta 1996, 79, 913-941. 
55. Seebach, D.; Gademann, K.; Schreiber, J. V.; Matthews, J. L.; Hintermann, T.; Jaun, B.; 
Oberer, L.; Hommel, U.; Widmer, H. 'Mixed' beta-peptides: A unique helical secondary 
structure in solution. Helvetica Chimica Acta 1997, 80, 2033-2038. 
56. Seebach, D.; Abele, S.; Sifferlen, T.; Hanggi, M.; Gruner, S.; Seiler, P. Preparation and 
structure of beta-peptides consisting of geminally disubstituted beta(2,2)- and beta(3,3)-
amino acids: A turn motif for beta-peptides. Helvetica Chimica Acta 1998, 81, 2218-
2243. 
57. Seebach, D.; Abele, S.; Gademann, K.; Jaun, B. Pleated sheets and turns of beta-peptides 
with proteinogenic side chains. Angewandte Chemie-International Edition 1999, 38, 
1595-1597. 
58. Daura, X.; Gademann, K.; Schafer, H.; Jaun, B.; Seebach, D.; van Gunsteren, W. F. The 
beta-peptide hairpin in solution: Conformational study of a beta-hexapeptide in methanol 
by NMR spectroscopy and MD simulation. J. Am. Chem. Soc. 2001, 123, 2393-2404. 
59. Hook, D. F.; Bindschadler, P.; Mahajan, Y. R.; Sebesta, R.; Kast, P.; Seebach, D. The 
proteolytic stability of 'designed' beta-peptides containing alpha-peptide-bond mimics 
and of mixed alpha,beta-peptides: Application to the construction of MHC-binding 
peptides. Chemistry & Biodiversity 2005, 2, 591-632. 
60. Gademann, K.; Seebach, D. Synthesis of cyclo-beta-tripeptides and their biological in 
vitro evaluation as antiproliferatives against the growth of human cancer cell lines. 
Helvetica Chimica Acta 2001, 84, 2924-2937. 
61. Nunn, C.; Rueping, M.; Langenegger, D.; Schuepbach, E.; Kimmerlin, T.; Micuch, P.; 
Hurth, K.; Seebach, D.; Hoyer, D. beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide 
derivatives as potent agonists at somatostatin sst(4) receptors. Naunyn-Schmiedebergs 
Archives of Pharmacology 2003, 367, 95-103. 
62. Gardiner, J.; Langenegger, D.; Hoyer, D.; Beck, A. K.; Mathad, R. I.; Seebach, D. The 
enantiomer of octreotate binds to all five somatostatin receptors with almost equal 
micromolar affinity - A comparison with SANDOSTATIN (R). Chemistry & Biodiversity 
2008, 5, 1213-1224. 
211 
63. Gademann, K.; Ernst, M.; Seebach, D.; Hoyer, D. The cyclo-beta-tetrapeptide (beta-
HPhe-beta-HThr-beta-HLys-beta-HTrp): Synthesis, NMR structure in methanol solution, 
and affinity for human somatostatin receptors. Helvetica Chimica Acta 2000, 83, 16-33. 
64. Appella, D. H.; Barchi, J. J.; Durell, S. R.; Gellman, S. H. Formation of short, stable 
helices in aqueous solution by beta-amino acid hexamers. J. Am. Chem. Soc. 1999, 121, 
2309-2310. 
65. Appella, D. H.; Christianson, L. A.; Karle, I. L.; Powell, D. R.; Gellman, S. H. Synthesis 
and characterization of trans-2-aminocyclohexanecarboxylic acid oligomers: An 
unnatural helical secondary structure and implications for beta-peptide tertiary structure. 
J. Am. Chem. Soc. 1999, 121, 6206-6212. 
66. Chung, Y. J.; Huck, B. R.; Christianson, L. A.; Stanger, H. E.; Krauthauser, S.; Powell, 
D. R.; Gellman, S. H. Stereochemical control of hairpin formation in beta-peptides 
containing dinipecotic acid reverse turn segments. J. Am. Chem. Soc. 2000, 122, 3995-
4004. 
67. Cheng, R. P.; Gellman, S. H.; DeGrado, W. F. beta-peptides: From structure to function. 
Chemical Reviews 2001, 101, 3219-3232. 
68. Sadowsky, J. D.; Fairlie, W. D.; Hadley, E. B.; Lee, H. S.; Umezawa, N.; Nikolovska-
Coleska, Z.; Wang, S. M.; Huang, D. C. S.; Tomita, Y.; Gellman, S. H. 
(alpha/beta+alpha)-Peptide antagonists of BH3 Domain/Bcl-x(L) recognition: Toward 
general strategies for foldamer-based inhibition of protein-protein interactions. J. Am. 
Chem. Soc. 2007, 129, 139-154. 
69. Sadowsky, J. D.; Murray, J. K.; Tomita, Y.; Gellman, S. H. Exploration of backbone 
space in foldamers containing alpha- and beta-amino acid residues: Developing protease-
resistant oligomers that bind tightly to the BH3-recognition cleft of Bcl-x(L). 
Chembiochem 2007, 8, 903-916. 
70. Horne, W. S.; Gellman, S. H. Foldamers with Heterogeneous Backbones. Accounts of 
Chemical Research 2008, 41, 1399-1408. 
71. Yang, D.; Ng, F. F.; Li, Z. J.; Wu, Y. D.; Chan, K. W. K.; Wang, D. P. An unusual turn 
structure in peptides containing alpha-aminoxy acids. J. Am. Chem. Soc. 1996, 118, 
9794-9795. 
72. Yang, D.; Qu, J.; Li, B.; Ng, F. F.; Wang, X. C.; Cheung, K. K.; Wang, D. P.; Wu, Y. D. 
Novel turns and helices in peptides of chiral alpha-aminoxy acids. J. Am. Chem. Soc. 
1999, 121, 589-590. 
73. Yang, D.; Li, B.; Ng, F. F.; Yan, Y. L.; Qu, J.; Wu, Y. D. Synthesis and characterization 
of chiral N-O turns induced by alpha-aminoxy acids. J. Org. Chem. 2001, 66, 7303-7312. 
74. Yang, D.; Qu, J.; Li, W.; Wang, D. P.; Ren, Y.; Wu, Y. D. A reverse turn structure 
induced by a D,L-alpha-aminoxy acid dimer. J. Am. Chem. Soc. 2003, 125, 14452-14457. 
212 
75. Yang, D.; Qu, J.; Li, W.; Zhang, Y. H.; Ren, Y.; Wang, D. P.; Wu, Y. D. Cyclic 
hexapeptide of D,L-alpha-aminoxy acids as a selective receptor for chloride ion. J. Am. 
Chem. Soc. 2002, 124, 12410-12411. 
76. Yang, D.; Li, X.; Sha, Y.; Wu, Y. D. A cyclic hexapeptide comprising alternating alpha-
aminoxy and alpha-amino acids is a selective chloride ion receptor. Chemistry-a 
European Journal 2005, 11, 3005-3009. 
77. Yang, D.; Li, X.; Fan, Y. F.; Zhang, D. W. Enantioselective recognition of carboxylates: 
A receptor derived from alpha-aminoxy acids functions as a chiral shift reagent for 
carboxylic acids. J. Am. Chem. Soc. 2005, 127, 7996-7997. 
78. Brown, N. J.; Czyzewski, A. M.; Steinhorn, D. M.; Barron, A. E. In Peptoid analogues of 
lung surfactant protein C, 2007; 2007; pp 432A-432A. 
79. Dohm, M. T.; Ivankin, A.; Brown, N. J.; Liu, C.; Gidalevitz, D.; Barron, A. E. In Insight 
into the effect of N-terminal alkylation on the in vitro, surface activity of mixed lipid films 
containing peptoid mimics of lung surfactant protein C, 2007; 2007; pp 252A-252A. 
80. Seurynck-Servoss, S. L.; Brown, N. J.; Dohm, M. T.; Wu, C. W.; Barron, A. E. Lipid 
composition greatly affects the in vitro surface activity of lung surfactant protein mimics. 
Colloids and Surfaces B-Biointerfaces 2007, 57, 37-55. 
81. Brown, N. J.; Johansson, J.; Barron, A. E. Biomimicry of Surfactant Protein C. Accounts 
of Chemical Research 2008, 41, 1409-1417. 
82. Brown, N. J.; Wu, C. W.; Seurynck-Servoss, S. L.; Barron, A. E. Effects of hydrophobic 
helix length and side chain chemistry on biomimicry in peptoid analogues of SP-C. 
Biochemistry 2008, 47, 1808-1818. 
83. Prince, R. B.; Saven, J. G.; Wolynes, P. G.; Moore, J. S. Cooperative conformational 
transitions in phenylene ethynylene oligomers: Chain-length dependence. J. Am. Chem. 
Soc. 1999, 121, 3114-3121. 
84. Heemstra, J. M.; Moore, J. S. Helix stabilization through pyridinium-pi interactions. 
Chemical Communications 2004, 1480-1481. 
85. Goto, K.; Moore, J. S. Sequence-specific binding of m-phenylene ethynylene foldamers 
to a piperazinium dihydrochloride salt. Org. Lett. 2005, 7, 1683-1686. 
86. Stone, M. T.; Moore, J. S. Supramolecular chelation based on folding. J. Am. Chem. Soc. 
2005, 127, 5928-5935. 
87. Brunsveld, L.; Meijer, E. W.; Prince, R. B.; Moore, J. S. Self-assembly of folded m-
phenylene ethynylene oligomers into helical columns. J. Am. Chem. Soc. 2001, 123, 
7978-7984. 
213 
88. Cary, J. M.; Moore, J. S. Hydrogen bond-stabilized helix formation of a m-phenylene 
ethynylene oligomer. Org. Lett. 2002, 4, 4663-4666. 
89. Kubel, C.; Mio, M. J.; Moore, J. S.; Martin, D. C. Molecular packing and morphology of 
oligo(m-phenylene ethynylene) foldamers. J. Am. Chem. Soc. 2002, 124, 8605-8610. 
90. Ray, C. R.; Moore, J. S., Supramolecular organization of foldable phenylene ethynylene 
oligomers. In Poly(Arylene Ethynylene)S: From Synthesis to Application, 2005; Vol. 177, 
pp 91-149. 
91. White, S. R.; Sottos, N. R.; Geubelle, P. H.; Moore, J. S.; Kessler, M. R.; Sriram, S. R.; 
Brown, E. N.; Viswanathan, S. Autonomic healing of polymer composites. Nature 2001, 
409, 794-797. 
92. Toohey, K. S.; Sottos, N. R.; Lewis, J. A.; Moore, J. S.; White, S. R. Self-healing 
materials with microvascular networks. Nature Materials 2007, 6, 581-585. 
93. Yang, J. L.; Keller, M. W.; Moore, J. S.; White, S. R.; Sottos, N. R. Microencapsulation 
of Isocyanates for Self-Healing Polymers. Macromolecules 2008, 41, 9650-9655. 
94. Yin, H.; Hamilton, A. D. Strategies for targeting protein-protein interactions with 
synthetic agents. Angewandte Chemie-International Edition 2005, 44, 4130-4163. 
95. Rodriguez, J. M.; Ross, N. T.; Katt, W. P.; Dhar, D.; Lee, G. I.; Hamilton, A. D. Structure 
and Function of Benzoylurea-Derived alpha-Helix Mimetics Targeting the Bcl-x(L)/Bak 
Binding Interface. Chemmedchem 2009, 4, 649-656. 
96. Yin, H.; Lee, G. I.; Park, H. S.; Payne, G. A.; Rodriguez, J. M.; Sebti, S. M.; Hamilton, 
A. D. Terphenyl-based helical mimetics that disrupt the p53/HDM2 interaction. 
Angewandte Chemie-International Edition 2005, 44, 2704-2707. 
97. Fletcher, S.; Hamilton, A. D. Targeting protein-protein interactions by rational design: 
mimicry of protein surfaces. Journal of the Royal Society Interface 2006, 3, 215-233. 
98. Saraogi, I.; Hamilton, A. D. alpha-Helix mimetics as inhibitors of protein-protein 
interactions. Biochemical Society Transactions 2008, 36, 1414-1417. 
99. Saraogi, I.; Hamilton, A. D. Recent advances in the development of aryl-based foldamers. 
Chem. Soc. Rev. 2009, 38, 1726-1743. 
100. Turkson, J.; Ryan, D.; Kim, J. S.; Zhang, Y.; Chen, Z.; Haura, E.; Laudano, A.; Sebti, S.; 
Hamilton, A. D.; Jove, R. Phosphotyrosyl peptides block Stat3-mediated DNA binding 
activity, gene regulation, and cell transformation. Journal of Biological Chemistry 2001, 
276, 45443-45455. 
101. Sun, J. Z.; Blaskovich, M. A.; Jain, R. K.; Delarue, F.; Paris, D.; Brem, S.; Wotoczek-
Obadia, M.; Lin, Q.; Coppola, D.; Choi, K. H.; Mullan, M.; Hamilton, A. D.; Sebti, S. M. 
Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that 
214 
inhibits binding of vascular endothelial growth factor to its receptor. Cancer Research 
2004, 64, 3586-3592. 
102. Sun, J. Z.; Wang, D. A.; Jain, R. K.; Carie, A.; Paquette, S.; Ennis, E.; Blaskovich, M. A.; 
Baldini, L.; Coppola, D.; Hamilton, A. D.; Sebti, S. M. Inhibiting angiogenesis and 
tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to 
their receptors. Oncogene 2005, 24, 4701-4709. 
103. Kim, U. I.; Suk, J. M.; Naidu, V. R.; Jeong, K. S. Folding and Anion-Binding Properties 
of Fluorescent Oligoindole Foldamers. Chemistry-a European Journal 2008, 14, 11406-
11414. 
104. Gong, B. Crescent oligoamides: From acyclic "macrocycles" to folding nanotubes. 
Chemistry-a European Journal 2001, 7, 4336-4342. 
105. Gong, B. Hollow Crescents, Helices, and Macrocycles from Enforced Folding and 
Folding-Assisted Macrocyclization. Accounts of Chemical Research 2008, 41, 1376-
1386. 
106. Helsel, A. J.; Brown, A. L.; Yamato, K.; Feng, W.; Yuan, L. H.; Clements, A. J.; 
Harding, S. V.; Szabo, G.; Shao, Z. F.; Gong, B. Highly Conducting Transmembrane 
Pores Formed by Aromatic Oligoamide Macrocycles. J. Am. Chem. Soc. 2008, 130, 
15784-+. 
107. Frackenpohl, J.; Arvidsson, P. I.; Schreiber, J. V.; Seebach, D. The outstanding biological 
stability of beta- and gamma-peptides toward proteolytic enzymes: An in vitro 
investigation with fifteen peptidases. Chembiochem 2001, 2, 445-455. 
108. Levins, C. G.; Schafmeister, C. E. The Synthesis of Functionalized Nanoscale Molecular 
Rods of Defined Length. J. Am. Chem. Soc. 2003, 125, 4702-4703. 
109. Levins, C. G.; Schafmeister, C. E. The Synthesis of Curved and Linear Structures from a 
Minimal Set of Monomers. J. Org. Chem. 2005, 70, 9002-9008. 
110. Levins, C. G.; Brown, Z. Z.; Schafmeister, C. E. Maximizing the Stereochemical 
Diversity of Spiro-Ladder Oligomers. Org. Lett. 2006, 8, 2807-2810. 
111. Habay, S. A.; Schafmeister, C. E. Synthesis of a bis-amino acid that creates a sharp turn. 
Org. Lett. 2004, 6, 3369-3371. 
112. Gupta, S.; Das, B. C.; Schafmeister, C. E. Synthesis of a Pipecolic Acid-Based Bis-amino 
Acid and Its Assembly into a Spiro Ladder Oligomer. Org. Lett. 2005, 7, 2861-2864. 
113. Gupta, S.; Macala, M.; Schafmeister, C. E. Synthesis of structurally diverse bis-peptide 
oligomers. J. Org. Chem. 2006, 71, 8691-8695. 
114. Gupta, S.; Schafmeister, C. E. Synthesis of a Carboxylate Functionalized Bis-Amino acid 
Monomer. J. Org. Chem. 2009, 74, 3652-3658. 
215 
115. Tanaka, H.; Kuroda, A.; Marusawa, H.; Hatanaka, H.; Kino, T.; Goto, T.; Hashimoto, M.; 
Taga, T. Structure of FK506, a novel immunosuppressant isolated from Streptomyces. J. 
Am. Chem. Soc. 1987, 109, 5031-3. 
116. Rosen, M. K.; Standaert, R. F.; Galat, A.; Nakatsuka, M.; Schreiber, S. L. Inhibition of 
FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate. Science 
(Washington, D. C., 1883-) 1990, 248, 863-6. 
117. Emmer, G.; Grassberger, M. A.; Meingassner, J. G.; Schulz, G.; Schaude, M. Derivatives 
of a Novel Cyclopeptolide. 1. Synthesis, Antifungal Activity, and Structure-Activity 
Relationships. J. Med. Chem. 1994, 37, 1908-17. 
118. Boger, D. L.; Chen, J.-H.; Saionz, K. W. (-)-Sandramycin: Total Synthesis and 
Characterization of DNA Binding Properties. J. Am. Chem. Soc. 1996, 118, 1629-44. 
119. Gupta, S.; Krasnoff, S. B.; Roberts, D. W.; Renwick, J. A. A.; Brinen, L. S.; Clardy, J. 
Structures of the efrapeptins: potent inhibitors of mitochondrial ATPase from the fungus 
Tolypocladium niveum. J. Am. Chem. Soc. 1991, 113, 707-9. 
120. Toniolo, C. Conformationally restricted peptides through short-range cyclizations. Int. J. 
Pept. Protein Res. 1990, 35, 287-300. 
121. Genin, M. J.; Gleason, W. B.; Johnson, R. L. Design, synthesis, and x-ray 
crystallographic analysis of two novel spirolactam systems as beta -turn mimics. J. Org. 
Chem. 1993, 58, 860-6. 
122. Matsoukas, J. M.; Agelis, G.; Hondrelis, J.; Yamdagni, R.; Wu, Q.; Ganter, R.; Moore, 
D.; Moore, G. J.; Smith, J. R. Synthesis and biological activities of angiotensin II, 
sarilesin, and sarmesin analogs containing Aze or Pip at position 7. J. Med. Chem. 1993, 
36, 904-11. 
123. Copeland, T. D.; Wondrak, E. M.; Tozser, J.; Roberts, M. M.; Oroszlan, S. Substitution 
of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV 
proteinase into a selective inhibitor. Biochem. Biophys. Res. Commun. 1990, 169, 310-14. 
124. Tsuda, Y.; Cygler, M.; Gibbs, B. F.; Pedyczak, A.; Fethiere, J.; Yue, S. Y.; Konishi, Y. 
Design of Potent Bivalent Thrombin Inhibitors Based on Hirudin Sequence: 
Incorporation of Nonsubstrate-Type Active Site Inhibitors. Biochemistry 1994, 33, 
14443-51. 
125. Toniolo, C.; Bardi, R.; Piazzesi, A. M.; Crisma, M.; Balaram, P.; Sukumar, M.; Paul, P. 
K. C. Preferred conformations of pipecolic acid-containing peptides. Pept., Proc. Eur. 
Pept. Symp., 20th 1989, 477-9. 
126. Didierjean, C.; Aubry, A.; Wyckaert, F.; Boussard, G. Structural features of the 
Pip/AzPip couple in the crystalline state: influence of the relative AzPip location in an 
aza dipeptide sequence upon the induced chirality and conformational characteristics. J. 
Pept. Res. 2000, 55, 308-317. 
216 
127. Jhon, J. S.; Kang, Y. K. Conformational Preferences of Proline Analogues with Different 
Ring Size. J. Phys. Chem. B 2007, 111, 3496-3507. 
128. Cowell, G. W.; Ledwith, A. Developments in the chemistry of diazo-alkanes. Quart. 
Rev., Chem. Soc. 1970, 24, 119-67. 
129. Gutsche, C. D. The reaction of diazomethane and its derivatives with aldehydes and 
ketones. Org. React. 1954, 364-429. 
130. Hashimoto, N.; Aoyama, T.; Shioiri, T. New methods and reagents in organic synthesis. 
10. Trimethylsilyldiazomethane(TMSCHN2). A new, stable, and safe reagent for the 
homologation of ketones. Tetrahedron Lett. 1980, 21, 4619-22. 
131. Krow, G. R. One carbon ring expansions of bridged bicyclic ketones. Tetrahedron 1987, 
43, 3-38. 
132. Maruoka, K.; Concepcion, A. B.; Yamamoto, H. Selective homologation of ketones and 
aldehydes with diazoalkanes promoted by organoaluminum reagents. Synthesis 1994, 
1283-90. 
133. Maruoka, K.; Concepcion, A. B.; Yamamoto, H. Organoaluminum-Promoted 
Homologation of Ketones with Diazoalkanes. J. Org. Chem. 1994, 59, 4725-6. 
134. Bolin, D. R.; Sytwu, I. I.; Humiec, F.; Meienhofer, J. Preparation of oligomer-free 
Nalpha -Fmoc and Nalpha -urethane amino acids. Int. J. Pept. Protein Res. 1989, 33, 
353-9. 
135. Patchett, A. A.; Witkop, B. Hydroxyproline. J. Am. Chem. Soc. 1957, 79, 185-92. 
136. Anderson, G. W.; Callahan, F. M. tert-Butyl esters of amino acids and peptides and their 
use in peptide synthesis. J. Am. Chem. Soc. 1960, 82, 3359-63. 
137. Pellicciari, R.; Natalini, B.; Luneia, R.; Marinozzi, M.; Roberti, M.; Rosato, G. C.; 
Sadeghpour, B. M.; Synyder, J. P.; Monahan, J. B.; Moroni, F. Enantioselective synthesis 
of naturally occurring trans-4-hydroxy-S-pipecolic acid-4-sulfate, a new potent and 
selective NMDA receptor agonist. Med. Chem. Res. 1992, 2, 491-6. 
138. Liu, H. J.; Ogino, T. New approach to the synthesis of hydrindanonecarboxylates. 
Tetrahedron Lett. 1973, 4937-40. 
139. Marchand, A. P.; Rajapaksa, D.; Reddy, S. P.; Watson, W. H.; Nagl, A. Tieffeneau-
Demjanov ring homologations of two pentacyclo[5.4.0.02,6.03,10.05,9]undecane-8,11-
diones. J. Org. Chem. 1989, 54, 5086-9. 
140. Tai, W. T.; Warnhoff, E. W. beta -Oxo esters from reaction of ethyl diazoacetate with 
ketones. Can. J. Chem. 1964, 42, 1333-40. 
217 
141. Krapcho, A. P.; Glynn, G. A.; Grenon, B. J. The decarbethoxylation of geminal 
dicarbethoxy compounds. Tetrahedron Lett. 1967, 8, 215-219. 
142. Bucherer, H. T.; Fischbeck, H. Hexahydrodiphenylamine and its Derivatives. J. Prakt. 
Chem. 1934, 140, 69-89. 
143. Bucherer, H. T.; Steiner, W. Syntheses of Hydantoins. I. Reactions of α-Oxy and α-
Amino Nitriles. J. Prakt. Chem. 1934, 140, 129-50. 
144. Ferguson, D. M.; Raber, D. J. A new approach to probing conformational space with 
molecular mechanics: random incremental pulse search. J. Am. Chem. Soc. 1989, 111, 
4371-8. 
145. Cornell, W. D.; Cieplak, P.; Bayly, C. I.; Gould, I. R.; Merz, K. M., Jr.; Ferguson, D. M.; 
Spellmeyer, D. C.; Fox, T.; Caldwell, J. W.; Kollman, P. A. A Second Generation Force 
Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules. J. Am. 
Chem. Soc. 1995, 117, 5179-97. 
146. MOE. 2005.06 ed.; Chemical Computing Group, Inc.: Montreal, Canada 2005. 
147. Kubik, S.; Meissner, R. S.; Rebek, J., Jr. Synthesis of alpha ,alpha -dialkylated amino 
acids with adenine or thymine residues. A new mild and facile hydrolysis of hydantoins. 
Tetrahedron Lett. 1994, 35, 6635-8. 
148. Rink, H. Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-
methyl ester resin. Tetrahedron Lett. 1987, 28, 3787-90. 
149. Carpino, L. A. 1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive. J. 
Am. Chem. Soc. 1993, 115, 4397-8. 
150. Bernatowicz, M. S.; Daniels, S. B.; Koster, H. A comparison of acid-labile linkage agents 
for the synthesis of peptide C-terminal amides. Tetrahedron Lett. 1989, 30, 4645-8. 
151. Ciufolini, M. A.; Rivera-Fortin, M. A.; Zuzukin, V.; Whitmire, K. H. Origin of 
Regioselectivity in Paterno-Buechi Reactions of Benzoquinones with 
Alkylidenecycloalkanes. J. Am. Chem. Soc. 1994, 116, 1272-7. 
152. Bunnett, J. F.; Cartano, A. V. Differing Behavior of Pyrrolidine and Piperidine as 
Nucleophiles toward 2,4-Dinitrophenyl and 2,4-Dinitro-6-methylphenyl Ethers. J. Am. 
Chem. Soc. 1981, 103, 4861-4865. 
153. Zhang, F.; Peng, Y.; Liao, S.; Gong, Y. Pyrrolidine as an efficient organocatalyst for 
direct aldol reaction of trifluoroactealdehyde ethyl hemiacetal with ketones. Tetrahedron 
2007, 63, 4636-4641. 
154. Carey, F. A.; Sundberg, R. J., Advanced Organic Chemistry, Part-A: Structure and 
Mechanism. 4th ed.; Kluwer Academics: New York, 2000; p 4636-4641. 
218 
155. Ciufolini, M. A.; Xi, N. Synthesis, chemistry and conformational properties of piperazic 
acids. Chem. Soc. Rev. 1998, 27, 437-445. 
156. Albericio, F.; Chinchilla, R.; Dodsworth, D. J.; Najera, C. New trends in peptide coupling 
reagents. Org. Prep. Proced. Int. 2001, 33, 203-303. 
157. Elmore, D. T. Peptide synthesis. Amino Acids, Pept., Proteins 2002, 33, 83-134. 
158. Knorr, R.; Trzeciak, A.; Bannwarth, W.; Gillessen, D. New coupling reagents in peptide 
chemistry. Tetrahedron Lett. 1989, 30, 1927-30. 
159. Dourtoglou, V.; Ziegler, J. C.; Gross, B. O-Benzotriazolyl-N,N-tetramethyluronium 
hexafluorophosphate: a new and effective reagent for peptide coupling. Tetrahedron Lett. 
1978, 1269-72. 
160. Sheehan, J. C.; Hess, G. P. A new method of forming peptide bonds. J. Am. Chem. Soc. 
1955, 77, 1067-8. 
161. Izdebski, J.; Pachulska, M.; Orlowska, A. N-cyclohexyl-N'-isopropylcarbodiimide: a 
hybrid that combines the structural features of DCC and DIC. Int J Pept Protein Res 
1994, 44, 414-9. 
162. Olah, G. A.; Nojima, M.; Kerekes, I. Synthetic methods and reactions. IV. Fluorination of 
carboxylic acids with cyanuric fluoride. Synthesis 1973, 487-8. 
163. Anderson, G. W.; Zimmerman, J. E.; Callahan, F. M. N-Hydroxysuccinimide esters in 
peptide synthesis. J. Am. Chem. Soc. 1963, 85, 3039. 
164. Bodanszky, M. Synthesis of peptides by aminolysis of nitrophenyl esters. Nature 1955, 
175, 685. 
165. Dondoni, A.; Franco, S.; Junquera, F.; Merchan, F. L.; Merino, P.; Tejero, T. 
Applications of Sugar Nitrones in Synthesis: The Total Synthesis of (+)-Polyoxin J. J. 
Org. Chem. 1997, 62, 5497-5507. 
166. Goddard, T. D.; Kneller, D. G. SPARKY 3 version 3.111. University of California, San 
Fransisco: 2004. 
167. Sheehan, J. C.; Preston, J.; Cruickshank, P. A. A Rapid Synthesis of Oligopeptide 
Derivatives without Isolation of Intermediates. J. Am. Chem. Soc. 1965, 87, 2492-2493. 
168. Falchi, A.; Giacomelli, G.; Porcheddu, A.; Taddei, M. 4-(4,6-Dimethoxy[1,3,5]triazin-2-
yl)-4-methylmorpholinium chloride (DMTMM): a valuable alternative to PyBOP for 
solid-phase peptide synthesis. Synlett 2000, 275-277. 
169. Fischer, P. M. Diketopiperazines in peptide and combinatorial chemistry. J. Pept. Sci. 
2003, 9, 9-35. 
219 
170. Dinsmore, C. J.; Beshore, D. C. Recent advances in the synthesis of diketopiperazines. 
Tetrahedron 2002, 58, 3297-3312. 
171. Gisin, B. F.; Merrifield, R. B. Carboxyl-catalyzed intramolecular aminolysis. Side 
reaction in solid-phase peptide synthesis. J. Am. Chem. Soc. 1972, 94, 3102-6. 
172. Gund, P.; Veber, D. F. Ease of base-catalyzed epimerization of N-methylated peptides 
and diketopiperazines. J. Am. Chem. Soc. 1979, 101, 1885-7. 
173. Fife, T. H.; DeMark, B. R. Intramolecular nucleophilic aminolysis of aliphatic esters. 
Cyclization of methyl 2-aminomethylbenzoate to phthalimidine. J. Am. Chem. Soc. 1976, 
98, 6978-82. 
174. Fife, T. H.; Chauffe, L. General Base and General Acid Catalyzed Intramolecular 
Aminolysis of Esters. Cyclization of Esters of Esters of 2-Aminomethylbenzoic Acid to 
Phthalimidine. J. Org. Chem. 2000, 65, 3579-3586. 
175. Rony, P. R. Polyfunctional catalysis. III. Tautomeric catalysis. J. Am. Chem. Soc. 1969, 
91, 6090-6. 
176. Nakamizo, N. Catalysis in peptide synthesis with active esters. I. Bifunctional catalysis in 
the aminolysis of benzyloxycarbonyl-L-phenylalanine p-nitrophenyl ester in dioxane. 
Bull. Chem. Soc. Jap. 1969, 42, 1071-7. 
177. Robins, M. J.; Sarker, S.; Xie, M.; Zhang, W.; Peterson, M. A. Nucleic acid related 
compounds. 90. Synthesis of 2',3'-fused (3.3.0) gamma -butyrolactone-nucleosides and 
coupling with amino-nucleosides to give amide-linked nucleotide-dimer analogs. 
Tetrahedron Lett. 1996, 37, 3921-3924. 
178. Openshaw, H. T.; Whittaker, N. The synthesis of emetine and related compounds. VII. 
The utility of Bi-functional catalysts in amine-ester interactions. J Chem Soc [Perkin 1] 
1969, 1, 89-91. 
179. Cossy, J.; Thellend, A. A 4-dimethylaminopyridine-catalyzed aminolysis of beta -keto 
esters. Formation of beta -keto amides. Synthesis 1989, 753-5. 
180. Melander, C.; Horne, D. A. Kinetic Analysis of Ester Aminolysis Catalyzed by 
Nucleosides in a Nonpolar Medium. Evidence of Bifunctional Catalysis. J. Org. Chem. 
1997, 62, 9295-9297. 
181. Hogberg, T.; Strom, P.; Ebner, M.; Ramsby, S. Cyanide as an Efficient and Mild Catalyst 
in the Aminolysis of Esters. J. Org. Chem. 1987, 52, 2033-2036. 
182. Ivanova, G.; Bratovanova, E.; Petkov, D. Catechol as a Nucleophilic Catalyst of Peptide 
Bond Formation. Journal of Peptide Science 2002, 8, 8-12. 
183. Wasserman, H. H.; Robinson, R. P.; Carter, C. G. Total synthesis of (+-)-chaenorhine. J. 
Am. Chem. Soc. 1983, 105, 1697-8. 
220 
184. Sakaitani, M.; Hori, K.; Ohfune, Y. One-pot conversion of the N-(benzyloxy)carbonyl 
group into an N-(tert-butoxycarbonyl) group. Tetrahedron Lett. 1988, 29, 2983-4. 
185. Matsueda, G. R.; Stewart, J. M. A p-methylbenzhydrylamine resin for improved solid-
phase synthesis of peptide amides. Peptides 1981, 2, 45-50. 
186. Gallant, M.; Phan Viet Minh, T.; Wuest, J. D. Hydrogen-bonded dimers. Direct study of 
the interconversion of pyridone dimers and hydroxypyridine monomers by low-
temperature nuclear magnetic resonance spectroscopy. J. Am. Chem. Soc. 1991, 113, 721-
3. 
187. Capasso, S.; Mazzarella, L. Activation of diketopiperazine formation by alkylammonium 
carboxylate salts and aprotic dipolar protophobic solvents. Peptides 1998, 19, 389-391. 
188. Giralt, E.; Pedroso, E.; Eritja, R. Diketopiperazine formation in acetamido- and 
Nitrobenzamido bridged polymeric supports. Tetrahedron Lett. 1986, 22, 3779-3782. 
189. Menger, F. M.; Smith, J. H. Mechanism of ester aminolyses in aprotic solvents. J. Am. 
Chem. Soc. 1972, 94, 3824-9. 
190. Menger, F. M.; Vitale, A. C. Anion-catalyzed ester aminolyses in a hydrocarbon solvent. 
J. Am. Chem. Soc. 1973, 95, 4931-4. 
191. Goldwasser, J. M.; Leznoff, C. C. The use of polymer supports in organic synthesis. Part 
XVI. The solid phase synthesis of monoester monoamides and monoester monoalcohols 
from symmetrical diacid chlorides. Can. J. Chem. 1978, 56, 1562-8. 
192. Goodman, C. M.; Choi, S.; Shandler, S.; DeGrado, W. F. Foldamers as versatile 
frameworks for the design and evolution of function. Nat. Chem. Biol. 2007, 3, 252-262. 
193. Karlsson, A. J.; Pomerantz, W. C.; Weisblum, B.; Gellman, S. H. Antifungal activity 
from 14-helical beta-peptides. J. Am. Chem. Soc. 2006, 128, 12630-12631. 
194. Epand, R. M.; Raguse, T. L.; Gellman, S. H.; Epand, R. M. Antimicrobial 14-helical β-
peptides: Potent bilayer disrupting agents. Biochemistry 2004, 43, 9527-9535. 
195. Werder, M.; Hauser, H.; Abele, S.; Seebach, D. β-peptides as inhibitors of small 
intestinal cholestoral and fat absorption. Helv. Chim. Acta 1999, 82, 1774-1783. 
196. Seurynck-Servoss, S. L.; Brown, N. J.; Dohm, M. T.; Wu, C. W.; Barron, A. E. Lipid 
composition greatly affects the in vitro surface activity of lung surfuctant protein mimics. 
Colloids Surf. B: Biointerfaces 2007, 57, 37-55. 
197. Patch, J. A.; Barron, A. E. Helical Peptoid Mimics of Magainin-2 amide. J. Am. Chem. 
Soc. 2003, 125, 12092-12093. 
198. Prince, R. B.; Barnes, S. A.; Moore, J. S. Foldamers Based Molecular Recognition. J. 
Am. Chem. Soc. 2000, 122, 2758-2762. 
221 
199. Schafmeister, C. E.; Belasco, L. G.; Brown, P. H. Observation of Contraction and 
Expansion in a Bis(peptide)-Based Mechanical Molecular Actuator. Chem. Eur. J. 2008, 
14, 6406-6412. 
200. Schafmeister, C. E.; Brown, Z. Z.; Gupta, S. Shape-Programmable Macromolecules. Acc. 
Chem. Res. 2008, 41, 1387-1398. 
201. Polgár, L. The catalytic triad of serine peptidases. Cellular and Molecular Life Sciences 
2005, 62, 2161. 
202. Peris, G.; Jakobsche, C. E.; Miller, S. J. Aspartate-Catalyzed Asymmetric Epoxidation 
Reactions. J. Am. Chem. Soc. 2007, 129, 8710-8711. 
203. Jakobsche, C. E.; Peris, G.; Miller, S. J. Functional analysis of an aspartate-based 
epoxidation catalyst with amide-to-alkene peptidomimetic catalyst analogues. Angew. 
Chem. Int. Ed. 2008, 47, 6707-6711. 
204. Whitesell, J. K.; Whitesell, M. A. Alkylation of ketones and aldehydes via their nitrogen 
derivatives. Synthesis 1983, 517. 
205. Garst, M. E.; Bonfiglio, J. N.; Grudoski, D. A.; Marks, J. Specific Enolates from α-
Amino ketones. J. Org. Chem. 1980, 45, 2307-2315. 
206. Sharma, R.; Lubell, W. D. Regioselective Enolization and Alkylation of 4-Oxo-N-(9-
phenylfluoren-9-yl)proline: Synthesis of Enantiopure Proline-Valine and 
Hydroxyproline-Valine Chimeras. J. Org. Chem. 1996, 61, 202-209. 
207. Lubell, W. D.; Jamison, T. F.; Rapoport, H. N-(9-phenylfluoren-9-yl)-.alpha.-amino 
ketones and N-(9-phenylfluoren-9-yl)-.alpha.-amino aldehydes as chiral educts for the 
synthesis of optically pure 4-alkyl-3-hydroxy-2-amino acids. Synthesis of the C-9 amino 
acid MeBmt present in cyclosporin. J. Org. Chem. 1990, 55, 3511-3522. 
208. Lubell, W.; Rapoport, H. Surrogates for chiral aminomalondialdehyde. Synthesis of N-
(9-phenylfluoren-9-yl)serinal and N-(9-phenylfluoren-9-yl)vinylglycinal. J. Org. Chem. 
1989, 54, 3824-3831. 
209. Lubell, W. D.; Rapoport, H. .alpha.-Amino acids as chiral educts for asymmetric 
products. Alkylation of N-phenylfluorenyl .alpha.-amino ketones. Synthesis of optically 
pure .alpha.-alkyl carboxylic acids. J. Am. Chem. Soc. 1988, 110, 7447-7455. 
210. Lubell, W. D.; Rapoport, H. Configurational stability of N-protected .alpha.-amino 
aldehydes. J. Am. Chem. Soc. 1987, 109, 236-239. 
211. Webb, T. R.; Eigenbrot, C. Conformationally restricted arginine analogs. J. Org. Chem. 
1991, 56, 3009-3016. 
212. Atfani, M.; Lubell, W. D. Synthesis of (S)-2-Amino-3-(3-tert-butyl-5-oxo-2H-isoxazol-4-
yl)propionic Acid. J. Org. Chem. 1995, 60, 3184-3188. 
222 
213. Mancuso, A. J.; Huang, S.-L.; Swern, D. Oxidation of long-chain and related alcohols to 
carbonyls by dimethyl sulfoxide "activated" by oxalyl chloride. J. Org. Chem. 1978, 43, 
2480-2482. 
214. Poisson, J. F.; Orellana, A.; Greene, A. E. Stereocontrolled Synthesis of (-)-Kainic Acid 
from trans-4-Hydroxy-L-proline. J. Org. Chem. 2005, 70, 10860-10863. 
215. Blanco, M. J.; Paleo, M. R.; Penide, C.; Sardina, F. J. Stereoselective Reactions of N-(9-
Phenylfluoren-9-yl)-4-oxoproline Enolates. An Expedient Route for the Preparation of 
Conformationally Restricted Amino Acid Analogues. J. Org. Chem. 1999, 64, 8786-
8793. 
216. Corey, E. J.; Link, J. O. A general, catalytic, and enantioselective synthesis of .alpha.-
amino acids. J. Am. Chem. Soc. 1992, 114, 1906-1908. 
217. Jocic, Z. Z. Zh. Russ. Fiz. Khim. Ova. 1897, 29, 97. 
218. Dominguez, C.; Ezquerra, J.; Baker, S. R.; Borrelly, S.; Prieto, L.; Espada, M.; Pedregal, 
C. Enantiospecific synthesis of (1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2,6-
dicarboxylic acid by a modified Corey-Link reaction Tetrahedron Lett. 1998, 39, 9305. 
219. Barlos, K.; Gatos, D.; Schäfer, W. Synthesis of Prothymosinα (ProTα)—a Protein 
Consisting of 109 Amino Acid Residues. Angew. Chem., Int. Ed. Eng. 1991, 30, 590. 
220. Brown, Z. Z.; Schafmeister, C. E. Exploiting an Inherent Neighboring Group Effect of 
α;-Amino Acids To Synthesize Extremely Hindered Dipeptides. J. Am. Chem. Soc. 2008, 
130, 14382-14383. 
221. Spivey A. C., M. A. Asymmetric catalysis of acyl transfer by Lewis acids and 
nucleophiles. Org. Prep. Proc. Int. 2000, 32, 331-365. 
222. Copeland, G. T.; Miller, S. J. A Chemosensor based approach to catalyst discovery in 
solution and on solid support. J. Am. Chem. Soc. 1999, 121, 4306-4307. 
223. Copeland, G. T.; Miller, S. J. Selection of enantioselective acyl transfer catalysts from a 
pooled library through a fluorescence-based activity assay: an approach to kinetic 
resolution of secondary alcohols of broad structural scope. J. Am. Chem. Soc. 2001, 123, 
6496-6502. 
224. Collman, J. P.; Zhong, M.; Costanzo, S.; Zhang, C. New Imidazole-Based Tripodal 
Ligands as CuB Site Mimics of Cytochrome c Oxidase. J. Org. Chem. 2001, 66, 8252-
8256. 
225. Dener, J. M.; Zhang, L. H.; Rapoport, H. An effective chirospecific synthesis of (+)-
pilocarpine from L-aspartic acid. J. Org. Chem. 1993, 58, 1159-1166. 
 
 
